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Abstract 
During spermatogenesis histones must be degraded in late round and early 
elongating spermatids to permit chromatin condensation. Ubiquitin conjugation is 
activated and histones are ubiquitinated at this stage, suggesting that histone 
degradation may be mediated by ubiquitination. The activation of ubiquitin 
conjugation during spermatogenesis is dependent on the ubiquitin conjugating 
enzyme (E2) UBC4. We therefore studied whether histones are ubiquitinated by a 
UBC4 dependent ubiquitin protein ligase (E3) during spermatogenesis. E3Histone was 
identified by a biochemical screen and purified to near homogeneity. Mass 
spectrometry identified E3Histone as LASUl, a 482 kDa HECT domain protein and 
E3Histone conjugates ubiquitin to an core histones in vitro. UBC4-1 and UBC4-testis 
were the preferred E2s for E3Histone -dependent ubiquitination of histones. E3Histone 
was the major UBC4-1 dependent histone ubiquitinating E3 in testis. Anti-LASUI 
antibody immunodepleted E3Histone activity. Immunohistochemistry showed that 
E3Histone /LASUI was predominantly expressed in nuclei from spermatogonia to 
mid-pachytene cens, but not detectable in spermatids. Histones are also 
ubiquitinated in spermatocytes. E3Histone /LASUI was widely expressed in different 
mouse tissues. It was mainly expressed in the cytoplasm in most tissues, except in 
neurons of the brain and in early germ cens of the testis where it was expressed in the 
nucleus. In most tissues, E3Histone /LASUI was expressed in epithelia. The wide 
expression of E3Histone /LASUI suggests the existence of substrates of this E3 other 
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than histones. Indeed, our assays showed that in vitro purified E3Histone stimulates 
polyubiquitination of Mel-l, a BH3 region containing antiapoptotic proteine E3Histone 
May therefore regulate ceU apoptosis by mediating degradation of Mcl-l. Since 
E3Histone ILASUI was found previously to affect gene transcription and histone 
monoubiquitination is known to regulate gene transcription, we also evaluated the 
role of E3Histone ILASUI in histone ubiquitination in somatic cells. Depletion of 
E3Histone ILASUI protein by siRNA did not affect the levels of free or ubiquitinated 
histones. In summary, E3Histone ILASUI is a novel multi-functional protein that May 
Mediate histone ubiquitination during meiosis and May be involved in apoptosis by 
triggering Mcl-l degradation. Its wide expression and large non-catalytic region 
indicate that there are likely Many other substrates of E3Histone ILASUI. 
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Résumé 
Durant la spermatogenèse, les histones doivent être dégradées aux derniers 
stades de différentiation des spermatides ronds et les premiers stades des 
spermatides en allongement afin de permettre la condensation de la chromatine. 
L'activation de la conjugaison de l'ubiquitine et l'ubiquitination des histones se 
produisant au cours de cette période, suggèrent que la dégradation des histones 
pourait être entraînée par l'ubiquitination. La conjugaison de l'ubiquitine durant 
la spermatogénèse est dépendante de UBC4, une enzyme de conjugaison de 
l'ubiquitine (E2). Nous avons donc tenté de déterminer si les histones sont 
ubiquitinées par une ligase d'ubiquitine (E3) dépendante d'UBC4, durant la 
spermatogénèse. Une E3Histone a été identifiée par un criblage biochimique et 
purifiée presque à homogénéité. La spectrométrie de masse a permis d'identifier 
cette E3Histone comme étant la protéine LASUl, une protéine de 42kDa comportant 
un domaine HECT. De plus, la protéine E3Histone conjugue l'ubiquitine à toutes les 
histones, in vitro. UBC4-1 et UBC4-testis sont les E2 de préférence pour l'activité 
de liaison de l'ubiquitine aux histones dépendante de la protéine E3Histone tandis que 
E3Histone est la principale E3 impliquée dans l'ubiquitination des histones dépendante 
de UBC4-1 dans les testicules. L'anticorps contre LASUI permet 
l'immuno-suppression de l'activité E3Histone. Les études d'immunohistochimie ont 
démontré que E3Histone ILASUI est exprimée de façon prédominante dans le noyau 
des cellules du stade de spermatogonies jusqu'au stade mi-pachytène mais n'est pas 
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détectée dans les spermatides. Les histones sont aussi ubiquitinées dans les 
spermatocytes. E3Histone ILASUI est largement exprimée dans düférent tissus 
murins. Elle est principalement exprimée dans le cytoplasme de presque tous les 
tissus à l'exception des neurones, du cerveau et des cellules germinales précoces des 
testicules où elle est exprimée dans le noyau. Dans la majorité des tissus, E3Histone 
ILASUI est exprimée dans l'épithélium. L'expression généralisée de E3Histone 
ILASUI suggère l'existence d'autres substrats que les histones pour cette E3. En 
effet, nos essais in vitro ont démontré que la protéine E3 purifiée peut stimuler la 
poly-ubiquitination de Mel-l, une protéine anti-apoptotique contenant un domaine 
BH3. E3Histone peut donc réguler l'apoptose des cellules en provoquant la 
dégradation de Mcl-l. Puisqu'il a déjà été démontré que E3Histone ILASUI affecte la 
transcription génique et que la mono-ubiquitination des histones est connue pour 
réguler la transcription génique, nous avons aussi évalué le rôle de E3Histone ILASUI 
dans l'ubiquitination des histones dans des cellules somatiques. La suppression de 
la protéine E3Histone ILASUI par ARN interférant n'a pas affecté le niveau d'histones 
ubiquitinées ou non-ubiquitinées. En résumé, E3Histone ILASUI est une nouvelle 
protéine multi-fonctionnelle qui peut entraîner l'ubiquitination des histones durant 
la méiose et qui peut être impliquée dans le processus d'apoptose en déclenchant la 
dégradation de Mcl-l. Son expression généralisé et la présence d'un grand 
domaine non-catalytique indiquent qu'il y a probablement plusieurs autres substrats 
pour E3Histone ILASUI. 
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Chapter 1. Introduction 
(Literature review) 
1.1. Spermatogenesis 
Spermatogenesis is a vital process leading to the formation of mature male gametes, 
the spermatozoa (Fig. 1). In this complex, but precisely regulated developmental process, 
stem cell spermatogonia are transformed into highly differentiated mature spermatids. 
This process can be divided into three phases: a proliferative or mitotic phase, a meiotic 
phase and the spermiogenic phase (Roosen-Runge 1977; Ewing, Davis et al. 1980; de 
Kretser, Loveland et al. 1998). 
In the first phase, the stem cell spermatogonia divide mitotically to produce 
proliferative spermatogonia, which further divide into differentiating spermatogonia 
(Clermont and Bustos-Obregon 1968; Huckins 1971; Ewing, Davis et al. 1980). 
Spermatogonia can be recognized on the bases of the spherical or oval nuclei, and their 
localization on the basement membrane of the seminiferous tubule. At the end of the 
proliferative phase, the most mature spermatogonia divide to form primary spermatocytes. 
The second phase is the meiotic phase in which the diploid number of chromosomes 
present in the primary spermatocytes are reduced to the haploid number present in 
spermatids. There are two sequential cell divisions in this phase. Cells in prophase of the 
fust meiotic division are located in the middle of the seminiferous epithelium and are 
characterized by highly condensed chromosomes (Russell 1977; Russell and Frank 1978; 
Russell 1978). Prophase of the first meiotic division is exceptionally long, lasting about 
three weeks. The size of the primary spermatocytes and their nuclei progressively 
increase during prophase (Russell and Frank 1978). Nuclear changes are the morphologic 
basis for subclassifying primary spermatocytes. In the transition from preleptotene to 
leptotene, nuclei gradually lose their peripheral chromatin and form condensed chromatin 
threads. Meiotic prophase begins in the leptotene cells. In zygotene cells, the chromatin 
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threads have progressed to chromosomes, which begin to pair in the synaptonemal 
complex. The chromosomes are fully paired in pachytene cells. Crossing over, the 
genetic recombination, occurs during this period, allowing germ cell chromosomes to 
possess a unique combination of genetic material distinct from that of the somatic cells of 
that animal. Pachytene cells become highly synthetic in the middle of their development 
(Monesi 1965) and grow rapidly in size (Russell and Frank 1978). The following 
diplotene phase is brief. In this phase, the synaptonemal complex dismisses, allowing 
chromosomal pairs to separate except at regions known as chiasmata. Diplotene cells are 
the large st germ cells. Diplotene is the last phase in the prophase of the tirst meiotic 
division. Subsequent metaphase, anaphase and telophase of the tirst meiotic division are 
completed rapidly. The tirst meiotic division results in secondary spermatocytes, which 
are short lived. The second meiotic division follows rapidly, generating haploid 
spermatids. 
The third phase of spermatogenesis is spermiogenesis, the process of remodeling 
haploid spermatids to form mature spermatozoa. In this process, round spermatids are 
transformed into elongating spermatids, during which the acrosome gradually forms and 
the flagellar apparatus develops. The volume of the spermatids is reduced to 
approximately 25% of its original size before sperm release (Sprando and Russell 1987). 
Mature spermatid loses almost aIl of its cytoplasm. The cytoplasmic fragments are 
phagocytosed by the adjacent Sertoli cells and transported within the cell to the base of 
the seminiferous tubule where they are digested (Kerr and de Kretser 1974). The nucleus 
also undergoes dramatic reduction in size. The volume of the mature spermatid is only 
about 5% of that of somatic cells (Sawada, Ochi et al. 1975). In mature spermatids, 
chromosomes are extremely compact. This is permitted by the substitution of histones by 
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Fig. 1 
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Fig. 1. Schematic representation of the various steps of 
spermatogenesis in the rat from type A spermatogonia 
(A) through type 8 spermatogonia (8) to spermatocytes 
(PL, preleptotene; L-Z, leptotene to zygotene; EP-MP, 
early to mid-pachytene; Di, diplotene) to spermatids 
(steps 3 to 19). The time (days after birth) of the first 
appearance of the germ cells is indicated. 
Discontinuous line shows the germ cells in which 
histones are degraded. 
transition proteins and in turn by protamines (Mills, Van et al. 1977; Meistrich 1989). 
The protamine of E. cirrhosa condenses spermiogenic chromatin in a pattern which 
comprises fibres with a progressively larger diameter and lamellae that finally undergo 
definitive coalescence (Gimenez-Bonafe, Ribes et al. 2002). Protamine is not just Arg 
and Lys rich protein. It is also Cys rich. The effective cross-linking of protamines by 
disulphide bonds is critical for chromatin condensation. The spermatozoa are released 
into the lumen of the seminiferous tubule. AlI these processes take place in the highly 
organized organ, testis. 
1.1.1. Organization of the testis 
The testis is covered by a tough fibrous capsule. Each testis is composed of two 
major compartments: an exocrine part (seminiferous tubules) and an endocrine part 
(interstitial compartment (interstitium)) (Russell 1990). The testis is divided into lobules 
by septa consisting of loose areolar connective tissue. Several seminiferous tubules are 
found in each lobule, and interstitial cells are found in the connective tissue septa 
surrounding the seminiferous tubules. The interstitial compartment contains the blood 
and the lymphatic glands. The most abundant cell type in the interstitium is the Leydig 
cell (Christensen 1975; Mori and Christensen 1980). The Leydig cell is the major source 
of the androgen, testosterone and various other steroids. This cell possesses abundant 
smooth endoplasmic reticulum and mitochondria with tubular cristae, both of which 
contain the enzymes associated with steroid synthesis. The macrophage is another cell 
type in the interstitium and accounts for about 25% of the cells in the interstitium 
(Christensen 1975). 
The seminiferous tubules are the exocrine portion of the testis producing and 
excreting spermatozoa (Russell, Saxena et al. 1989). The seminiferous tubules are 
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convoluted loops that have both ends connected into the beginning of the excurrent duct 
system (the rete testis) by the straight tubules (tubuli recti) (Fig. 2). The seminiferous 
tubules are lined by a stratified epithelium that consists ofthe developing germ cells and 
supporting cells (Sertoli cells). 
Sertoli cells are the somatic cells present amongst and in close contact with the germ 
cells within the seminiferous tubule (Vilar, Perez Del Cerro et al. 1962; Schulze 1974; 
Fawcett 1975). Sertoli cells are thought to provide structural and metabolic support to the 
developing germ cells. A single Sertoli cell extends from the basement membrane to the 
lumen of the seminiferous tubule. However, its cytoplasm at the distal end is difficult to 
distinguish at the light microscopic level. Sertoli cells are characterized by the presence 
of a vesicular, oval, basally positioned nucleus which contains a prominent nucleolus. 
They are endocrine cells which secrete the polypeptide hormone, inhibin. Inhibin acts at 
the level of the pituitary to reduce the secretion of follicle stimulating hormone, a 
glycoprotein gonadotropin that is critical for spermatogenesis. Sertoli cells are also 
hypothesized to deliver nutrients to germ cells such as lactate, which inhibits apoptosis of 
germ cells (Vilar, Perez Del Cerro et al. 1962; Mita and Hall 1982). In addition, Sertoli 
cells phagocytose germ cells that degenerate in the normal course of spermatogenesis or 
as the result of damage from sorne deleterious agent or condition. Furthermore, during 
spermiogenesis, Sertoli cells phagocytose tubulobulbar complexes, a testis specific actin-
based adherens junction type (Russell 1980; Russell 1993; Lin, Harman et al. 1997), 
resulting in elimination of cytoplasm (Russell and Clermont 1976) from the spermatid as 
well as elimination of the contacts between germ cells and Sertoli cells (Russell, Goh et 
al. 1988). Finally, the Sertoli cell also phagocytoses the large mass of discarded 
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Fig. 2 
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Russell LD, Ettlin RA, SinhaHikim AP, Clegg ED, Histological and Histopathological Evalution of the Testis, Cache River Press 
Fig. 2. The seminiferous tubule. Left panel, the course of 
one convoluted rat seminiferous tubule and its connections 
to the rete testis are shown. The tubule joins the rete at both 
ends. The tubule is convoluted; however, its straightened 
portions course primarily in the long axis of the testis. The 
cranial end of this tubule is nearer the surface of the testis 
than the caudal ends (Russell 1990). Right panel, stages of 
the seminiferous tubule. Roman numerals indicate the 
stages. Segments descend in order from the rete. When the 
end of the series is reached (stage 1), the series begins to 
descend from stage XIV again. The site of reversai marks 
the meeting place of two patterns of descent. 
cytoplasm and organelles (residual bodies) extruded from the spermatid (Kerr and de 
Kretser 1974). 
1.1.2. Stages ofspermatogenesis (cycles ofseminiferous epithelium) 
The stratified epithelium of the seminiferous tubules is composed of different stages 
of developing germ cells. A cell association or stage is a defined grouping of germ cell 
types at particular phases of development in cross sectioned tubules. Each cell type of the 
cell association is morphologically integrated with others in its developmental processes. 
Each cell association or stage has a constant germ cell composition. In rats, there are 
fourteen designated cell association or stages (Fig. 3). A complete series of changes in 
cell associations (stages) arranged in the logical sequence of developmental progression 
is called the cycle of the seminiferous epithelium. Many studies have been done on 
staging in the rat (Roosen-Runge and Giese11950; Leblond and Clermont 1952; Leblond 
and Clermont 1952; Clermont and Perey 1957; Clermont and Harvey 1965; Lalli 1972). 
The important criteria used to determine the stage of the cycle of the seminiferous 
epithelium in the rat are listed in Table 1. Spermatids are the cell type commonly used to 
classify stages of spermatogenesis because the less mature spermatids have the most 
easily recognizable morphological features. Changes in the acrosomal system of the 
spermatids and their nuclear shape are used to distinguish different spermatids, and 
thereby to determine the stages of spermatogenesis. 
1.1.3. Structure and function of acrosome 
The acrosome is a sac of secreted enzymes required for penetration of egg vestments. 
Acrosomal formation is a slow but continuous process that is not complete untillate 
spermatogenesis (Le blond and Clermont 1952; Lalli and Clermont 1981). Most immature 
rat spermatids contain no acrosome, but only a perinuclear Golgi apparatus. Shortly after 
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Table 1 
STAGE 
1 
II-III 
IV 
V 
VI 
vn 
VIII 
IX 
X 
XI 
XII 
XIII 
XIV 
Important Criteria Used to Determine the Stage of of tlte Cycle 
of the Seminiferous Epithelium in the Rat 
CRITERIA 
No acrosomal system is seen in spermatids by light microscopy; step 1 spennatids are smaller 
than 2° spennatocytes. 
The stage begins as the proacrosomal granules and/or acrosomal granule are flfSt seen. The 
acrosomal vesicle has not yet flattened sufficiently to form a hemisphere on the nuclear 
surface. 
The stage begins as the acrosomal vesicle fonns a hemisphete on the nuclear surface and ends 
before the angle subtended by the spreading acrosome (on the nuclear surface) becomes 40°. 
The angle subtended by the acrosome extends from 40° to a maximum of 95°. 
The angle subtended by the acrosome extends from greater than 95° to a maximum of 120°; 
elongate spennatids remain withiIl deep crypts of the Scrtoli ccu. 
Elongate spennatids move to the luminal aspect of the seminiferous epithelium and line the 
lumen; the angle subtended by the acrosome is greater than 120°; nuclei of round spermatids 
(acrosome intervening) have not yet made contact with the cell surface. 
Nuclei of step 8 spennatids make contact with the plasma membrane, but their shape is not yet 
distorted from round or slightly oval. 
The spennatid nucleus first becomes defonned from its round or ovoid shape, but a ventral 
angle has not formed. 
The spennatid shows a ventral angle, but no dorsal angle is yet seen. 
The spennatid elongates and shows a dorsal angle; the spermatid Mad displays a gently curved 
dorsal surface and bas not yet taken on a "bent rod" appearance. 
The dorsal surface of the spermatid head has a bent rod appearance; dense staining of the chro-
matin is not yet complete, indicating chromatin condensation bas not reached the caudal 
head. 
Dense staining extends throughout the spermatid nucleus indicating dense chromatin is seen 
throughout the head; the stage ends before meiotic metaphase of diplotene spermatocytes 
begins. 
The presence of meiotic anaphase or telophase ôf meiosis 1. secondary spermatocytes. or any of 
the phases of meiosis II defmes this stage. 
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Fig. 3. Cycle map of spermatogenesis for the rat. The 
vertical columns, designated by Roman numerals, depict 
cell associations (stages). In the scheme provided, stages 
Il and III are combined into a single stage called II-III. A 
cycle is a complete series of cel! associations which are 
placed in logical order. The developmental progression of 
a cell is followed horizontally until the right hand border of 
the cycle map is reached. The cell progression continues 
at the left of the cycle map one row up. The inset 
describes acrosome development, which is used to 
designate specifie phases of cell development. 
the formation of spermatids, the Golgi apparatus is involved in producing small 
condensing proacrosomal vesicles that contain dense material referred to as proacrosomal 
granules. The four very small proacrosomal granules eventually coalesce within one 
large membrane bounded vesicle containing a single granule known as the acrosomal 
vesicle. The acrosomal vesicle is rounded until it contacts with the nucleus, where after it 
becomes flattened on the side that makes contact with the surface of the nucleus and 
spreads out with the acrosomal granule intact and bulging. The spermatid nucleus moves 
to the cell surface through an unknown mechanism (Russell, Lee et al. 1983). The 
acrosomal region of the spermatid becomes apposed to the plasma membrane tightly. As 
time passes, the nucleus progressively elongates. The Golgi apparatus moves away from 
the acrosome and migrates to the caudal aspect of the cell. The progression of changes on 
the acrosome is the primary basis for classifying spermiogenesis into steps and for using 
these steps to classify cell associations into stages. The acrosome contains various 
hydrolytic enzymes, including typicallysosomal enzymes, which are released to digest 
the egg membrane to permit the fusion of egg and sperm during fertilization. It has been 
shown that the acrosome also contains functional molecules required for the complex 
steps of sperm-egg interaction, including binding to the zona pellucida, induction of the 
acrosome reaction and penetration through the zona (Saxena, Tanii et al. 1999; Saxena, 
Tanii et al. 2000; Kim, Foster et al. 2001). 
1.1.4. Protein degradation in spermatogenesis 
In the third phase of spermatogenesis, before sperm release, the spermatid volume is 
reduced to about 25% of its original size upon remodeling. There are at least three steps 
in the process of making spermatids smaller and more streamlined: water elimination, 
cytoplasm elimination by tubulobulbar complex and separation of cytoplasmic package 
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as a residual body (Huckins 1978). The cytoplasmic fragments are phagocytosed by the 
Sertoli cell (Elftman 1950). Exclusion of residual body is responsible for one fourth of 
the volume reduction (Huckins 1978). After cytoplasmic elimination, a small amount of 
cytoplasm, the cytoplasmic droplet, remains around the neck of the spermatid and is shed 
later in the epididymis. 
In addition to elimination of the cytoplasm, nuclear volume decreases to only ~5% 
that of a somatic cell nucleus. The haploid genome is extremely compacted within the 
nucleus in the sperm head. This remarkable reorganization of the chromosomes is 
permitted by replacing histones with protamines, arginine and cysteine rich proteins that 
are even more basic than histones (Mills, Van et al. 1977; Meistrich 1989). Protamines 
organize the haploid male genome into a highly specialized chromatin structure that is 
much more compact than the classical nucleosomal architecture (Mills, Van et al. 1977; 
Meistrich 1989). The substitution of histones by protamines is probably related to the 
high compaction potential of nucleoprotamines and the requirement for a unique 
chromatin architecture that would enable a specific transcription schedule after 
fertilization (Sassone-Corsi 2002). In mammals, histones are not replaced directly by 
protamines. Transition proteins (TPl and TP2) are smaIl, basic nuclear proteins that 
replace histones in late round and early elongating spermatids. They are further replaced 
by protamines at around step 14 spermatids. Deletion of TP 1 or TP2 genes, individuaIly, 
does not yield a phenotype, suggesting a redundant role for the se two transition proteins 
(Yu, Zhang et al. 2000; Zhao, Shirley et al. 2001). Mice lacking both TPs are sterile 
(Zhao, Shirley et al. 2004). In these double knockout mice, chromatin condensation is 
irregular in aIl spermatids, with many late spermatids showing DNA breaks (Zhao, 
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Shirley et al. 2004). Thus, mammalian TPs are required for normal chromatin 
condensation, fertility, and for preventing the loss of genomic integrity. 
The molecular mechanism underlying this bulk reduction of cytoplasm and the 
degradation of specific proteins such as histones remains unclear. The phagocytic uptake 
ofproteins by Sertoli cells may lead to degradation within lysosomes. However, a large 
body of accumulating evidence indicates that the ubiquitin proteasome pathway of 
degradation also appears to be involved. 
1.2. Ubiquitin system 
The ubiquitin system is a system involving multiple enzymes that regulate 
conjugation of ubiquitin to substrate proteins. Ubiquitination subsequently mediates 
protein degradation or modulates a number of other cellular processes. The ubiquitin 
system is increasingly recognized as playing a vital role in multiple cell functions (details 
are introduced later in this section). 
Ubiquitin was originally isolated from the thymus and thought to be a thymic peptide 
hormone (Goldstein, Scheid et al. 1975). It is a ubiquitous and highly conserved 8 kDa 
protein of 76 amino acids. Not long later, an ATP dependent proteolytic system was 
identified in reticulocyte lysates (Etlinger and Goldberg 1977; Ciehanover, Hod et al. 
1978). Later studies established that this ATP dependent degradation required a heat 
stable factor in the lysate. The factor was subsequently identified as the peptide ubiquitin. 
The ATP was shown to be required at two steps: the conjugation of ubiquitin to substrate 
proteins and the degradation of the ubiquitinated substrates by a large protease, 
proteasome (Ciechanover, Heller et al. 1980; Hershko, Ciechanover et al. 1980). In the 
following 30 years and especially in the last decade, much has been leamed about the 
ubiquitin system. Although originally thought to be required only for degradation of 
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misfolded proteins, the ubiquitin system is now recognized to de grade the majority of 
cell proteins (Rock, Gramm et al. 1994). Furthermore, it can serve as a multifunctional 
signaling mechanism, and has also many nonproteolytic functions such as regulation of 
membrane protein trafficking (Hicke 1999; Hicke and Dunn 2003), ribosomal function 
(Spence, Gali et al. 2000), postreplication DNA repair (Spence, Sadis et al. 1995; 
Hofmann and Pickart 1999), the initiation of the inflammatory response (Deng, Wang et 
al. 2000), and the function of certain transcription factors (Kaiser, Flick et al. 2000). 
Ubiquitin was the first protein shown to be covalently conjugated to other 
intracellular proteins (Hochstrasser 1996; Hershko and Ciechanover 1998). 
Ubiquitination is a highly precise, temporally controlled, and tightly regulated process 
that modulates, in a specific manner, numerous cellular proteins (Fig. 4) (Varshavsky 
1997; Hershko, Ciechanover et al. 2000; Pickart 2001). It is carriedout by the sequential 
action ofthree enzymes: ubiquitin activating enzyme El, ubiquitin conjugating enzyme 
E2 and ubiquitin protein ligase E3 (Hershko, HelIer et al. 1983) (Fig. 4). El catalyses the 
first step which is the formation of a high energy thioester bond between Gly76 of 
ubiquitin and a specific Cys residue of El. This step requires ATP hydrolysis. The El 
linked ubiquitin is then moved from El to a Cys residue of an E2, and from there to a Lys 
residue of an ultimate protein substrate, resulting in a ubiquitin protein conjugate. This 
last step requires E3, which is the principal substrate recognition factor that determines 
the specificity of ubiquitination. In sorne cases there are additional protein components 
involved such as E4 proteins, (polyubiquitin chain elongation factors) (Koegl, Hoppe et 
al. 1999; Hoppe, Cassata et al. 2004), which serve to lengthen the polyubiquitin chains 
(Kuhlbrodt, Mouysset et al. 2005). 
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In many cases, proteins are modified with multiple moieties of ubiquitin that generate 
a branched polyubiquitin chain. Most frequently the C-terminus of each ubiquitin unit is 
linked to Lys48 of the previous ubiquitin. Lys48 linked polyubiquitination results in 
degradation of the ubiquitinated protein by the 26S proteasome, a reaction that also 
requires ATP hydrolysis (Fig. 4A) (Chau, Tobias et al. 1989; Hochstrasser 1996; 
Hershko and Ciechanover 1998). The polyubiquitin chain is generally not degraded but 
removed from the substrate, and then depolymerized into free ubiquitin. 
Although the first and best known property of ubiquitination is to target proteins for 
degradation via attachment of Lys 48linked chains to substrates, more recent findings 
clearly reveal other functions ofubiquitination which include modification of the activity, 
interactions with other proteins, and subcellular localization of the target proteins. These 
nonproteolytic functions appear to be modulated by monoubiquitination or by 
polyubiquitination via Lys residues ofubiquitin other than Lys 48. Monoubiquitination, 
which does not target proteins for degradation, has important functions in endocytosis, 
gene transcription, DNA repair, and DNA replication (Hicke 2001; Sigismund, Polo et al. 
2004). Polyubiquitination does not always generate Lys 48linked polyubiquitin chains. 
Ubiquitin has seven lysine residues, and so there could be other types and mixed types of 
polyubiquitination. Indeed, in yeast ubiquitin itselfwas found to be conjugated to other 
ubiquitin molecules at all seven lysine residues, with a relative abundance order of Lys48 
> Lys63 and Lysll »Lys33, Lys27 and Lys6 (Peng, Schwartz et al. 2003). A chain 
linked through the Lys63 residues of its ubiquitin moieties appears to have roles in DNA 
repair (Spence, Sadis et al. 1995; Ulrich and Jentsch 2000; Andersen, Zhou et al. 2005), 
transcription (Yu, Zhang et al. 2000; Van Landuyt, Lissens et al. 2001; Andersen, Zhou 
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Fig. 4. Ubiquitin proteasome pathway. Details are in the text. 
et al. 2005), endocytosis (Hein, Springael et al. 1995; Galan and Haguenauer-Tsapis 
1997; Huang, Kirkpatrick et al. 2006), mitochondrial inheritance (Fisk and Yaffe 1999), 
ribosomal function (Spence, Gali et al. 2000) and cell cycle (Bothos, Summers et al. 
2003). Not surprisingly, in view of the se many functions, deregulated ubiquitin system 
has been implicated in the pathogenesis of many diseases, including certain malignancies, 
neurodegenerative disorders, and pathologies of the inflammatory and immune response 
(Scheffner, Wemess et al. 1990; Kishino, Lalande et al. 1997; Loda, Cukor et al. 1997; 
Matsuura, Sutcliffe et al. 1997; Staub, Gautschi et al. 1997; van Leeuwen, de Kleijn et al. 
1998; Joazeiro, Wing et al. 1999; Maxwell, Wiesener et al. 1999; Saigoh, Wang et al. 
1999; Waterman, Levkowitz et al. 1999; Bignell, Warren et al. 2000; Lam, Pickart et al. 
2000; Shimura, Hattori et al. 2000). 
While a series of enzymes conjugate ubiquitin to substrates, there are also at least 19 
deubiquitinating enzymes (DUBs) in yeast and 95 DUBs in human that remove ubiquitin 
from polyubiquitin chains or from the substrate (Wilkinson 1997; D'Andrea and Pellman 
1998; Wilkinson 2000; Wing 2003; Soboleva and Baker 2004). DUBs can negatively 
regulate ubiquitination to protect proteins from degradation or to terminate the signal or 
property changes generated by ubiquitination (Fig. 5). Deubiquitination of the ubiquitin 
chains released by the proteasome from proteolytic substrates, after the substrates have 
been targeted there, is necessary to maintain a sufficient pool of free ubiquitin within the 
cell for normal ubiquitination. In this way, DUBs keeps the 26S proteasome free of 
unanchored ("free") ubiquitin chains that can compete with ubiquitinated substrates for 
ubiquitin binding sites (Amerik and Hochstrasser 2004; Nijman, Luna-Vargas et al. 
2005). Moreover, DUBs are also responsible for processing inactive ubiquitin precursors, 
generated by polyubiquitin genes which contain tandemly repeated copies of the 
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Fig. 5 
Fig. 5. Functions of DUBs in the ubiquitin pathway. 
Ubiquitin is encoded in the genome as polyubiquitin 
genes (1) and as fusion genes to either the L40 or 
527a subunits of the ribosome (2). Deubiquitinating 
enzymes process the gene products to the monomeric 
proteins (1) and (2). DUBs can also serve to salvage 
ubiquitin from adducts ligated to abundant small 
nucleophiles such as glutathione or polyamines (X) (3). 
DUSs can recycle ubiquitin (4) or ubiquitin chains (6) 
from ubiquitinated proteins. The process can also 
serve to rescue inappropriate ubiquitinated proteins. 
Finally, DUS can disassemble anchored (5) or 
unanchored ubiquitin chains (7). 
ubiquitin coding sequence (Dworkin-Rastl, Shrutkowski et al. 1984; Ozkaynak, Finley et 
al. 1984). 
1.2.1. Ubiquitin conjugation system 
As described above, it has now been well established that the E1-E2-E3 cascade is 
the enzymatic machinery responsible for attaching ubiquitin to various protein substrates 
(Hershko, HelIer et al. 1983). Although ubiquitination ofallproteins uses the same El, 
there are about 40 different E2s and 500 different E3s or E3 multiprotein complexes for 
ubiquitination of different proteins in mammalian cells (pickart 2001; Shcherbik and 
Haines 2004). El works with all E2s, while each E2 has specificity for several E3s (Fig. 
4B). Conversely, an E3 can also be supported by several specific E2s. 
1.2.1.1. Ubiquitin activating enzyme-El 
El is a ~ 100 kDa protein that contains the nucleotide binding motif Gly-X-Gly-X-X-
Gly. El activates ubiquitin and thereby starts ubiquitination. The end result ofthis 
activation is the C-terminal Gly of ubiquitin is bound to the active site Cys residue via a 
high energy thioester bond. The initial step of this reaction is the nucleophilic attack of 
ATP with ubiquitin, which results in the formation of ubiquitin adenylate and the release 
ofPPj. The active site Cys then reacts with the ubiquitin adenylate, resulting in the 
binding of ubiquitin to the Cys residue of Elin a thioester linkage, with the release of 
AMP (Huang, Miller et al. 2004). The El can then adenylate another molecule of 
ubiquitin. Each fully loaded El molecule therefore carries two molecules of activated 
ubiquitin: one bound as a thioester, the other as an adenylate. The ubiquitin loaded El 
can interact with the full spectrum of ubiquitin E2 enzymes, and in a transthiolation 
reaction, ubiquitin is transferred from the active site cysteine of the El to the active site 
cysteine of the E2. The catalysis by El is very efficient. The process of ATP-AMP 
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exchange, which requires all steps from A TP binding to thioester formation, occurs at a 
maximum turnover number of 1-2 S-1 (Haas and Rose 1982), while the catalytic rate (kcat) 
of substrate ubiquitination reported later is 10- to 100- fold slower (Mastrandrea, You et 
al. 1999). This relatively high efficiency of E 1 aIlows production of sufficient activated 
ubiquitin for the entirety of downstream conjugation reactions, even though the El 
concentration is usually less than the total E2 concentration (Hershko, HelIer et al. 1983). 
While structural determination of the El enzyme has proven elusive, further insights 
into the El mechanism have come from structural and biochemical analysis of the El 
like enzyme responsible for activation of the ubiquitin like protein (Ubl), Nedd8 (Walden, 
Podgorski et al. 2003; Walden, Podgorski et al. 2003; Huang, Walden et al. 2004), as 
weIl as analogies with the bacterial MoeB and ThiF enzymes. The Nedd 8 activating 
enzyme consists of two subunits, APPBP 1 and Uba3. MoeB and ThiF function with 
orthologs of ubiquitin, MoaD and ThiS, and play roles in bacterial molybdopterin and 
thiamin biosynthesis, respectively (Lake, Wuebbens et al. 2001; Rudolph, Wuebbens et 
al. 2001; Wang, Xi et al. 2001). The structure and associated mutational analyses reveal 
that the activation of ubiquitin and Ubl is a two-step mechanism as described above in 
which the C terminus of ubiquitin or Ubl is first adenylated and then ubiquitin or Ubl is 
transferred from the adenyl group to an El cysteine. The common feature ofE1s for 
ubiquitin and all Ubl is a region of sequence homology to MoeB and ThiF which is 
required for adenylation, suggesting that the common function associated with aIl those 
Els is the C-terminal adenylation ofubiquitin or a Ubl. The cocrystal structures ofMoeB 
and ThiF complex and of the APPBP 1 and Uba3 complex revealed that this sequence 
homology region adopts a Rossmann fold, a structure frequently found in nucleotide 
binding proteins (Rossmann, Moras et al. 1974; Lake, Wuebbens et al. 2001; Walden, 
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Podgorski et al. 2003). In addition to playing a role in nucleotide binding, this sequence 
homology region is also involved in dimerization. The structural homology between the 
two heterodimer complexes extends beyond the region of significant sequence homology, 
and also includes the C-terminal part of the MoeB sequence, which is involved in 
binding to MoaD. This raises the possibility that even distally related E1s may bind to 
their cognate Ubls via a similar structure. 
Ubiquitin activating enzyme is a very abundant protein localized in both the 
cytoplasm and the nucleus. Genes encoding El for ubiquitination have been cloned from 
different species, including yeast (UBAi) (McGrath, Jentsch et al. 1991), wheat (UBAi) 
(Hatfield, Callis et al. 1990) and human (UBEi) (Zacksenhaus and Sheinin 1990; 
Handley, Mueckler et al. 1991). Most organisms have a single gene encoding the El 
enzyme, which appears to be an essential gene in all eukaryotes (Zacksenhaus and 
Sheinin 1990; Jentsch, Seufert et al. 1991; McGrath, Jentsch et al. 1991). Isoforms of 
mammalian El enzymes may be present in sorne cell types (Cook and Chock 1992; 
Shang, Deng et al. 2001), as well as multiple phosphorylated states of El (Cook and 
Chock 1995; Stephen, Trausch-Azar et al. 1996). However, biochemical characteristics 
have not been shown to differ among any of these alternative products. Phosphorylation 
has been reported to regulate localization of El to the nucleus (Stephen, Trausch-Azar et 
al. 1996; Stephen, Trausch-Azar et al. 1997). 
1.2.1.2. Ubiquitin conjugating enzyme-E2 
Ubiquitin conjugating enzymes, E2s, are encoded by a gene family and differ in their 
properties and intracellular localization (Jentsch, Seufert et al. 1990). Each E2 must have 
specificity for El, as well as for one or more E3s. This specificity is generally encoded 
within the ~150-200 amino acid residues of the highly conserved catalytic domain, 
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although in sorne cases N- and/or C-terminal extensions appear to be important as weIl. 
Within the catalytic domain of E2, there is an active site cysteine residue required for the 
thioester linkage ofE2 and ubiquitin, mutation ofwhich results in inactivation of the E2 
(Sung, Prakash et al. 1991; Sommer and Jentsch 1993; Seufert, Futcher et al. 1995). 
There are 13 E2s in S. cerevisiae, and even more in higher organisms, reflecting 
multiple orthologs to the yeast E2s (Jensen, Bates et al. 1995; Rajapurohitam, Morales et 
al. 1999) as weIl as the evolution ofnew E2s (Wefes, Mastrandrea et al. 1995; Liu, Haas 
et al. 1996; Hauser, Bardroff et al. 1998). Different E2s have distinct biological functions 
through interaction of different E2s with specific E3s, and is most evident from genetic 
studies in yeast (Hochstrasser 1996). Mutations of different E2s in yeast lead to distinct 
phenotypes, indicating that those E2s have different functions. For example, mutants in 
yeast CDC34 (UBC3) gene are defective in the transition from G1 to the S phase of the 
cell cycle (Goebl, Yochem et al. 1988). Mutations of UBC2 (RAD6) cause a variety of 
phenotypes, including extreme vulnerability to DNA damaging agents; deficiencies in 
sporulation, meiotic recombination and induced mutagenesis; and enhanced rates of 
mitotic recombination and spontaneous mutagenesis (Friedberge, Siede et al. 1991). 
Turnover of short lived proteins is markedly reduced in ubc4/ubc5 mutants (Seufert and 
Jentsch 1990) 
The three dimensional structure of E2 has been determined by X ray crystallography 
(Cook, Jeffrey et al. 1993; Worthylake, Prakash et al. 1998; Jiang and Basavappa 1999). 
The structure ofE2 charged with ubiquitin (Miura, Klaus et al. 1999) and the structure of 
E21E3 cocrystals (Huang, Kinnucan et al. 1999; Zheng, Wang et al. 2000) have also been 
characterized. The active core domain ofE2 folds into a conserved structure with four a 
helices and a four stranded antiparallel ~ sheet. The active site cysteine is located in a 
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cleft between two loops. Not surprisingly, many of the most highly conserved E2 
residues surround the active site cysteine (Cook, Jeffrey et al. 1993; Worthylake, Prakash 
et al. 1998; Jiang and Basavappa 1999). Sorne ofthese residues interact with ubiquitin. 
There are two major E3 families, one containing a conserved HECT domain and the 
other possessing a conserved RING domain. Both ofthese conserved domains are 
required for binding of E2s, as revealed by deletion analysis (Schwarz, Rosa et al. 1998; 
Seol, Feldman et al. 1999; Skowyra, Koepp et al. 1999). Certain E2s, such as UbcH7, 
work with E3s from both of the two E3 families, although the catalytic modules of the 
two E3 families are distinct in sequence and structure (Huang, Kinnucan et al. 1999; 
Borden 2000; Zheng, Wang et al. 2000). UbcH7 efficiently binds to the HECT domain 
enzyme E6AP (Nuber, Schwarz et al. 1996; Huang, Kahana et al. 1997; Kumar, Kao et al. 
1997) and to several RING domain E3s, including c-Cbl which ubiquitinates several 
membrane receptors (Moynihan, Ardley et al. 1999; Y okouchi, Kondo et al. 1999; Zheng, 
Wang et al. 2000). The crystal structures of the UbcH7-E6AP HECT domain and 
UbcH7-c-Cbl RING domain complexes (Huang, Kinnucan et al. 1999; Zheng, Wang et al. 
2000) reveal that the E2-E3 contacts involve many of the same E2 residues in both 
complexes (Fig. 6, A-B). Most ofthese residues are located in two loops at the end of the 
UbcH7 ~ sheet. From these findings it is easier to understand how the presence of a few 
divergent surface residues of E2 could modulate the binding properties of a particular E2 
to an E3. 
1.2.1.3. Ubiquitin protein ligase-E3 
E3 catalyzes the final step of ubiquitination to link ubiquitin to an e-amino group of a 
Lys residue on the substrate protein or on ubiquitin itselfto form a ubiquitin chain. E3s 
range from single polypeptides to large complexes in which distinct subunits are 
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Fig. 6. Crystal Structures of E2/E3 complexes. A. Overall view of the ternary complex of 
the TKB and the RING domains of c-Cbl, UbcH7, and the substrate, phosphorylated 
ZAP-70 Peptide. The TKB domain is colored green, the RING domain red, and the linker 
region of c-Cbl yellow. UbcH7 is colored in cyan and its active site cysteine in orange. 
The two zinc ions are shown as gray spheres. B. Orthogonal views of the overall U-
shaped structure of the E6AP HECT domain-UbcH7 complex. The E6AP HECT domain 
N lobe (consisting of 12 helices and six strands), C lobe (six helices and four strands), 
and UbcH7 (four helices and four strands) are colored in green, red, and cyan, 
respectively. The active site loops of the E2/E3 are colored yellow. The UbcH7 active-
site loop consists of residues 70 to 101. The dotted line indicates the open line of sight 
between the active-site cysteines of E6AP and UbcH7 (Huang, Kinnucan et al. 1999). 
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Fig. 6. C. Overall structure of Smurf2 HECT domain with modeled UbcH7 (yellow). (Ci) The 
E2, UbcH7 was docked on the Smurf2 HECT domain based on E6AP-UbcH7 complex 
structure. Smurf2 HECT domain revealed an open L-shaped conformation for the two lobes, 
N- and C-terminal. The N-terminallobe (residues 369--624) consists of two subdomains: the 
large subdomain in red (residues 369-514 and 597--624) and the sm ail subdomain that 
contains the E2 binding groove in pink. The two subdomains of the N-terminallobe are 
connected by short linker sequences between residues 515--517 and 593--596. The C-
terminal lobe (residues 628-741, colored blue) contains the catalytic Cys-716. The structure 
of E6AP-UbcH7 complex with the C lobe (blue) and the N lobe (red and pink) is shown in 
panel (Cii). In panel (Ciii), the structure of \/'MIP1 with modeled UbcH7 revealed a T-shaped 
conformation of \/'MIP1 with the N lobe colored red and pink and the C-Iobe in blue. D. 
Superimposed ribbon diagrams of Smurf2 HECT (red-pink-blue) showing the motion of the 
C lobe (blue) and the E2 binding lobe (pink) about the hinge region wh en compared to (Cii) 
E6AP (cyan) and (Ciii) \/'MIP1 (cyan). Schematics of the superimposed structures are 
represented to the right of each ribbon diagram. Note the rotation of the E2 binding lobe by 
24.1 0 and the translation of the C lobe by 13 A when compared to E6AP (i) (Ogunjimi, Briant 
et al. 2005). 
responsible for substrate recognition and for ubiquitin conjugation (Fig. 7). Multisubunit 
E3s are often organized in a modular fashion in which substrate recognization subunits 
can be readily exchanged to facilitate the specifie recognition of diverse substrates (Fig. 7, 
C-D). 
A given E3 usually binds its cognate substrate(s) through a structural motifknown as 
a ubiquitination signal (Chau, Tobias et al. 1989; Hochstrasser 1996; Varshavsky 1997; 
Gilon, Chomsky et al. 1998; Hershko and Ciechanover 1998; Deshaies 1999; Koepp, 
Harper et al. 1999; Laney and Hochstrasser 1999; Page and Hieter 1999; Tyers and 
Jorgensen 2000). Ubiquitination signaIs on target proteins can be genetically encoded 
such as various destruction motifs, or can be acquired such as by phosphorylation, by 
binding to an adapter protein, or by protein damage due to fragmentation or oxidation 
(Laney and Hochstrasser 1999). Destruction motifs are short sequences of amino acids 
that are necessary and sufficient to direct their ubiquitination. The first identified 
ubiquitination signal in this category were N-end rule proteins whose ubiquitination rate 
depends strongly on the identity of the N-terminal residue (Bachmair and Varshavsky 
1989). A number of other sequences have since been identified. The RING domain 
containing E3, the Anaphase Promoting Complex (APC), can recognize several such 
motifs, such as the D Box (Glotzer, Murray et al. 1991; Koepp, Harper et al. 1999; Page 
and Hieter 1999; Owens and Hoyt 2005), the Ken box (Ptleger and Kirschner 2000) and 
the A box (Castro, Vigneron et al. 2002; Littlepage and Ruderman 2002). Hydrophobie 
surfaces have also been shown to lead to the degradation of certain proteins (Gilon, 
Chomsky et al. 1998; Johnson, Swanson et al. 1998; Laney and Hochstrasser 1999). 
The ubiquitination of many cellular regulators has been shown to be regulated by 
phosphorylation. These include: cyclins and cyclin kinase inhibitors; other 
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Fig. 7 
A 
E6AP (HECT E3 ) 
B 
Cbl (RING E3 ) 
c 
APC (RING E3) 
D 
SCF (RING E3 ) 
Fig. 7. Diagram of representative enzymes of 
different ubiquitin protein ligases (E3s). A-B, 
mono mer forms of E3; C-D, multisubunit E3 
complexes. 
checkpoint regulators such as cdc6p (replication) and Swe1p (budding); signal 
transduction components such as Smads, TGFp, Cb1, numerous cell surface receptors 
and transporters, and proteins regulating transcription such as I1cBa, P catenin, p53, Jun, 
and even RNA polymerase (Koepp, Harper et al. 1999; Laney and Hochstrasser 1999). 
The RING domain containing E3, Skp1-Cull-F box protein complex, requires its 
substrates to be phosphorylated before ubiquitination (Cardozo and Pagano 2004). 
For damaged and misfolded proteins, interaction with chaperones and the 
cytoskeleton appears to induce their degradation. Abnormal proteins in the cytoplasm are 
bound to the microtubule network and 10calized to the centrosome along with many of 
the enzymes of the pathway (Johnston, Ward et al. 1998; Stumptner, Heid et al. 1999). 
Misfolded proteins in the ER are shuttled back to the cytoplasm by retro grade transport 
and ubiquitinated and degraded there (Plemper and Wolf 1999). 
Ubiquitination sites on the substrate can be specific or nonselective. Potential 
ubiquitination sites have been analyzed on c-Jun (Hou, Cenciarelli et al. 1994; Treier, 
Staszewski et al. 1994), the T cell receptor ç subunit (Hou, Cenciarelli et al. 1994), and 
the encephalomyocarditis (EMC) virus 3C protease (Lawson, Gronros et al. 1999). In 
each case, aIl of the single lysine to arginine mutants retained nearly the same level of 
ubiquitination as that of the wild type, suggesting that their ubiquitination are not site 
specific. In contrast, Mdm2, a RING E3, promotes its own degradation via the 
ubiquitination of a specific lysine residue (Buschmann, Fuchs et al. 2000). The 
ubiquitination site on histone H2A has been mapped to the highly conserved residue Lys 
119 (Nickel, Roth et al. 1987; Wang, Wang et al. 2004). Histone H2B is also specifically 
ubiquitinated on Lys 120 inhuman H2B and Lys123 in yeast H2B, respectively (Thome, 
Sautiere et al. 1987). The transcription factor MyoD and the latent membrane protein 1 of 
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Epstein-Barr virus are polyubiquitinated at a noncanonical site, the N terminus, as 
suggested by ubiquitination of a Lys-Iess mutants of each protein (Breitschopf, Bengal et 
al. 1998; Aviel, Winberg et al. 2000). In both cases, N-terminal residues ofboth proteins 
are sufficient and necessary for promotion ofubiquitin conjugation and subsequent 
degradation of the polyubiquitinated protein by the 268 proteasome. Very interestingly, 
ubiquitination can occur on proteins lacking accessible lysines or an accessible N 
terminus as weIl (Cadwell and Coscoy 2005). MHC 1 molecules (Major 
Histocompatibility Complex) are ubiquitinated by MIRI (the Modulators of Immune 
Recognition) (Ishido, Wang et al. 2000). One recent study shows that MIRI can stimulate 
ubiquitination on a cysteine residue in the intracytoplasmic tail ofMHC 1 molecules, 
lacking lysine residues in the intracytoplasmic domain, and promotes downregulation of 
the MHC 1 molecules (Cadwell and Coscoy 2005). 
As described before, most known E3s are characterized into two families, HECT E3s 
and RING E3s, which are introduced in details in the following sections. 
1.2.1.3.1. RING E3s 
RING Œeally Interesting New Gene) E3s are defined by the presence of multiple Cys 
and His residues that coordinate two zinc ions to form a globular E2 binding domain 
(Petroski and Deshaies 2005). RING E3s bind both the ubiquitin charged E2 and the 
substrate, thus facilitating direct attack of the substrate Lys on the E2linked ubiquitin 
(Joazeiro and Weissman 2000; Zheng, Wang et al. 2000; Weissman 2001; Zheng, 
8chulman et al. 2002). 
There are ~500 RING finger proteins in databases and they are involved in diverse 
cellular processes (Deshaies 1999; Borden 2000; Joazeiro and Weissman 2000). 
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Although it is not known if aIl RING finger proteins are E3s, it is clear that there is a 
larger family of RING E3s than HECT E3s. 
1.2.1.3.1.1. Typical RING E3s 
Typical RING E3s includes single subunit and multiprotein complex RING E3s 
(Deshaies 1999; Page and Hieter 1999; Joazeiro and Weissman 2000; Tyers and 
Jorgensen 2000) (Fig. 7, B-D). 
One group of typical and weIl studied single subunit E3s is the Cbl family. The Cbl 
proteins comprise a highly conserved family of RING E3s that play a central role in the 
downregulation of signaling cascades involving receptor and nonreceptor tyrosine 
kinases (Thien and Langdon 2001; Dikic, Szymkiewicz et al. 2003; Duan, Reddi et al. 
2004). There are three mammalian Cbl proteins, c-Cbl, Cbl-b and Cbl-c (also known as 
Cbl-3), encoded by separate genes. Structurally, all Cbl proteins have aN-terminal 
tyrosine kinase binding (TKB) domain for substrate binding and a RING finger domain 
to recruit the E2 (Fig. 6A, 7B). The C-terminal portion includes a proline rich region in c-
Cbl and Cbl-b, but this region is rudimentary in Cbl-c/Cbl-3. AIso, present in the C-
terminus of c-Cbl and Cbl-b, but absent in Cbl-c/Cbl-3 are a number of tyrosine residues 
which can be phosphorylated by protein tyrosine kinases, a ubiquitin associated domain 
(UBA) and leucine zipper (LZ). Cbls regulate the signaling process through 
ubiquitination of the plasma membrane receptors and various downstream signaling 
components. 
The Cbl proteins are regulated by an increasingly complex network to ensure the 
accurate effects of Cbl proteins on signaling. First, the ubiquitin protein ligase activity of 
c-Cbl is regulated. The E3 activity of c-Cbl is negatively regulated by domains present in 
the N-terminal half of the protein (the TKB and linker helix domains between TKB and 
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RING) and this negative regulation is removed when the protein is phosphorylated on 
tyrosine residues, which alters the conformation of c-CbI (Kassenbrock and Anderson 
2004). CbI dependent ubiquitination and degradation of the receptor tyrosine kinase, Fyn, 
is dependent on the kinase activity ofFyn (Ghosh, Reddi et al. 2004). Secondly, the 
stability of CbI proteins is regulated. Autoubiquitination of CbIs is regulated by 
activation of the receptor substrate EGFR (widermal Growth factor ,Receptor) 
(Ettenberg, Magnifico et al. 2001), by receptor tyrosine kinases c-Src (Bao, Gur et al. 
2003), or by CD28 costimulation in T cell activation (Zhang, Bardos et al. 2002). CbI 
proteins can also be ubiquitinated by other E3 s, such as N edd4 and Itch, two WW 
domain HECT E3s (detail in 1.2.1.3.2, HECT E3s) (Magnifico, Ettenberg et al. 2003). 
Moreover, the activity of CbIs can be regulated through interacting of CbIs with other 
signaling proteins (Feshchenko, Smimova et al. 2004; Kowanetz, Crosetto et al. 2004). 
Finally, there is a Ievei ofregulation by deubiquitination of the CbI substrates (Gesbert, 
Malarde et al. 2005; Mizuno, Iura et al. 2005). Since CbIs play an important role in 
downregulation of activated tyrosine kinases to terminate signaling, defects in the 
regulatory mechanisms that result in impaired CbI function are implicated in pathological 
conditions such as immunologicai and malignant diseases (Roussel, Shurtleff et al. 1990; 
Muthuswamy, Gilman et al. 1999; Peschard, Fournier et al. 2001; Mancini, Koch et al. 
2002; Wu, Tu et al. 2003). 
The cocrystai structure of c-CbI bound to a cognate E2, UbcH7, and an Il residue 
peptide containing the c-CbI recognition sequence from the ZAP-70 shows how the 
RING domain recruits the E2 (Zheng, Wang et al. 2000) (Fig. 6A). The RING domain of 
c-CbI is anchored onto the TKB domain by interacting with the four helix bundle of TKB. 
UbcH7 adopts an a/p structure characteristic of the E2 fold and binds to c-CbI with one 
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end of its elongated structure. The crystal structure reveals that c-Cbl binds UbcH7 using 
both its RING domain and its linker helix. Two UbcH7 loops pack in and around a 
shallow groove on the c-Cbl RING domain and a UbcH7 helix interacts with the c-Cbl 
linker helix. The UbcH7 active site cysteine is located on the side of the complex 
opposite from where the ZAP-70 recognition peptide binds and is separated by ...... 60 A 
from the peptide. UbcH7 and the TKB and RING domains of c-Cbl are tightly associated 
by interactions across multiple interfaces. These involve conserved c-Cbl residues. The 
structure reveals a rigid coupling between the peptide binding and the E2 binding 
domains and a conserved surface channelleading from the peptide to the E2 active site, 
suggesting that the precise relative position and orientation of the substrate binding and 
E2 binding domains are important for ubiquitination. 
Important multisubunit RING E3s include the APC/C (Anaphase Eromoting Complex 
or cyclosome) and the SCF ~p1-Cullin-Ebox) complex (Fig. 7, C-D). APC was 
identified through a genetic screen for mutants defective in cyclin destruction in budding 
yeast (Irniger, Piatti et al. 1995) and from two different biochemical studies in clam and 
Xenopus egg extracts which screened for the E3 ligase required for cyclin degradation 
(King, Peters et al. 1995; Sudakin, Ganoth et al. 1995). This approximately 1500 kDa 
complex is a multisubunit E3 that contains at least Il subunits. The catalytic core 
consists of the adaptor prote in Apc2 and a RING containing protein Apc11 (Fig.7C). 
Substrate recognition is mediated by two activators, Cdc20 or Hctl p/Cdh1 p (Page and 
Hieter 1999; Castro, Vigneron et al. 2002). The APC functions predominantly to induce 
progression and exit from mitosis by inducing proteolysis of different cell cycle 
regulators. These include securin proteins (Pds1p in budding yeast and Cut2p in fission 
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yeast), whose destruction is required for the separation of sister chromosomes at 
anaphase (Cohen-Fix, Peters et al. 1996; Funabiki, Kumada et al. 1996; Ciosk, Zachariae 
et al. 1998) and mitotic cyclins, such as cyclin B, which must be destroyed before mitotic 
exit (Glotzer, Murray et al. 1991; Irniger, Piatti et al. 1995; King, Peters et al. 1995; 
Sudakin, Ganoth et al. 1995). APC activity must therefore be tightly regulated to ensure 
that the timing and order of mitotic events are strictly maintained. The works of several 
groups have shown that APC activity is regulated at multiple levels, including APC 
subunit phosphorylation (King, Peters et al. 1995; Lahav-Baratz, Sudakin et al. 1995; 
Peters, King et al. 1996; Shirayama, Zachariae et al. 1998; Kotani, Tanaka et al. 1999), 
selective association with substrates via Cdc20p or Hct! p/Cdhl p (Schwab, Lutum et al. 
1997; Visintin, Prinz et al. 1997) and the spindle assembly checkpoint, which ensures 
that duplicated chromosomes are properly aligned and attached to spindles before being 
separated at anaphase (He, Patterson et al. 1997; Huang, Kahana et al. 1997; Fang, Yu et 
al. 1998; Chung, Shin et al. 2000; Hwang, Venkatasubrahmanyam et al. 2003). 
The SCF E3 ubiquitin ligase family was discovered through genetic analysis of cell cycle 
progression in the budding yeast Saccharomyces cerevisiae (Patton, Willems et al. 1998). 
The core complex ofthese multisubunit enzymes is composed of the Cdc53/Cull 
scaffold protein, Skpl adaptor and the Rbxl (also known as Rocl or Hrtl) RING domain 
protein (Fig. 7D). The Skpl adaptor binds to a family ofF box proteins that recognize 
specific substrates for ubiquitination (Haas, Bright et al. 1988; Patton, Willems et al. 
1998; Deshaies 1999). In particular, the F box proteins recognize phosphorylated SCF 
targets. The SCF controls cell proliferation and cell cycle, principally at the G liS and 
G2/M boundaries, by inducing the degradation of different critical regulators such as 
cyclin A and E (Krajewski, Bodrug et al. 1995; Zhang, Kobayashi et al. 1995; Connelly 
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and Hieter 1996; Skowyra, Koepp et al. 1999; Strohmaier, Spruck et al. 2001) and CDK 
inhibitors p21, p27 and Sicl (Schwob, Bohm et al. 1994; Sudakin, Ganoth et al. 1995; 
Yamanaka, Hatakeyama et al. 2000; Spruck, Strohmaier et al. 2001; Venna, Aravind et 
al. 2002; Bomstein, Bloom et al. 2003). The SCF can also control gene transcription. For 
example, SCF can indirectly activate NFKB mediated transcription by ubiquitination and 
downregulation of the hcB asubunit, or directly inhibit p catenin mediated transcription 
by ubiquitination and downregulation of p catenin (Yaron, Hatzubai et al. 1998; Winston, 
Strack et al. 1999; Deng, Wang et al. 2000; Liu, Stevens et al. 2001). Sorne complexes 
analogous to the SCF complex have been described. These complexes retain the RING 
domain protein Rbx 1, but have different cullin homology domain containing proteins and 
adapter proteins that recognizing substrates. For example, VHL ('~on Hippel-Lindau') 
tumor suppressor protein is a E3 complex analogous to SCF. In VHL complex, the VHL 
prote in, analogous to F-box protein, is linked to a Cul2/Rbxl module by the ubiquitin 
like Elongin B and Skp 1 like Elongin C adaptor proteins (Duan, Pause et al. 1995; Kibel, 
Iliopoulos et al. 1995). Recent structural insights into SCF like complexes have begun to 
illuminate aspects of substrate recognition and catalytic reaction mechanisms (Min, Yang 
et al. 2002; Zheng, Schulman et al. 2002; Orlicky, Tang et al. 2003). The crystal structure 
of the Cull-Rbxl-Skpl-F box protein Skp2 complex generates a 50 A gap between the 
structure of Skp2 substrate adapter and the E2 active site. The space could be bridged by 
the substrate such that it is now ready for ubiquitination by the E2 Cdc34 bond to Rbx 1. 
1.2.1.3.1.2. Special RING E3 family members 
Ufd2 promotes elongation ofpolyubiquitination chains and so was referred to as an 
E4 enzyme (Koegl, Hoppe et al. 1999; Skowyra, Koepp et al. 1999). U box is a motif 
identified in Ufd2. This U box has an overall structure closely related to that of the RING 
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finger (Makarova, Aravind et al. 2000) and has been shown to be sufficient for both E2 
binding and polyubiquitination in the absence of any other known E3 (Hatakeyama, Yada 
et al. 2001; Jiang, Ballinger et al. 2001). Thus, U box containing proteins are a subfamily 
of RING E3 family. 
PHD domain is another structure closely related to that of the RING finger (Pascual, 
Martinez-Yamout et al. 2000; Capili, Schultz et al. 2001). PHD domain containing 
proteins have recently been shown to bind ubiquitin loaded E2 and promote 
polyubiquitination (Boname and Stevenson 2001; Coscoy, Sanchez et al. 2001; Henry, 
Wyce et al. 2003). Sorne ofthese E3s have important functions on transcription (Aasland, 
Gibson et al. 1995), immune system (Boname and Stevenson 2001; Coscoy, Sanchez et 
al. 2001; Coscoy and Ganem 2003) and MAP kinase pathways (Henry, Wyce et al. 2003). 
1.2.1.3.2. HECT E3s 
The second main E3 family is the HECT domain containing E3s. The HECT domain 
was first identified through studies of the degradation of the p53 tumor suppressor caused 
by an oncogenic form of papilloma virus in cervical cancer cells (Scheffner, Huibregtse 
et al. 1993). Virus induced degradation ofp53 depends on the HPV E6 gene product and 
a ,.100 kDa host cellular protein E6AP (E64.ssociated Erotein). E6 and E6AP form a 
complex that functions as a p53 specific E3 which mediates degradation ofp53 by 
ubiquitination (Scheffner, Huibregtse et al. 1993). E6AP is the catalytic component of the 
ligase and requires a cysteine residue in the C-terminus for the activity. The C-terminus 
of E6AP was found to contain a sequence around the essential cysteine, conserved in a 
number of other proteins. This conserved ~350 residue C-terminal region became known 
as a HECT domain (Homologous to E.6AP C-Ierminus). It contains the strictly 
conserved cysteine residue positioned ~,35 residues upstream of the C-termÏnus 
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(Huibregtse, Scheffner et al. 1995; Scheffner, Nuber et al. 1995). The HECT dornains are 
35-45% identical. The active site Cys residue ofHECT E3 forms a thioester linkage with 
ubiquitin which is transferred frorn a cognate E2, prior to attack of the substrate Lys 
residue (Huibregtse, Scheffner et al. 1995; Scheffner, Nuber et al. 1995) (Fig. 6 B-D, 7 A). 
An isolated HECT dornain interacts tightly with the E2 and forms a thioester with 
ubiquitin. Deletion of the HECT dornain does not affect substrate binding (Huibregtse, 
Yang et al. 1997; Kumar, Talis et al. 1999; Qiu, Joazeiro et al. 2000), suggesting that the 
unique N-terminus of each HECT dornain E3 interacts with specifie substrate(s). 
However, one HECT dornain cannot substitute for another (Schwarz, Rosa et al. 1998), 
probably due to the HECT dornain itself contributing to the interaction with the substrate 
to sorne extent or to the specificity of the E2 (Huibregtse, Scheffner et al. 1993). 
To gain insight into the biochernical rnechanisrn ofubiquitin transfer rnediated by this 
family of ubiquitin ligases, the interaction of HECT dornain and E2 was studied by 
determining the structures of the UbcH7-E6AP HECT cornplex (Huang, Kahana et al. 
1997) (Fig. 6B) and UbcH7-Srnurf-HECT cornplex (Ogunjirni, Briant et al. 2005) (Fig. 6, 
C-D). The HECT dornain is L-shaped, the short arm ofwhich is formed by the final 100 
residues ofE6AP, while the long arm is formed by the N-terminal part ofthe HECT 
dornain (Huang, Kahana et al. 1997). The E2 binds at one end ofthis long arm. The 
active site c1eft, defined by the side chain of the catalytic cysteine residue, is at the 
junction of the two arms ofE6AP (Huang, Kahana et al. 1997). The rnost highly 
conserved residues of the HECT dornain are within and around the c1eft. Both of these 
studies of the E2-E3 HECT dornain reveal separations of 41-50 A between the active site 
Cys residues of the E2 and E3 (Fig. 6, B-C) (Huang, Kahana et al. 1997; Ogunjirni, 
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Briant et al. 2005), which is surprisingly far apart for the transfer of ubiquitin from the 
active Cys residue ofE2 to that ofE3. 
However, the crystal structure of the HECT domain of human ubiquitin ligase 
WWPl/AIP5 shows that, relative to E6AP, rotation about a hinge region results in a 
predicted separation of only 16 A between the E2 and E3 Cys residues (Verdecia, 
Joazeiro et al. 2003) (Fig. 6C). Continued rotation along the same direction could bring 
these two residues to a distance that might reasonably bridge the gap. Such proximity 
would allow the chain to be built up at the E3 active site through successive transfers of 
E2 bound ubiquitin to the E3 bound ubiquitin or to a E3 bound ubiquitin chain (Fig. 6D). 
This model is supported by the observation that synthe sis of Lys48 linked diubiquitin 
catalyzed by the E6AP-HECT domain occurs through the reaction of two thioester 
bound ubiquitins: one linked to the E2 and the other linked to the E3 (Zhong, Gao et al. 
2005). However, another HECT domain E3, KIAAI0, uses a different mechanism of 
chain synthesis than E6AP (Zhong, Gao et al. 2005). KIAAI0 synthesizes the chain as a 
free entity: a noncovalently bound acceptor ubiquitin or ubiquitin chain is the substrate 
for sequential ubiquitin transfer events. The HECT domain may therefore specify both 
the linkage of a polyubiquitin chain and the mechanism of its assembly. 
Screening the human genome database suggests that there are .....,90 HECT domain 
E3s, the majority ofwhich are functionally uncharacterized. The remaining structure 
outside of the C-terminal HECT domain likely plays roles in targeting the HECT E3 to 
substrates or for other purpose such as subcellular localization. A number of domains 
have been recognized in these N-terminal regions. In particular is a group of ligases with 
a protein kinase C related C2 domain and multiple WW domains. The C2 domain 
functions in lipid binding and thus targets proteins to the plasma membrane. The WW 
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domain represents two highly conserved tryptophan (W) residues, which are spaced 20-
22 amino acids apart. Sorne of these WW domains bind phosphoserine or 
phosphothreonine (Henry, Wyce et al. 2003), while the others bind to proline rich motifs, 
including the PPXY (Nguyen, Turck et al. 1998), PY, PPLP and PGM motifs (Kilinc, 
Guve1 et al. 2004). 
1.2.1.3.2.1. HE CT domain E3s with C2 and WW domains 
Members of this subfamily of the HECT domain E3 are involved in different cellular 
functions, such as endocytosis, DNA damage response, protein precursor processing, ion 
transportation and cell cycle. Rsp5, the best characterized RECT E3 in this subfamily, is 
an essential Saccharomyces cerevisiae yeast enzyme. WW domains of Rsp5 are required 
for the recognition of its substrates. Rsp5 has been shown to be required for endocytosis 
of membrane proteins. It is recruited to plasma membrane via its C2 domain and 
recognizes a set of plasma membrane permeases and receptors, including uracil permease 
(Fur4p) (Galan, Moreau et al. 1996), ageneral amino acid permease (Gaplp) (Hein, 
Springae1 et al. 1995) and a receptor for Cl mating pheromone (Ste2p) (Hicke, Zanolari et 
al. 1998). Ubiquitination of these substrates is required for subsequent endocytosis (Rotin, 
Staub et al. 2000). Rsp5 has also been shown to regulate gene transcription through 
mediating ubiquitination and degradation ofRpbl, the large subunit of RNA polymerase 
II (Pol II LS), upon induction ofDNA damage (Huibregtse, Yang et al. 1997; Beaudenon, 
Huacani et al. 1999). In murine and human cells, Rpbl is also a substrate ofNedd4, the 
murine/human ortholog of Rsp5 (Beaudenon, Huacani et al. 1999). Finally, Rsp5 is 
involved in processing of the transcription factors Spt23 and Mga2. Rsp5 ubiquitinates 
endoplasmic reticulum bound precursor forms of Spt23 and Mga2 (Hoppe, 
Matuschewski et al. 2000). This ubiquitination induces a limited processing event, 
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catalyzed by the proteasome, which releases the active Spt23 and Mga2 for translocation 
to the nucleus. 
E3s in this subfamily have also been shown to be involved in modulating ion 
transport. The epithelial Na+ channel protein ENaC is a substrate ofNedd4 and is 
endocytosed upon ubiquitination (Schild, Lu et al. 1996; Staub, Dho et al. 1996; Staub, 
Gautschi et al. 1997). The localization ofNedd4 to membranes through its C2 domain is 
required for ENaC ubiquitination (Plant, Lafont et al. 2000). PPXY motifs of ENaC is 
recognized by WW domains ofNedd4 (Staub, Gautschi et al. 1997). Certain ENaC 
mutations that predispose to the inherited disorder known as Liddle syndrome involve 
mutations of these PPXY motifs (Schild, Lu et al. 1996; Staub, Dho et al. 1996). In 
transfected cells, such mutations abrogate Nedd4 dependent ubiquitination and 
intemalization ofENaC (Staub, Gautschi et al. 1997), resulting in an increased number of 
channel molecules in the plasma membrane. This deregulated ENaC turnover results in 
increased Na+ reabsorption and contributes to the hypertension seen in Liddle syndrome. 
1.2.1.3.2.2. HECT domain E3s without C2 and WW do mains 
HECT E3s ofthis subfamily are involved in multiple cellular processes and pathways, 
including DNA replication, gene transcription, cell proliferation, cell signaling, 
nucleotide excision repair, mRNA export and spermatogenesis. E6AP, the tirst ever 
identitied HECT domain E3, mediates ubiquitination and degradation ofp53 in cervical 
carcinoma cells by forming a complex with the HPV E6 gene product (Scheffner, 
Huibregtse et al. 1993). 
E6AP also plays important roles in cell signaling, nucleotide excision repair and 
DNA replication in uninfected cells. E6AP selectively ubiquitinates the activated form of 
Src family tyrosine kinases Blk and Src and targets them for degradation by the 26S 
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proteasome (Harris, Shoji et al. 1999; Oda, Kumar et al. 1999). The nucleotide excision 
repair factor HHR23A is also ubiquitinated by E6AP in a cell cycle dependent manner 
(Kumar, Talis et al. 1999). In addition, Mcm7, a subunit of the replication licensing 
factor, is another substrate of E6AP (Kuhne and Banks 1998). Mutations in the E6AP 
gene cause Angelman syndrome, an inherited condition characterized by severe mental 
retardation (Kishino, Lalande et al. 1997; Matsuura, Sutcliffe et al. 1997). It is not known 
if Angelman syndrome is a result of losing any of the E6AP functions illustrated above. 
EDD is a HECT E3 that appears to be involved in spermatogenesis. It is the 
mammalian ortholog of Hyd (Callaghan, Russell et al. 1998), which is the product of 
Drosophila melanogaster hyperplastic disc gene Hyd and has a critical role in control of 
cell proliferation during development (Mansfield, Hersperger et al. 1994). Mutation of 
Hyd in Drosophila results in sterility and defects in germ tissue morphology (Mansfield, 
Hersperger et al. 1994). Rat Edd (RATIOO) is expressed predominantlyin germ cells and 
precisely regulated during spermatogenesis within the testis (Muller, Rehbein et al. 1992; 
Oughtred, Bedard et al. 2002). EDD family genes (Edd, hyd, and Ratl 00) encode highly 
conserved, large, predominantly nuclear proteins (approximately 300 kDa) that contain a 
HECT domain, a RING like zinc finger domain, a UBA domain and a poly(A) binding 
protein (P ABP) like domain near the C terminus (K won, Reiss et al. 1998; Deo, 
Sonenberg et al. 2001; Wilkinson, Seeger et al. 2001; Henderson, Russell et al. 2002). 
PABP binds to the mRNA 3' poly(A) tail and stimulates recruitment of the ribosome to 
the mRNA at the 5' end. P ABP activity is tightly controlled by its inhibitor, P ABP-
interacting protein 2 (Paip2). EDD was found recently to stimulate the turnover of Paip2 
in the cell (Y oshida, Y oshida et al. 2006). This function of EDD is negatively regulated 
by P ABP (Y oshida, Y oshida et al. 2006). This mechanism serves as homeostatic 
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feedback to control the activity of P ABP in cells. Amplification and overexpression of 
EDD occurs frequently in several cancers, including breast and ovary cancers (Clancy, 
Henderson et al. 2003; Fuja, Lin et al. 2004). Truncating mutations of EDD are also 
observed in gastric and colon cancer with micro satellite instability (Mori, Sato et al. 
2002). 
Toml is a HECT E3 that is implicated in cell cycle, mRNA export and gene 
transcription. Toml (Irigger Qfmitosis) is a 3268 amino acidSaccharomyces cerevisiae 
protein containing two domains with unknown function at the N-terminus, DUF 908 
Womain with Unknown Eunction) and DUF 913. It was identified by a genetic studyof 
genes involved in the G2/M transition (Utsugi, Toh-e et al. 1995). Cells that have the 
HECT domain of Toml deleteddisplay temperature sensitivity and growth arrest at the 
G2/Mtransition of the cell cycle (Utsugi, Hirata et al. 1999). Furthermore, Toml is 
required for efficient mRNA export (Utsugi, Hirata et al. 1999; Duncan, Umen et al. 
2000). Mutations in tomi predicted to abolish ubiquitin ligase activity block efficient 
export ofNab2p and mRNA, causing Nab2p-mRNA complexes to accumulate in a 
punctuate pattern coincident with the nuclear pore complex, while the subcellular 
distribution of several other hnRNP proteins is not affected (Duncan, Umen et al. 2000). 
Null mutation studies show Toml has a role in transcriptional regulation as well (Saleh, 
Collart et al. 1998). These effects ofToml are likely mediated through the ADA 
transcriptional coactivator complexes. Ubiquitination appears essential for the regulation 
by Toml since a cysteine residue for thioester bond formation with ubiquitin is required 
for transcriptional regulation by Toml. Toml associates with the ADA proteins and is 
required for the ubiquitination of a 210 kDa protein, likely SPT7p, that 
coimmunoprecipitates with the ADA components (Saleh, Collart et al. 1998). In the 
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absence ofToml, the normal associations of the ADA proteins with 8PT3p and the 
TATA binding protein are reduced, which results in transcription defects (8aleh, Collart 
et al. 1998). Finally, gene deletion studies reveal Toml is required for full induction of 
the general stress and heat shock responses (Utsugi, Hirata et al. 1999; 8asaki, Toh-e et al. 
2000). 
UreB 1 (Ilpstream regulatory ~lement l!inding protein) is another HECT E3 of this 
subfamily that is involved in gene transcription. UreB 1 was originally identified as a 310 
amino acid HECT protein that has a role in transcriptional regulation through direct DNA 
binding (Gu, Ren et al. 1994; Gu, Irving et al. 1997). UreBI Was later predicted by 
cDNA sequences to be a much larger protein named LA8Ul (gi:22090626). The E3 
ligase described in this thesis turns out to be the same protein as LA8Ul (gi:60549639 
for human, gi:60549637 for mouse), but even longer than as described in the sequence 
database (gi:22090626). We designated this E3 as E3HistoneILA8Ul. Detailed results are 
in the following chapters. Interestingly, the complete E3Histone/LA8Ulsequence 
(gi:60549639 for human, gi:60549637 for mouse) also contains unknown function 
domains DUF 908 and DUF 913 at the N terminus as yeast Tom 1 , suggesting that 
E3HistoneILA8Ul could be mammalian ortholog of Tom 1. 
1.2.2. Proteasome 
Proteins ligated to Lys 48linked polyubiquitin chains are degraded by the 268 
proteasome complex. This complex consists of a 208 proteasome and two 198 regulatory 
partic1es, one at each end of the core (Voges, Zwickl et al. 1999). 
The 208 proteasome is a 700 kDa complex composed of a cylindrical stack of four 
heptameric rings, each of which contains seven subunits (Fig. 8). The two identical inner 
rings are made up of structurally similar subunits and designated p type. Three of these 
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subunits, ~1, ~2 and ~5, are catalyticaUy active, and their distinct active sites are directed 
toward the inner chamber. The two identical outer rings are composed of a type subunits. 
Access to the chamber of the 20S proteasome is limited by the two narrow openings in 
the outer rings that are occluded by N-terminal strands ofthese a type subunits.(Rivett 
1989; Orlowski 1990; Rechsteiner, Hoffman et al. 1993; Hilt and Wolf 1996; GroU, 
Ditzel et al. 1997; DeMartino and Slaughter 1999; Orlowski and Wilk 2000; Zwickl, 
Baumeister et al. 2000). 
The 20S proteasomes are extremely inefficient in degrading ubiquitinated substrates 
unless one or two multisubunit 19S regulatory particles bind to the ends of the 20S 
proteasome cylinder, forming the 26S proteasome. These regulatory complexes are able 
to recognize Lys 48linked ubiquitin chains and therefore bind proteasome substrates. In 
all eukaryotic cells, the 19S regulatory complex is made up of two main classes of 
subunits: the non-ATPases (Rpn1 to Rpn3 and Rpn5 to Rpn12) and the ATPases (Rptl to 
Rpt6) (Glickman, Rubin et al. 1998) (Fig. 8). The 19S regulatory complex consists of 
two subcomplexes: the base subcomplex which contains all six ATPase subunits and 
three non-ATPase subunits, and the lid subcomplex which contains at least eight non-
ATPase subunits (Glickman, Rubin et al. 1998) (Fig. 8). Among the non-ATPases, 
Rpn11 (POH1 in humans) is a deubiquitinating enzyme (belongs to the JAMM family of 
DUBs, details in 1.2.3 deubiquitinating enzyme) and is required for deconjugation of 
polyubiquitin chains from the substrate protein (Verma, Aravind et al. 2002; Yao and 
Cohen 2002). The 19S regulatory complex appears to initiate unfolding of the substrates 
and their translocation into the proteolytic chamber of the 20S proteasome, where they 
are broken down into peptides of 3-25 amino acids. 
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Fig. 8. Diagram of proteasome (one 195 proteasome and 
one 205 proteasome). The 195 regulatory particle can be 
divided into a base and a lid. The base contains AAA 
ATPases Rpt1-6 (Green), non-ATPase Rpn 1,2 (Purple) 
and Rpn 10 (Red). The lid is composed of eight subunits, 
Rpn3, 5,6, 7, 9, 12 (Orange), Rpn8, 11 (Cyan). The 205 
proteasome is represented by 4 stacked, 7-member rings 
representing alpha (Brick colour) and beta (Blue) 
proteasome subunits. 
A distinct complex is fonned by binding of a heptameric 118 regulator (P A28 
activator) to both ends of the 208 proteasome (Dubiel, Ferrell et al. 1992; Ma, 8laughter 
et al. 1992). This binding leads to a rearrangement of the a subunit chains resulting in 
widening of the two openings in the outer rings, thereby facilitating access of some 
substrates to and egress of proteolytic products from the proteolytic chamber (Whitby, 
Masters et al. 2000). Fonnation ofthis complex leads to an acceleration of the 
degradation of small peptides, but not proteins, in an ATP independent manner. There is 
also evidence for the existence of a hybrid complex in which the 208 core proteasome is 
capped by the 198 regulatory complex at one end and an 118 regulator at the other end 
(Tanahashi, Murakami et al. 2000). 
1.2.3. Deubiquitinating enzyme 
Ubiquitin conjugation can be countered by the action of deubiquitinating enzymes 
(DUBs), which remove the ubiquitin moiety from the protein substrate (Wilkinson 1997; 
D'Andrea and Pellman 1998; Wilkinson 2000; Wing 2003; 80boleva and Baker 2004). 
DUBs are proteases that cleave the isopeptide bond at the C-tenninal Gly76 residue of 
ubiquitin, either removing ubiquitin from the substrate or processing the polyubiquitin 
chain (Fig. 5). There are five classes of DUBs based on conserved sequence motifs: 
ubiquitin specifie protease (U8P), ubiquitin C-tenninal hydrolase (UCH), Otubain 
protease (OTU), Machado-Joseph disease protease (MJD), and JAB1IMPNIMov34 
metalloenzyme (JAMM). AlI ofthose classes except JAMM are cysteine proteases 
containing the catalytic triad, Cys, His and Asp. The human genome project has led to 
identification ofapproximately 95 putative DUBs, including 58 U8P, 4 UCH, 5 MJD, 14 
OUT, and 14 JAMM domain containing genes (Nijman, Luna-Vargas et al. 2005). DUBs 
are involved in various biological processes, such as cell growth, differentiation, immune 
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function, and memory consolidation; mutation of DUBs are implicated in the 
pathogenesis of diseases such as cancer (Wilkinson 1997; Chung and Baek 1999; Fischer 
2003; Soboleva and Baker 2004). 
UCH and USP are the two major families of DUBs. The UCHs are papain like thiol 
proteases with a 230 amino acid core catalytic domain, whereas the core catalytic domain 
ofUBPs is ~350 amino acids (D'Andrea and Pellman 1998). USP is the largest family of 
DUB. USPs have conserved Cys-box and His-box, which are required for proteolytic 
cleavage (Wilkinson 1997; Hu, Li et al. 2002). USPs mainly differ by insertions between 
the catalytic boxes or by having divergent N- or C- terminal extensions, all ofwhich may 
be involved in substrate selectivity (Wilkinson 1997; Lin and Wing 2000). 
Ataxin-3 and a number of Ataxin-3 like proteins were identified by a bioinformatics 
search as possible ubiquitin proteases (Burnett, Li et al. 2003; Scheel, Tomiuk et al. 
2003). They are classified into the MJD subfamily of DUB, characterized by a domain 
called the Josephin domain. The cysteine in the active site is required for the DUB 
enzyme activity in vitro (Burnett, Li et al. 2003). The sequence similarity is low between 
the catalytic domain of Ataxin-3 and other DUBs, but NMR structures reveal that the 
catalytic triad is conserved (Mao, Senic-Matuglia et al. 2005; Nicastro, Menon et al. 
2005). 
The DTU (Ovarian tumor) related proteases were predicted by a bioinformatics 
analysis as thiol proteases (Makarova, Aravind et al. 2000). The OTU gene may regulate 
the localization and translation of certain RNA transcripts and is involved in the 
development of the Drosophila melanogaster ovary (Steinhauer, Walsh et al. 1989; 
Goodrich, Clouse et al. 2004). Otubain-l, Otubain-2 and Cezanne, OTU DUBs, have 
been shown to display DUB activity in vitro (Balakirev, Tcherniuk et al. 2003; Evans, 
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Smith et al. 2003). For most OTU proteases, their physiological role in vivo, including 
their putative role as DUBs, remains to be investigated. 
JAMMs are DUBs which are metalloproteases. A subunit of the proteasome, 
Rpn11/POH1 was the first identified JAMM (Maytal-Kivity, Reis et al. 2002; Verma, 
Aravind et al. 2002). AMSH (A.ssociated Molecule with the sm domain of ST AM), 
another protein with the MPN+/JAMM motif, was also found to have deubiquitinating 
activity (McCullough, Clague et al. 2004). 
1.2.4. Functions of ubiquitination 
With the many substrates targeted by the ubiquitin pathway, it is not surprising to 
find that this pathway is responsible, directly or indirectly, for regulation of many 
biological systems, including DNA repair (Pastushok and Xiao 2004), transcription 
(Desterro, Rodriguez et al. 2000; Yang, Li et al. 2004; Dhananjayan, Ismail et al. 2005), 
membrane protein trafficking (Marmor and Yarden 2004; d'Azzo, Bongiovanni et al. 
2005; Rubin, Our et al. 2005), ER quality control (Hampton 2002; Ye 2005), cell 
signaling pathways (Moustakas, Souchelnytskyi et al. 2001; Daniel, Torok et al. 2004; 
Hammond, Carter et al. 2004; Rome, Meugnier et al. 2004; Strous, dos Santos et al. 2004; 
Wojcikiewicz 2004; Chen, Kon et al. 2005; Laine and Ronai 2005), cell cycle 
(Vodermaier 2004; Hershko 2005), ion transport (Rotin, Staub et al. 2000), skeletal 
muscle wasting (Lecker 2003; Taillandier, Combaret et al. 2004; Attaix, Ventadour et al. 
2005; Cao, Kim et al. 2005; Wing 2005), synaptic plasticity (Schwartz, Ooldfinger et al. 
1993; DiAntonio and Hicke 2004; Yi and Ehlers 2005), and the immune system (Ben-
Neriah 2002; Liu 2004; Mueller 2004; Liu, Penninger et al. 2005). Dynamic modification 
of proteins by ubiquitin enables reversible switches between different functional states 
(Pickart and Eddins 2004; Varshavsky 2005). 
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1.2.5 The ubiquitin system in spermatogenesis 
A variety of elements involved in the ubiquitin system have been detected in the 
testis (Kay, Ashworth et al. 1991; Baarends, Hoogerbrugge et al. 1999; Bebington, 
Doherty et al. 2001; Sutovsky, Terada et al. 2001). The ubiquitin is expressed in the 
round spermatids and mature sperm in roosters (Agell and Mezquita 1988), bulls 
(Sutovsky, Moreno et al. 2000), and mice (Tipler, Hutchon et al. 1997). Ubiquitin system 
is activated during spermatogenesis (Baarends, Roest et al. 1999; Baarends, van der Laan 
et al. 2000; Bebington, Doherty et al. 2001; Sutovsky 2003). In testis, the enzymes for 
ubiquitin conjugation, El (Kay, Ashworth et al. 1991; Mitchell, Woods et al. 1991), E2 
(Wing and Jain 1995; Roest, van Klaveren et al. 1996; Wing, Bedard et al. 1996; 
Rajapurohitam, Morales et al. 1999; Sutovsky, Moreno et al. 2000) and E3 (Mitchell, 
Woods et al. 1991; Dickins, Frew et al. 2002; Oughtred, Bedard et al. 2002; Kwon, Xia 
et al. 2003; Lorenzetti, Bishop et al. 2004; Liu, Oughtred et al. 2005; Nishito, Hasegawa 
et al. 2006) are present. Our lab has been studying the rodent homologs ofUBC4/5, 
which in yeast are essential for the degradation of short lived and abnormal proteins 
(Seufert and Jentsch 1990). UBC4/5 have been shown to be responsible for the activation 
of ubiquitin conjugation during spermatogenesis (Rajapurohitam, Morales et al. 1999). 
There are multiple isoforms of these homologs in higher eukaryotes. In mammals, three 
rat orthologs (Wing and Jain 1995; Wing, Bedard et al. 1996) and four human orthologs 
ofUBC4/5 (Scheffner, Huibregtse et al. 1994; Jensen, Bates et al. 1995; Rolfe, Beer-
Romero et al. 1995), have been identified. Two of the rat orthologs are widely expressed 
in rat tissues, consistent with their fundamental cellular function, while one isoform, 
UBC4-testis which although having more than ninety percent amino acid identity with 
the other isoforms, is expressed in the testis only (Wing, Bedard et al. 1996). UBC4-testis 
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is absent in early life, but is induced during sexual maturation. It is induced at the stage 
when histones are degraded during spermatogenesis. Although this property of UBC4-
testis suggests it may be required for spermatid maturation, mice lacking the UBC4-testis 
gene show normal spermatogenesis and fertility, but only a minor defect, a delay in 
postnatal testis development (Bedard, Hingamp et al. 2005). 
Polyubiquitin chain binding prote in Mcb 1 is expressed in testis and there is a testis 
specific longer Mcbl transcript in mouse testis (Pusch, Jahner et al. 1998). DUBs are also 
activated during spermatogenesis. Ubiquitin C-terminal hydrolase L-l is essential for the 
early apoptotic wave of germinal cells and for sperm quality control (K won, Kikuchi et al. 
2003; Kwon, Wang et al. 2004; Kwon, Mochida et al. 2005). The ubiquitin C-terminal 
hydrolase PGP 9.5 is expressed in both the testis (Chen, Kon et al. 2005) and the 
epididymis (Santamaria, Martin et al. 1993; Fraile, Martin et al. 1996). Deletions in the 
ubiquitin specific protease USP9 result in infertile males with defective spermatogenesis 
(Sun, Skaletsky et al. 1999; Van Landuyt, Lissens et al. 2001; Lee, Song et al. 2003). 
Proteasomes are present in testis (Mochida, Tres et al. 2000; Wojcik, Benchaib et al. 
2000; Bialy, Ziemba et al. 2001). A testis specific homolog ofhuman 19S proteasome 
subunit, TPB-l, is present in manchettes and in the cytoplasmic lobe of rat elongating 
spermatids (Rivkin, Cullinan et al. 1997). There are two testes specific 20S proteasome 
genes expressed during specific stages of spermatogenesis in Drosophila (Yuan, Miller et 
al. 1996). The importance of proteasomes in normal spermatogenesis has been 
highlighted by the suggestion that C5, a 20S proteasome subunit, may be a candidate for 
the hybrid sterility 1 gene ofinbred mice (Trachtulec, Mnukova-Fajdelova et al. 1997). 
In addition, spermatozoa from patients with varicocele associated sterility show abnormal 
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localization of the proteasome to sperm chromatin and large residual bodies compared to 
normal spermatozoa (Ziemba, Bialy et al. 2002). 
Unique expression of different elements of the ubiquitin system in developing germ 
cells and maturing spermatozoa suggests that different phases of mammalian 
spermatogenesis probably require different specialized activities of the ubiquitin system. 
There is very likely a direct link between ubiquitination and other cellular events such as 
meiosis, gene transcriptionlsilencing, spermatid remodeling, and apoptosis or elimination 
of defective cells during spermatogenesis. The ubiquitin system is highly regulated and 
activated during spermiogenesis (Rajapurohitam, Morales et al. 1999). This may be 
related to the massive breakdown of cytoplasmic and nuclear proteins during this last 
phase of spermatogenesis. 
Development of mature spermatozoa involves the significant reduction of 
mitochondria. It appears that mitochondria are degraded during spermatogenesis and in 
fertilized eggs (Sutovsky, Moreno et al. 1999). The colocalization ofubiquitin with 
mitochondria in spermatids and mature sperm suggests the ubiquitination of the 
spermatid mitochondria (Sutovsky, Moreno et al. 1999; Sutovsky, Moreno et al. 2000). 
Ubiquitin tagged proteins in the mammalian sperm mitochondria may target sperm 
mitochondria for destruction in the egg cytoplasm after fertilization, and may therefore 
explain the exclusive maternaI mitochondria in cells of the offspring. Both lysosomal and 
proteasomal proteolysis have been implicated in such targeteddegradation of the sperm 
mitochondria inside the fertilizedoocyte (Sutovsky, Moreno et al. 2000). A recent study 
(Thompson, Ramalho-Santos et al. 2003) has shown that the mitochondrial membrane 
protein prohibitin is one of the ubiquitinated substrates and may play a role in the 
regulation of mitochondrial inheritance and sperm quality control. 
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Centrosome reduction is a hallmark of spermatid elongation (Manandhar, Sutovsky et 
al. 1998). The centrosome must be reduced during spermatogenesis to avoid its doubling 
in the successive generation. In a somatic cell, like in an immature spermatid, the 
centrosome is composed oftwo centrioles and a halo ofpericentriolar, microtubule 
nucleating material. After fulfilling its role in generating the sperm axoneme, this 
centrosome is either completely removed (mouse, rat, hamster, probably most other 
rodents) or reduced to a single inactive centriole (other mammals, including humans) 
(Sutovsky P 1999). Ubiquitin immunoreactivity can be detected in the centrosomal part 
of the human and rhesus sperm tail (Sutovsky 2003). Proteasomal subunits were also 
detected inside or near the sperm centriole (Mochida, Tres et al. 2000; Wojcik, Benchaib 
et al. 2000; Bialy, Ziemba et al. 2001). Ubiquitin system may therefore be involved in 
centrosome reduction. 
A key event during spermatogenesis is the degradation of histones. Histones are 
found ubiquitinated during spermatogenesis (Agell, Chiva et al. 1983; Agell and 
Mezquita 1988; Chen, Sun et al. 1998; Baarends, Hoogerbrugge et al. 1999). 
Ubiquitination may be required for somatic histones replacement by testis specific 
histones during meiosis and the subsequent substitution of most histones by transition 
proteins which are later replaced by protamines during spermiogenesis, both of which 
result in chromatin reorganization. Ubiquitination of histones may also play an important 
role in meiosis as described in detail in the later section, "the role of histone 
ubiquitination in spermatogenesis". 
1.3. Histone ubiquitination 
Histones are small basic proteins that bind to DNA in chromatin. The most 
fundamental structural unit of chromatin and the first level ofDNA organization is the 
41 
nucleosome core particle, which consists of 146 bp ofDNA wrapped around an octamer 
of very basic proteins called histones. Each nucleosome core has a core histone octamer 
which consists oftwo copies of each of the histones: H2A, H2B, H3 and H4. A (H3-
H4)2 tetramer associates with two H2A-H2B dimers core on each side of the tetramer 
(Arents, Bur1ingame et al. 1991; Pruss 1995; Luger, Mader et al. 1997; Ramakrishnan 
1997). A fifth histone, Hl, protects an extra 20 bp ofDNA that links the nucleosome. 
The evolutionarily conserved histones on nucleosomes have a globular C-terminal 
domain critical to nucleosome formation and a flexible N-terminal tail that protrudes 
from the nucleosome core which is accessible to enzymatic machinery responsible for 
posttranscriptional modification. Histone tails are highly flexible and dynamic. For years, 
histones were assumed to be merely inert structural components, a scaffold for the DNA 
in nucleosome formation, despite the fact that the histone tails are subject to many 
posttranslational modifications such as acetylation, methylation, phosphorylation, ADP 
ribosylation, and ubiquitination (Strahl and Allis 2000; Ausio, Abbott et al. 2001; Berger 
2001). Now it has become increasingly recognized that posttranslational modifications of 
the histones are a key factor in chromatin dynamics and folding, which has fundamental 
impact on many cellular processes including DNA replication and repair, transcriptional 
activation and silencing, gene expression, and cell cycle progression (Garcia-Ramirez, 
Dong et al. 1992; Hansen and Ausio 1992; Moore and Ausio 1997; Wang, He et al. 
2001). Compared to extensive functional and structural studies on histone acetylation 
(Roth, Denu et al. 2001), methylation (Zhang and Reinberg 2001; Lachner and Jenuwein 
2002), and phosphorylation (Cheung, Allis et al. 2000), much less is known about 
histone ubiquitination (AusubeI1993; Jason, Moore et al. 2002; Zhang 2003). 
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Different histones are capable of being ubiquitinated, including H2A (Nickel, Roth et 
al. 1987; Bonner 1988; Wang, Wang et al. 2004), H2B (West and Bonner 1980; Nickel, 
Roth et al. 1987; Thome, Sautiere et al. 1987; Robzyk, Recht et al. 2000), Hl (Pham and 
Sauer 2000), H3 (Chen, Sun et al. 1998) and histone H2A variants H2A.1, H2A.2, 
H2A.Z and H2A.X (West and Bonner 1980). Histone H2A was the first protein ever 
identified to be ubiquitinated (Goldknopf, Taylor et al. 1975). Most studies by far have 
concentrated on the ubiquitination of histones H2A and H2B (uH2A and uH2B), which 
are the most abundant ubiquitinated histones. In eukaryotic cells, lOto 15% of total 
histone H2A is ubiquitinated (West and Bonner 1980), while 10% ofhistone H2B is 
ubiquitinated in yeast (Saccharomyces cerevisiae) (Robzyk, Recht et al. 2000) and 1.5% 
ofhistone H2B is monoubiquitinated in higher eukaryotes (West and Bonner 1980). The 
ubiquitin on uH2A and uH2B is exchanged via conjugation and deconjugation and is in 
equilibrium with free ubiquitin within the nucleus (Matsui, Seon et al. 1979; Wu, Kohn 
et al. 1981; Carlson and Rechsteiner 1987). 
The ubiquitination site on histone H2A has been mapped to the highly conserved 
residue Lys 119 (Nickel, Roth et al. 1987; Wang, Wang et al. 2004). The majority of 
uH2A is in monoubiquitinatedform; however, polyubiquitinated H2A has also been 
detected in many tissues and cell types (Nickel, Roth et al. 1987). In H2B, the 
ubiquitinated site is also on a specifie lysineresidue, Lys 120 inhuman and Lys 123 in 
yeast (Thome, Sautiere et al. 1987). So far, only monoubiquitinated H2B and di-
ubiquitinated H2B have been reported (Nickel, Roth et al. 1987; Davie, Lin et al. 1991). 
The ubiquitination site onH3 or Hl has not been determined. 
Low levels of different polyubiquitinated histones have been identified in many 
tissues, including trout liver and testes, human breast cancer cells, bovine thymus, and 
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tetrahymena (Davie and Nickel 1987; Nickel, Roth et al. 1987; Davie and Murphy 1990; 
Jasinskiene, Jasinskas et al. 1995). Among aIl histones, the highest level of 
polyubiquitination is seen with histone H2A where tetra- and hexa-ubiquitinated fonns 
have been identified (Davie and Nickel 1987; Nickel, Roth et al. 1987). 
1.3.1. Enzymes involved in histone ubiquitination 
Different E2s and E3s have been identified as capable ofubiquitinating different 
histones. Two budding yeast proteins, Rad6 and Cdc34, have been shown to ubiquitinate 
H2B in vitro even without the presence ofE3 (Jentsch, McGrath et al. 1987; Goebl, 
y ochem et al. 1988). However, in vivo in yeast only Rad6 appears to be indispensable for 
H2B ubiquitination (Robzyk, Recht et al. 2000). HR6B (Human homolog of EadQ) and 
its nearly identical homolog HR6A are the mammalian homologs of yeast Rad6. They are 
multifunctional proteins with ubiquitin conjugating activity and essential roles in 
postreplication DNA repair (Roe st, van Klaveren et al. 1996; Baarends, Hoogerbrugge et 
al. 1999; Adegoke, Bedard et al. 2002; Shekhar, Lyakhovich et al. 2002; Baarends, 
Wassenaar et al. 2003; Lyakhovich and Shekhar 2004; Roest, Baarends et al. 2004; 
Kavakebi, Hausott et al. 2005). They can partially complement mutations ofyeast Rad6 
in vivo and are able to ubiquitinate histones in vitro without any E3 (Wing, Dumas et al. 
1992). Just like rnHR6B knockout mouse embryonic fibroblasts, rnHR6A-deficient cells 
appear to have nonnal DNA damage resistance properties (Baarends, Roest et al. 1999; 
Roest, Baarends et al. 2004). Neither animals lacking both proteins nor females with only 
one intact rnHR6A allele are viable, suggesting it is important to keep at least one 
functional rnHR6A or rnHR6B allele in aIl somatic cell types (Roe st, Baarends et al. 
2004). The different phenotype is that mHR6B knockout males show a severe 
spennatogenic defect (Baarends, Roest et al. 1999), while rnHR6A knockout males are 
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normally fertile, but rnHR6A knockout females fail to pro duce offspring despite a normal 
ovarian histology and ovulation (Roest, Baarends et al. 2004). Taken together these 
observations suggest that HR6A and HR6B have redundant but possibly also dose 
dependent roles in somatic cell types and germ line cells in mammals. Recent studies 
have identified Brel, a Rad6 associated RING finger protein, as the E3 ligase for H2B 
ubiquitination (Hwang, Venkatasubrahmanyam et al. 2003; Wood, Krogan et al. 2003) 
(Table 2). Two putative orthologs of Bre 1 have also been identified in humans (Hwang, 
Venkatasubrahmanyam et al. 2003). The Mdm2 oncoprotein, a RING domain E3 known 
to ubiquitinate p53, has been recently shown to interact directly with histones and 
promote in vitro monoubiquitination of histones H2A and H2B (Minsky and Dren 2004). 
Moreover, Mdm2 induces H2B monoubiquitination in vivo, suggesting that Mdm2 cou1d 
be another E3 catalyzing H2B monoubiquitination (Table 2). 
Several enzymes capable of histone H2A ubiquitination have also been reported. In 
vitro studies show that Rad6 is capable of ubiquitinating both H2A and H2B with simi1ar 
kinetics (Haas, Reback et al. 1991). However, it is unknown if Rad6 supports 
ubiquitination ofH2A as it do es for H2B in vivo. uH2A is not detectable in the budding 
yeast Saccharomyces cerevisiae (Robzyk, Recht et al. 2000), which prevents the 
identification of the relevant E2 and E3 enzymes for H2A ubiquitination in yeast. In 
mouse, H2A ubiquitination level appears to be strongly correlated with the level of 
HR6B during spermatogenesis (Baarends, Hoogerbrugge et al. 1999). However, there is 
no defect in the overall pattern of ubiquitinated H2A during mouse spermatogenesis in 
HR6B knockout mice (Baarends, Hoogerbrugge et al. 1999), suggesting that HR6B may 
not be the major E2 for H2A ubiquitination in vivo. Functional redundancy between 
HR6A and HR6B could be another explanation. Recently, an E3 ubiquitin ligase 
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Table 2. Ali identified E3s that mediate histone ubiquitination 
Types of E2 Types Mono- or poly- in- in- Regulation 
histone ofE3 ubiquitination vitro vivo of 
proof proof transcription 
NP95 Ali UbcH5B Ring Mono-I poly-? + + Activation? 
domain 
TAFn250 Hi ? Ring Mono- + + Activation 
domain 
Bre1 H2B Rad6 Ring Mono- + + Activationl 
domain Repression 
dRing1A H2A UbcH5C Ring Mono- + + Repression 
liB domain 
Mdm2 H2A1H2B UbcH5C Ring Mono- + + Repression 
domain 
BRCA1I Ali, UbcH5A1 Ring Mono-l poly- + 
BARD1 except UbcH5B domain 
Hi 
complex, hPRCIL (Human ,Eolycomb Repressive Complex 1 L.ike), has been identified 
that is specific for histone H2A ubiquitination (de Napoles, Mermoud et al. 2004; Fang, 
Chen et al. 2004; Wang, Wang et al. 2004). The complex is composed of several 
Polycomb group proteins including Ringl, Ring2, Bmil and HPH2. hPRCIL 
monoubiquitinates nucleosomal histone H2A at lysine 119 (Table 2). Reducing the 
expression of Ring2 results in a dramatic decrease in the level of ubiquitinated H2A in 
cells. 
Histone Hl is also ubiquitinated. It has been reported that TAFII250, a component of 
the general transcription factor TFIID, possesses ubiquitin activating/conjugating activity 
for Hl in vitro (Pham and Sauer 2000) (Table 2). This is the flIst report that El and E2 
activities can be contained within the same protein. Point mutations on T AFII250 that 
abolish the Hl ubiquitination activity in vitro also lead to decreases in the level of 
ubiquitinated Hl in the Drosophila embryo (Pham and Sauer 2000), suggesting that Hl 
may represent a real in vivo target for TAFII250. 
Np95, a RING E3 that is important in regulating cell cycle, has been found to bind 
histones directly and ubiquitinate histones as an E3 ligase, with a remarkable preference 
for histone H3 (Citterio, Papait et al. 2004) (Table 2). A novel protein domain, the SRA-
YDG domain contained in Np95, is indispensable both for the interaction with histones 
and for chromatin binding in vivo and is required for the E3 ubiquitin ligase activity of 
Np95 on histone ubiquitination in vitro. 
Human BRCAI/BARDI heterodimeric complex has been shown to be capable of 
monoubiquitinating histones in vitro, including the variant histone H2AX (Mallery, 
Vandenberg et al. 2002) (Table 2). 
1.3.2. Deubiquitinating enzymes for histones 
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Ubiquitin can be added and removed from histones as with other reversible 
posttranslational modifications, such as acetylation and phosphorylation. Therefore, the 
levels of histone ubiquitination are determined by the availability offree ubiquitin and of 
the enzymatic activities involved in adding or removing the ubiquitin moiety from 
histones. Several deubiquitinating enzymes have been identified that negatively regulate 
histone ubiquitination. It has been demonstrated that yeast Ubp8 is a stable and 
stoichiometric subunit of the Spt-Ada-Gcn5-acetyltransferase (SAGA), a complex that 
mediates histone acetylation and is required for the expression of a subset of genes, and 
Ubp8 has a role in H2B deubiquitination in vitro and in vivo (Henry, Wyce et al. 2003; 
Daniel, Torok et al. 2004). Mutation of Ubp8 results in the accumulation ofubiquitinated 
H2B (Henry, Wyce et al. 2003). Furthermore, SAGA complex purified from wild type 
strain, but not from ubp8 deletion strain, can deubiquitinate H2B in vitro. The 
deubiquitination function of Ubp8 is specific to H2B but not to other histones. Thus 
SAGA is a complex that possesses both a histone deubiquitination function and a histone 
acetylation function. Potential Ubp8 orthologs exist in various species from plants to 
humans. It remains to be determined whether these Ubp8 orthologs deubiquitine H2B. 
The ubiquitin protease Ubp lOis another DUB that targets H2B for deubiquitination 
in yeast (Emre, Ingvarsdottir et al. 2005). Ubp 1 0 serves to maintain low level of H2B 
Lys123 ubiquitination proximal to telomeres. Very recently it was reported that 
Drosophila ubiquitin specific protease 7 (USP7) also deubiquitinates uH2B (van der 
Knaap, Kumar et al. 2005). USP7 forms a heteromeric complex with guano sine 5'-
monophosphate synthetase (GMPS). The USP7-GMPS complex catalyzes the selective 
deubiquitination of histone H2B, but not H2A. Mutation studies show that USP7 binding 
to GMPS is required for histone H2B deubiquitination. 
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1.3.3. Functions of histone ubiquitination 
Most ubiquitination of histones does not seem to lead to their increased turnover or 
degradation (Seale 1981; Wu, Kohn et al. 1981). Regulatory roles ofhistone 
ubiquitination and deubiquitination include gene transcription, cell cycle and 
spermatogenesis (Jason, Moore et al. 2002; Zhang 2003; Emre and Berger 2004; Kao, 
Hillyer et al. 2004). 
1.3.3.1. The role of histone ubiquitination in gene transcription, activation and 
silencing 
1.3.3.1.1. Role of mA ubiquitination 
Ubiquitination of histones has been linked to the complex processes that regulate 
eukaryotic gene transcription. However, the cellular factors that mediate this histone 
modification during the processes of transcriptional activation are not weIl characterized. 
Very recently, sorne of the important roles of histone ubiquitination on gene transcription 
have been determined. Evidence from early studies suggested that H2A ubiquitination 
may participate in gene activation. It has been reported that transcriptionally active Hsp 
70 genes contain up to 50% uH2A, whereas nucleosomes of nontranscribed DNA contain 
only one uH2A per 25 nucleosomes (Levinger and Varshavsky 1982). Furthermore, 
diubiquitinated H2A was found to be preferentially enriched around the first exon of the 
actively transcribedmouse dihydrofolate reductase (DHFR) gene (Barsoum and 
Varshavsky 1985). Both uH2A and uH2B were found to be enriched around 
transcriptionally active sequences in bovine thymus, chicken erythrocyte, and 
Tetrahymena macronuclei (Nickel, Roth et al. 1987). In contrast, recent studies showed a 
link of H2A ubiquitination with gene repression (Wang, Wang et al. 2004) and to the 
inactive X chromosome (de Napoles, Mermoud et al. 2004; Fang, Chen et al. 2004). 
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hPRCILI PRCI positively regulate Polycomb silencing through H2A ubiquitination via 
its E3 ubiquitin ligase activity (de Napoles, Mermoud et al. 2004; Fang, Chen et al. 2004; 
Wang, Wang et al. 2004). dRing, which is a RING domain subunit ofhPRCIL, 
colocalizes with ubiquitinated H2A at the PRE (Eolycomb response ~lement) and 
promoter regions of the Drosophila Ubx gene in wing imaginal discs and localize on the 
inactive X chromosome. Removal of dRing in SL2 tissue culture cells by RNA 
interference resulted in loss ofH2A ubiquitination accompanied by derepression of Ubx 
(Wang, Wang et al. 2004). Similarly, analysis of RinglB null embryonic stem (ES) cells 
revealed extensive depletion of global uH2A levels (de Napoles, Mermoud et al. 2004). It 
is remained to determine if inactive X chromosome is actived in Ring l B null ES cells. 
Also RinglB mediated H2A ubiquitination is likely involved in the initiation ofboth 
imprinted and random X inactivation (Fang, Chen et al. 2004). These studies suggest that 
the function of H2A ubiquitination on gene transcription may be gene dependent. 
TAFII250 mediates histone Hl monoubiquitination and is likely to be required for 
activation of transcription (Pham and Sauer 2000). T AFII250 is the central subunit 
within the general transcription factor TFIID. In the Drosophila embryo, inactivation of 
the TAFII250 EllE2 activity reduces the cellular level ofmonoubiquitinated histone Hl 
and the expression of genes targeted by the maternaI activator Dorsal. Thus, T AFII250 
mediated Hl ubiquitination may contribute to the process of directing activation of 
eukaryotic transcription. Interestingly, TAFII250 mutations that impair the EllE2 activity 
do not cause a general transcriptional defect, suggesting that Hl ubiquitination may 
participate in transcriptional regulation of a subset of genes such as those controlled by 
the transcriptional factor Dorsal (Pham and Sauer 2000). 
1.3.3.1.2. Role of H2B ubiquitination 
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More has been learned about histone H2B monoubiquitination. Mdm2 mediated H2B 
monoubiquitination is implicated in transcriptional repression rather than activation 
(Minsky and Oren 2004). Mdm2 was originally determined to ubiquitinate and mediate 
p53 degradation under normal conditions (Michael and Oren 2003). It now appears that 
there is another form ofregulation in which Mdm2 associates with p53 inducible genes 
in a p53 dependent manner to repress them through monoubiquitination ofH2B on 
Lys120 and/or Lys125 (Minsky and Oren 2004). Rad6 mediated ubiquitination ofH2B is 
involved in transcription, including gene activation (Kao, Hillyer et al. 2004) and 
repression (Turner, Ricci et al. 2002; Carvin and Kladde 2004), as well as telomeric and 
HMR gene (one of the silent (HM) mating type loci) silencing (Huang, Kahana et al. 
1997). Thus, the function ofH2B Lys123 ubiquitination on gene transcription is gene 
specific. The ability of Rad6, in cooperation with the RING domain E3 Brel, to 
ubiquitinate H2B is specifically required for these transcriptional activities (Huang, 
Kahana et al. 1997; Sun and Allis 2002; Turner, Ricci et al. 2002; Henry, Wyce et al. 
2003; Hwang, Venkatasubrahmanyam et al. 2003; Wood, Krogan et al. 2003; Carvin and 
Kladde 2004; Kao, Hillyer et al. 2004). Rad6 is recruited to gene promoters (Wood, 
Krogan et al. 2003) in a Brel dependent manner (Kao, Hillyer et al. 2004), resulting in 
increased H2B ubiquitination (Henry, Wyce et al. 2003; Kao, Hillyer et al. 2004). 
So far, several studies have shown that H2B monoubiquitination and deubiquitination 
cross talk to methylation of histone and tightly regulate gene transcription through this 
mechanism. Ubiquitination ofH2B is required for methylation of histone H3 on both 
Lys4 (Dover, Schneider et al. 2002; Sun and Allis 2002) and Lys79 (Briggs, Xiao et al. 
2002; Ng, Xu et al. 2002). Either H2B Lys123Arg substitution or RAD6/BREl deletion 
abolishes detectable methylation (Hwang, Venkatasubrahmanyam et al. 2003; Wood, 
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Krogan et al. 2003). However, methylation ofH3 on Lys36 does not require uH2B 
(Briggs, Xiao et al. 2002; Ng, Xu et al. 2002). The function of histone ubiquitination on 
transcription is likely mediated by the cross talk with methylation, since there are strong 
parallels between the alterations in uH2B and methylation ofH3. Similar to uH2B, 
methylation of Lys79 and Lys4 on H3 by the methyltransferase Dot! and Set!, 
respectively, are implicated in silencing (Nislow, Rayet al. 1997; Singer, Kahana et al. 
1998; Briggs, Bryk et al. 2001; Bryk, Briggs et al. 2002; Feng, Wang et al. 2002; Krogan, 
Dover et al. 2002; Ng, Feng et al. 2002; van Leeuwen, Gafken et al. 2002), gene 
activation (Noma and Grewal 2002; Santos-Rosa, Schneider et al. 2002), and repression 
(Carvin and Kladde 2004). 
H2B deubiquitination both positively and negatively regulates gene transcription, as 
can H2B ubiquitination. Ubp8 deubiquitinates H2B in the context of SAGA in vitro and 
in vivo (Henry, Wyce et al. 2003; Daniel, Torok et al. 2004). Consistent with previous 
studies (Henry, Wyce et al. 2003; Kao, Hillyer et al. 2004), this confirms a link between 
H2B ubiquitination and SAGA complex dependent gene activity. Ubpl0 has a broader 
role than Ubp8, helping to maintain quiescence of certain regions within the yeast 
genome (Emre, Ingvarsdottir et al. 2005). Ubp 1 0 targets H2B for deubiquitination on 
Lys123, resulting in low H3 Lys4 and Lys79 methylation, thus helping to localize Sir2 to 
the telomere for telomeric silencing. Ubp 1 0 also similarly regulates gene silencing on the 
rDNA locus, a second silenced domain. Deletion of UBP 10 leads to increased uH2B, 
specifically at a telomere proximal region, and expression of a normally strongly silenced 
gene within this affected region is increased in the absence of Ubp 10 (Emre, 
Ingvarsdottir et al. 2005). Compared to Ubp8 which is the SAGA associated H2B 
deubiquitinating enzyme involved in gene activation, UbplO shows mainly telomeric and 
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gene silencing functions. Drosophila USP7, another H2B specific deubiquitinating 
enzyme, contributes to epigenetic silencing ofhomeotic genes by Polycomb (van der 
Knaap, Kumar et aI. 2005). 
Interestingly, both ubiquitination and deubiquitination ofH2B are required for the 
proper activation of SAGA dependent genes (Henry, Wyce et al. 2003). The intriguing 
fact is that H3 Lys4 trimethylation transactivated by H2B ubiquitination occurs at the 5' 
end of the ORF early during transcript elongation (Santos-Rosa, Schneider et aI. 2002; 
Ng, Ciccone et al. 2003), while H3 Lys36 methylation occurs primarily later during 
transcript elongation (Krogan et al. 2003b; Xiao et al. 2003). As described above, H2B 
ubiquitination is required for H3 Lys4 and Lys79 methylation, but not for H3 Lys36 
methylation. In fact while ubiquitination is required for methylation ofH3 on Lys4, 
deubiquitination is required for methylation of H3 on Lys36. Thus sequentiaI 
ubiquitination and deubiquitination of H2B establishes the correct balance among H3 
methylations required for proper gene activation (Henry, Wyce et al. 2003; Wyce, Henry 
et aI. 2004). Both the histone deubiquitination function and the histone acetylation 
function of SAGA complex are required for the role of SAGA in transcriptional 
activation of certain genes. Histone ubiquitination is increased early in gene activation 
and then, in contrast to histone acetylation, is rapidly cleaved by deubiquitination. The 
failure to remove ubiquitin results in the failure to progress from H3 Lys4 methylation to 
H3 Lys36 methylation, and thus blocks gene activation (Henry, Wyce et al. 2003). 
In summary, histone ubiquitination and deubiquitination have emerged as key 
regulatory signaIs for gene transcription. Similar to histone acetylation, ubiquitination 
regulates two distinct aspects of transcriptional regulation: gene specific activation and 
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silencing in yeast. In contrast to the role of histone acetylation in transcription, both 
adding and removing ubiquitin is required for gene activation by SAGA in yeast. 
1.3.3.2. The role of histone ubiquitination in cell cycle 
The levels of H2A and H2B ubiquitination change during the cell cycle (Wu, Kohn et 
al. 1981). Both uH2A and uH2B have been reported to disappear during the G2 to M 
phase transition when chromatin becomes condensed, but reappear as chromatin 
decondenses at the M to G1 transition (Wu, Kohn et al. 1981). Because the ubiquitin 
molecule is as big as half of the size of core histones, it was believed that incorporation of 
ubiquitinated histones into the nucleosome would impact nucleosome structure and 
hamper chromatin folding. However, biochemical studies reported so far have failed to 
demonstrate a major role for histone ubiquitination in nucleosome core particle assembly 
and nucleosome folding (Moore, Jason et al. 2002). 
Mutation of the conserved site of H2B monoubiquitination is shown to confer defects 
in mitotic cell growth and meiosis, suggesting H2B monoubiquitination regulates cell 
cycle and cell division (Robzyk, Recht et al. 2000). Recently, it is reported that Np95 
may regulate cell cycle by ubiquitinating core histones with a preference for H3 (Citterio, 
Papait et al. 2004). Np95 (Fujimori, Matsuda et al. 1998; Hopfner, Mousli et al. 2000) is 
a cell cycle regulated protein that is expressed at the G1/S boundary and in S phase and is 
absent in Go and G1 (Fujimori, Matsuda et al. 1998; Uemura, Kubo et al. 2000; Miura, 
Watanabe et al. 2001; Bonapace, Latella et al. 2002). Np95 is absolutely required for the 
G liS transition (Muto, Kanari et al. 2002). Np95 has been determined to be tightly bound 
to chromatin in vivo and it binds to histones in vivo and in vitro (Citterio, Papait et al. 
2004). Thus, Np95 may regulate cell cycle through specifie histone ubiquitination. 
1.3.3.3. The role of histone ubiquitination in spermatogenesis 
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The presence of uH2A during spennatogenesis has been weIl documented for a 
number ofyears (AgeIl, Chiva et al. 1983; Agell and Mezquita 1988). uH2A has been 
found during spennatogenesis in different species, such as the rooster (AgeIl, Chiva et al. 
1983), trout (Nickel, Roth et al. 1987), rat (Chen, Sun et al. 1998), and mouse (Baarends, 
Hoogerbrugge et al. 1999). However, it remains unc1ear how histone ubiquitination 
regulates spennatogenesis. 
There are two peaks of H2A ubiquitination during spennatogenesis (Hendriksen, 
Hoogerbrugge et al. 1995; Baarends, Hoogerbrugge et al. 1999). Since it has been 
reported that histone modification alters nuc1eosome stability and thereby may facilitate 
processes that require access to DNA (Li, Nagaraja et al. 1993), ubiquitination of histone 
H2A during pachytene may facilitate replacement of somatic histones by the testis 
specifie isotypes that are synthesized in pachytene (Poccia, Simpson et al. 1987; 
Meistrich 1989; Drabent, Bode et al. 1996). The other peak ofH2A ubiquitination occurs 
post-meiotically during nuc1ear elongation and condensation phases of spennatogenesis 
(Hendriksen, Hoogerbrugge et al. 1995), when histones are replaced by transition 
proteins (Mills, Van et al. 1977; Meistrich 1989). Ubiquitinated histone H2As are at the 
highest levels at this stage during rooster (AgeIl, Chiva et al. 1983) and mouse (Baarends, 
Hoogerbrugge et al. 1999) spennatogenesis. Thus, ubiquitination ofH2A is likely 
required for its degradation, but this is yet to be proved. 
H2B ubiquitination could be important for spennatogenesis. Mutation of rad6 in 
Saccharomyces cerevisiae shows a meiotic prophase arrest (Robzyk, Recht et al. 2000; 
Yamashita, Shinohara et al. 2004). The rad6 mutant exhibits multiple phenotypes during 
meiosis. RAD6 is required for efficient fonnation of double strand breaks (DSBs) in 
meiotic recombination. Similarly, the disruption of the ligase Brel as weIl as substitution 
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of the ubiquitination site of histone H2B also reduees sorne DSB formation, suggesting 
that Rad6-Brel, through ubiquitination of histone H2B, is neeessary for efficient 
reeruitment and/or stabilization of a DSB forming maehinery. Therefore H2B 
ubiquitination may be indispensable for meiotie reeombination during spermatogenesis. 
Knoek out of the gene for mouse HR6B generates a sole phenotype, male infertility 
(Roest, van Klaveren et al. 1996; Baarends, Hoogerbrugge et al. 1999; Baarends, 
Wassenaar et al. 2003). In HR6B knoekout miee, spermatogenesis appears to start up 
normally. The first prominent morphologie al signs of defeetive spermatogenesis beeome 
visible when the spermatids differentiate during the first wave of spermatogenesis. The 
number of elongating and condensing spermatids is redueed in HR6B knoekout compared 
to wild-type mouse testes, and the nuclear morphology is highly abnormal (Roest, van 
Klaveren et al. 1996). However, the overall pattern of histone ubiquitination remains 
unchanged in theHR6B knoekout mice (Baarends, Hoogerbrugge et al. 1999). Thus, the 
exaet role of HR6B mediated H2B ubiquitination in mammalian spermatogenesis 
remains to be determined. 
Ubiquitinated histone H3 and testes specifie H3 (TH3) were first identified in a study 
ofrat spermatogenesis, with the highest level in elongated spermatids (Chen, Sun et al. 
1998). Overall, the role of histone ubiquitination during spermatogenesis remains largely 
unknown. However, based on the above described studies, it is probably involved in gene 
sileneing, meiosis, specific gene induction and degradation of the histones. 
1.4. Summary 
• Upon degradation in early and late elongated spermatids, histones are replaced by 
transition proteins, which in tum are replaced by protamines; 
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• The replacement of histones by protamines is required for chromatin 
condensation; 
• Since ubiquitination is activated during spermatogenesis, and ubiquitinated 
histones have been detected in different species, the degradation of histones 
during the haploid spermatid maturation may be mediated by the ubiquitin 
mediated degradation pathway. 
• Inactivation of mouse HR6B leads to defective spermatogenesis but does not 
appear to prevent histone degradation, suggesting histones may be degraded in a 
HR6B independent ubiquitination pathway. 
• Activation of ubiquitination during spermatogenesis is dependent on a specifie E2, 
UBC4. UBC4-testis is induced in late round and early elongating spermatids in 
which histones are degraded. 
1.5. Objective of the project 
The objective ofthis project is to study the mechanism ofhistone degradation during 
spermatogenesis, specifically, to identify an E3 that polyubiquitinates histones during 
spermatogenesis. 
56 
Aasland, R, T. J. Gibson, et al. (1995). "The PHD finger: implications for chromatin-
mediated transcriptional regulation." Trends Biochem Sci 20(2): 56-9. 
Adegoke, O. A., N. Bedard, et al. (2002). "Ubiquitin-conjugating enzyme E214k1HR6B 
is dispensable for increased protein catabolism in muscle of fasted mice." Am J 
Physiol Endocrinol Metab 283(3): E482-9. 
Agell, N., M. Chiva, et al. (1983). "Changes in nuclear content ofprotein conjugate 
histone H2A-ubiquitin during rooster spermatogenesis." FEBS Lett 155(2): 209-
12. 
Agell, N. and C. Mezquita (1988). "Cellular content ofubiquitin and formation of 
ubiquitin conjugates during chicken spermatogenesis." Biochem J 250(3): 883-9. 
Amerik, A. Y. and M. Hochstrasser (2004). "Mechanism and function of deubiquitinating 
enzymes." Biochim Biophys Acta 1695(1-3): 189-207. 
Andersen, P. L., H. Zhou, et al. (2005). "Distinct regulation ofUbc13 functions by the 
two ubiquitin-conjugating enzyme variants Mms2 and UevlA." J Cell Biol 
170(5): 745-55. 
Arents, G., R W. Burlingame, et al. (1991). "The nucleosomal core histone octamer at 
3.1 A resolution: a tripartite protein assembly and a left-handed superhelix." Proc 
Nat! Acad Sci USA 88(22): 10148-52. 
Attaix, D., S. Ventadour, et al. (2005). "The ubiquitin-proteasome system and skeletal 
muscle wasting." Essays Biochem 41: 173-86. 
Ausio, J., D. W. Abbott, et al. (2001). "Histone variants and histone modifications: a 
structural perspective." Biochem Cell Biol 79(6): 693-708. 
Ausubel, F. M., R Brent, D. D. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and 
K. Struhl (ed.) (1993). CUITent protocols in molecular biology. New York, John 
Wiley & Sons. 
Aviel, S., G. Winberg, et al. (2000). "Degradation of the epstein-barr virus latent 
membrane protein 1 (LMPl) by the ubiquitin-proteasome pathway. Targeting via 
ubiquitination of the N-terminal residue." J Biol Chem 275(31): 23491-9. 
Baarends, W. M., J. W. Hoogerbrugge, et al. (1999). "Histone ubiquitination and 
chromatin remodeling in mouse spermatogenesis." Dev Biol 207(2): 322-33. 
Baarends, W. M., H. P. Roest, et al. (1999). "The ubiquitin system in gametogenesis." 
Mol Cell EndocrinoI151(1-2): 5-16. 
Baarends, W. M., R van der Laan, et al. (2000). "Specific aspects of the ubiquitin system 
in spermatogenesis." J Endocrinol Invest 23(9): 597-604. 
Baarends, W. M., E. Wassenaar, et al. (2003). "Loss ofHR6B ubiquitin-conjugating 
activity results in damaged synaptonemal complex structure and increased 
crossing-over frequency during the male meiotic prophase." Mol Cell Biol 23(4): 
1151-62. 
Bachmair, A. and A. Varshavsky (1989). "The degradation signal in a short-lived 
protein." Ce1l56(6): 1019-32. 
Balakirev, M. Y., S. O. Tcherniuk, et al. (2003). "Otubains: a new family of cysteine 
proteases in the ubiquitin pathway." EMBO Rep 4(5): 517-22. 
Bao, J., G. Gur, et al. (2003). "Src promotes destruction of c-Cbl: implications for 
oncogenic synergy between Src and growth factor receptors." Proc Nat! Acad Sei 
USA 100(5): 2438-43. 
57 
Barsoum, J. and A. Varshavsky (1985). "Preferentiallocalization of variant nucleosomes 
near the 5'-end of the mouse dihydrofolate reductase gene." J Biol Chem 260(12): 
7688-97. 
Beaudenon, S. L., M. R. Huacani, et al. (1999). "Rsp5 ubiquitin-protein ligase mediates 
DNA damage-induced degradation of the large subunit of RNA polymerase II in 
Saccharomyces cerevisiae." Mol Cell Biol 19(10): 6972-9. 
Bebington, C., F. J. Doherty, et al. (2001). "The possible biological and reproductive 
functions ofubiquitin." Hum Reprod Update 7(1): 102-11. 
Bedard, N., P. Hingamp, et al. (2005). "Mice lacking the UBC4-testis gene have a delay 
in postnatal testis development but normal spermatogenesis and fertility." Mol 
Cell Biol 25(15): 6346-54. 
Ben-Neriah, Y. (2002). "Regulatory functions ofubiquitination in the immune system." 
Nat ImmunoI3(1): 20-6. 
Berger, S. L. (2001). "An embarrassment of niches: the many covalent modifications of 
histones in transcriptional regulation." Oncogene 20(24): 3007-13. 
Bialy, L. P., H. T. Ziemba, et al. (2001). "Localization of a proteasomal antigen in human 
spermatozoa: immunohistochemical electron microscopic study." Folia 
Histochem Cytobiol 39(2): 129-30. 
Boname, J. M. and P. G. Stevenson (2001). "MHC class 1 ubiquitination by a viral 
PHD/LAP finger protein." Immunity 15(4): 627-36. 
Bonapace, 1. M., L. Latella, et al. (2002). "Np95 is regulated by ElA during mitotic 
reactivation ofterminally differentiated cells and is essential for S phase entry." l 
Cell Biol 157(6): 909-14. 
Bonner, W. M. (1988). Metabolism ofubiguitinated H2A. CUITent communications in 
molecular biology: the ubiguitin system .. Plainview, N.Y. , Cold Spring Harbor 
Laboratory Press. 
Borden, K. L. (2000). "RING domains: master builders of molecular scaffolds?" J Mol 
Biol 295(5): 1103-12. 
Bornstein, G., J. Bloom, et al. (2003). "Role of the SCFSkp2 ubiquitin ligase in the 
degradation ofp21Cip1 in S phase." J Biol Chem 278(28): 25752-7. 
Bothos, J., M. K. Summers, et al. (2003). "The Chfr mitotic checkpoint protein functions 
with Ubc13-Mms2 to form Lys63-linked polyubiquitin chains." Oncogene 22(46): 
7101-7. 
Breitschopf, K., E. Bengal, et al. (1998). "A novel site for ubiquitination: the N-terminal 
residue, and not internai lysines of MyoD, is essential for conjugation and 
degradation of the protein." Embo J 17(20): 5964-73. 
Briggs, S. D., M. Bryk, et al. (2001). "Histone H3 lysine 4 methylation is mediated by 
Setl and required for cell growth and rDNA silencing in Saccharomyces 
cerevisiae." Genes Dev 15(24): 3286-95. 
Briggs, S. D., T. Xiao, et al. (2002). "Gene silencing: trans-histone regulatory pathway in 
chromatin." Nature 418(6897): 498. 
Bryk, M., S. D. Briggs, et al. (2002). "Evidence that Setl, a factor required for 
methylation of histone H3, regulates rDNA silencing in S. cerevisiae by a Sir2-
independent mechanism." CUIT Biol 12(2): 165-70. 
Bumett, B., F. Li, et al. (2003). "The polyglutamine neurodegenerative protein ataxin-3 
binds polyubiquitylated proteins and has ubiquitin protease activity." Hum Mol 
Genet 12(23): 3195-205. 
58 
Buschmann, T., S. y. Fuchs, et al. (2000). "SUMO-1 modification ofMdm2 prevents its 
self-ubiquitination and increases Mdm2 ability to ubiquitinate p53." Celll0l(7): 
753-62. 
Cadwell, K. and L. Coscoy (2005). "Ubiquitination on nonlysine residues by a viral E3 
ubiquitin ligase." Science 309(5731): 127-30. 
Callaghan, M. J., A. J. Russell, et al. (1998). "Identification of a human HECT family 
protein with homology to the Drosophila tumor suppressor gene hyperplastic 
discs." Oncogene 17(26): 3479-91. 
Cao, P. R., H. J. Kim, et al. (2005). "Ubiquitin-protein ligases in muscle wasting." Int J 
Biochem Cell Biol 37(10): 2088-97. 
Capili, A. D., D. C. Schultz, et al. (2001). "Solution structure of the PHD domain from 
the KAP-1 corepressor: structural determinants for PHD, RING and LIM zinc-
binding domains." Embo J 20(1-2): 165-77. 
Cardozo, T. and M. Pagano (2004). "The SCF ubiquitin ligase: insights into a molecular 
machine." Nat Rev Mol Cell Biol 5(9): 739-51. 
Carlson, N. and M. Rechsteiner (1987). "Microinjection ofubiquitin: intracellular 
distribution and metabolism in HeLa cells maintained under normal physiological 
conditions." J Cell Biol 104(3): 537-46. 
Carvin, C. D. and M. P. Kladde (2004). "Effectors oflysine 4 methylation ofhistone H3 
in Saccharomyces cerevisiae are negative regulators ofPH05 and GAL1-10." l 
Biol Chem 279(32): 33057-62. 
Castro, A., S. Vigneron, et al. (2002). "The D-Box-activating domain (DAD) is a new 
proteolysis signal that stimulates the silent D-Box sequence of Aurora-A." EMBO 
Rep 3(12): 1209-14. 
Chau, V., J. W. Tobias, et al. (1989). "A multiubiquitin chain is confined to specific 
lysine in a targeted short-lived protein." Science 243(4898): 1576-83. 
Chen, D., N. Kon, et al. (2005). "ARF-BP1/Mule is a critical mediator of the ARF tumor 
suppressor." CelII21(7): 1071-83. 
Chen, H. Y., J. M. Sun, et al. (1998). "Ubiquitination of histone H3 in elongating 
spermatids of rat testes." J Biol Chem 273(21): 13165-9. 
Cheung, P., C. D. Allis, et al. (2000). "Signaling to chromatin through histone 
modifications." CelIl03(2): 263-71. 
Christensen, A. K. (1975). Leydig cells. In: Handbook ofphysiology (Hamilton, D.W. 
and Greep, R.O., eds). Wash., D.C., Am. Physiological Soc. 
Chung, C. H. and S. H. Baek (1999). "Deubiquitinating enzymes: their diversity and 
emerging roles." Biochem Biophys Res Commun 266(3): 633-40. 
Chung, Y. H., C. Shin, et al. (2000). "Immunocytochemical study on the distribution of 
p53 in the hippocampus and cerebellum of the aged rat." Brain Res 885(1): 137-
41. 
Ciechanover, A., H. HelIer, et al. (1980). "ATP-dependent conjugation ofreticulocyte 
proteins with the polypeptide required for protein degradation." Proc Natl Acad 
Sci USA 77(3): 1365-8. 
Ciehanover, A., y. Hod, et al. (1978). "A heat-stable polypeptide component of an ATP-
dependent proteolytic system from reticulocytes." Biochem Biophys Res 
Commun 81(4): 1100-5. 
59 
Ciosk, R, W. Zachariae, et al. (1998). "An ESPIIPDSI complex regulates loss ofsister 
chromatid cohesion at the metaphase to anaphase transition in yeast." Ce1l93(6): 
1067-76. 
Citterio, E., R Papait, et al. (2004). "Np95 is a histone-binding protein endowed with 
ubiquitin ligase activity." Mol Cell Biol 24(6): 2526-35. 
Clancy, J. L., M. J. Henderson, et al. (2003). "EDD, the human orthologue of the 
hyperplastic discs tumour suppressor gene, is amplified and overexpressed in 
cancer." Oncogene 22(32): 5070-8I. 
Clermont, Y. and E. Bustos-Obregon (1968). "Re-examination of spermatogonial 
renewal in the rat by means ofseminiferous tubules mounted "in toto"." Am J 
Anat 122(2): 237-47. 
Clermont, Y. and S. C. Harvey (1965). "Duration Of The Cycle Of The Seminiferous 
Epithelium Of Normal, Hypophysectomized And Hypophysectomized-Hormone 
Treated Albino Rats." Endocrinology 76: 80-9. 
Clermont, Y. and B. Perey (1957). "The stages of the cycle of the seminiferous 
epithelium of the rat: practical definitions in PA-Schiff-hematoxylin and 
hematoxylin-eosin stained sections." Rev Can Biol 16(4): 451-62. 
Cohen-Fix, O., J. M. Peters, et al. (1996). "Anaphase initiation in Saccharomyces 
cerevisiae is controlled by the APC-dependent degradation of the anaphase 
inhibitor Pdslp." Genes Dev 10(24): 3081-93. 
Connelly, C. and P. Hieter (1996). "Budding yeast SKPI encodes an evolutionarily 
conserved kinetochore protein required for cell cycle progression." Ce1l86(2): 
275-85. 
Cook, J. C. and P. B. Chock (1992). "Isoforms ofmammalian ubiquitin-activating 
enzyme." J Biol Chem 267(34): 24315-2I. 
Cook, J. C. and P. B. Chock (1995). "Phosphorylation ofubiquitin-activating enzyme in 
cultured cells." Proc Nad Acad Sei USA 92(8): 3454-7. 
Cook, W. J., L. C. Jeffrey, et al. (1993). "Tertiary structures of class l ubiquitin-
conjugating enzymes are highly conserved: crystal structure ofyeast Ubc4." 
Biochemistry 32(50): 13809-17. 
Coscoy, L. and D. Ganem (2003). "PHD domains and E3 ubiquitin ligases: viruses make 
the connection." Trends Cell Biol 13(1): 7-12. 
Coscoy, L., D. J. Sanchez, et al. (2001). "A novel class ofherpesvirus-encoded 
membrane-bound E3 ubiquitin ligases regulates endocytosis of proteins involved 
in immune recognition." J Cell Biol 155(7): 1265-73. 
D'Andrea, A. and D. Pellman (1998). "Deubiquitinating enzymes: a new class of 
biological regulators." Crit Rev Biochem Mol Biol 33(5): 337-52. 
d'Azzo, A., A. Bongiovanni, et al. (2005). "E3 ubiquitin ligases as regulators of 
membrane protein trafficking and degradation." Traffic 6(6): 429-4I. 
Daniel, J. A., M. S. Torok, et al. (2004). "Deubiquitination of histone H2B by a yeast 
acetyltransferase complex regulates transcription." J Biol Chem 279(3): 1867-7I. 
Davie, J. R, R Lin, et al. (1991). "Timing of the appearance ofubiquitinated histones in 
developing new macronuclei of Tetrahymena thermophila." Biochem Cell Biol 
69(1): 66-7I. 
Davie, J. Rand L. C. Murphy (1990). "Level ofubiquitinated histone H2B in chromatin 
is coupled to ongoing transcription." Biochemistrv 29(20): 4752-7. 
60 
Davie, J. Rand B. E. Nickel (1987). "The ubiquitinated histone species are enriched in 
histone Hl-depleted chromatin regions." Biochim Biophys Acta 909(3): 183-9. 
de Kretser, D. M., K. L. Loveland, et al. (1998). "Spermatogenesis." Hum Reprod 13 
Suppl 1: 1-8. 
de Napoles, M., J. E. Mermoud, et al. (2004). "Polycomb group proteins RinglAIB link 
ubiquitylation of histone H2A to heritable gene silencing and X inactivation." 
Dev Cell 7(5): 663-76. 
DeMartino, G. N. and C. A. Slaughter (1999). "The proteasome, a novel protease 
regulated by multiple mechanisms." J Biol Chem 274(32): 22123-6. 
Deng, L., C. Wang, et al. (2000). "Activation of the IkappaB kinase complex by TRAF6 
requires a dimeric ubiquitin-conjugating enzyme complex and a unique 
polyubiquitin chain." Celll03(2): 351-61. 
Deo, R C., N. Sonenberg, et aL (2001). "X-ray structure of the human hyperplastic discs 
protein: an ortho log of the C-terminal domain ofpoly(A)-binding protein." Proc 
Nat! Acad Sci USA 98(8): 4414-9. 
Deshaies, R J. (1999). "SCF and CullinlRing H2-based ubiquitin ligases." Annu Rev 
Cell Dev Biol 15: 435-67. 
Desterro, J. M., M. S. Rodriguez, et al. (2000). "Regulation of transcription factors by 
protein degradation." Cell Mol Life Sci 57(8-9): 1207-19. 
Dhananjayan, S. C., A. Ismail, et al. (2005). "Ubiquitin and control of transcription. " 
Essays Biochem 41: 69-80. 
DiAntonio, A. and L. Hicke (2004). "Ubiquitin-dependent regulation of the synapse." 
Annu Rev Neurosci 27: 223-46. 
Dickins, RA., I. J. Frew, et al. (2002). "The ubiquitin ligase component Siahla is 
required for completion of meiosis 1 in male mice." Mol Cell Biol 22(7): 2294-
303. 
Dikic, I., I. Szymkiewicz, et al. (2003). "Cbl signaling networks in the regulation of cell 
function." Cell Mol Life Sci 60(9): 1805-27. 
Dover, J., J. Schneider, et al. (2002). "Methylation of histone H3 by COMPASS requires 
ubiquitination of histone H2B by Rad6." J Biol Chem 277(32): 28368-71. 
Drabent, B., C. Bode, et aL (1996). "Expression of the mouse testicular histone gene HIt 
during spermatogenesis." Histochem Cell Biol 106(2): 247-51. 
Duan, D. R, A. Pause, et al. (1995). "Inhibition of transcription elongation by the VHL 
tumor suppressor protein." Science 269(5229): 1402-6. 
Duan, L., A. L. Reddi, et al. (2004). "The Cbl familyand other ubiquitin ligases: 
destructive forces in control of antigen receptor signaling." Immunity 21(1): 7-17. 
Dubiel, W., K. Ferrell, et aL (1992). "Subunit 4 of the 26 S protease is a member of a 
novel eukaryotic ATPase family." J Biol Chem 267(32): 22699-702. 
Duncan, K., J. G. Umen, et al. (2000). "A putative ubiquitin ligase required for efficient 
mRNA export differentially affects hnRNP transport." CUIT Biol 10(12): 687-96. 
Dworkin-Rastl, E., A. Shrutkowski, et al. (1984). "Multiple ubiquitin mRNAs during 
Xenopus laevis development contain tandem repeats of the 76 amino acid co ding 
sequence." Ce1l39(2 Pt 1): 321-5. 
Elftman, H. (1950). "The Sertoli cell cycle in the mouse." Anat Rec 106(3): 381-92. 
Emre, N. C. and S. L. Berger (2004). "Histone H2B ubiquitylation and deubiquitylation 
in genomic regulation." Cold Spring Harb Symp Quant Biol 69: 289-99. 
61 
Emre, N. C., K. Ingvarsdottir, et al. (2005). "Maintenance of low histone ubiquitylation 
by Ubpl0 correlates with telomere-proximal Sir2 association and gene silencing." 
Mol Celll7( 4): 585-94. 
Etlinger,1. D. and AL. Goldberg (1977). "A soluble ATP-dependent proteolytic system 
responsible for the degradation of abnormal proteins in reticulocytes." Proc Nad 
Acad Sei USA 74(1): 54-8. 
Ettenberg, S. A, A. Magnifico, et al. (2001). "Cbl-b-dependent coordinated degradation 
of the epidermal growth factor receptor signaling complex." J Biol Chem 276(29): 
27677-84. 
Evans, P. C., T. S. Smith, et al. (2003). "A novel type of deubiquitinating enzyme." J 
Biol Chem 278(25): 23180-6. 
Ewing, L. L., J. C. Davis, et al. (1980). "Regulation oftesticular function: a spatial and 
temporal view." Int Rev Physiol22: 41-115. 
Fang, G., H. Yu, et al. (1998). "The checkpoint protein MAD2 and the mitotic regulator 
CDC20 form a temary complex with the anaphase-promoting complex to control 
anaphase initiation." Genes Dev 12(12): 1871-83. 
Fang, J., T. Chen, et al. (2004). "Ringlb-mediated H2A ubiquitination assoeiates with 
inactive X chromosomes and is involved in initiation of X inactivation." J Biol 
Chem 279(51): 52812-5. 
Fawcett, D. W. (1975). Ultrastructure and function ofteh Sertoli cell. In: Handbook 0 
Physiology (Hamilton, D.W. and Greep RO., eds) Wash., D.C., American 
Physiological Society. 
Feng, Q., H. Wang, et al. (2002). "Methylation ofH3-lysine 79 is mediated by a new 
family ofHMTases without a SET domain." CUIT Biol 12(12): 1052-8. 
Feshchenko, E. A, E. V. Smimova, et al. (2004). "TULA: an SH3- and UBA-containing 
protein that binds to c-Cbl and ubiquitin." Oncogene 23(27): 4690-706. 
Fischer, 1. A. (2003). "Deubiquitinating enzymes: their roles in development, 
differentiation, and disease." Int Rev Cytol 229: 43-72. 
Fisk, H. A. and M. P. Yaffe (1999). "A role for ubiquitination in mitochondrial 
inheritance in Saccharomyces cerevisiae." J Cell Biol 145(6): 1199-208. 
Fraile, B., R Martin, et al. (1996). "Light and electron microscopic 
immunohistochemicallocalization of protein gene product 9.5 and ubiquitin 
immunoreactivities in the human epididymis and vas deferens." Biol Reprod 
55(2): 291-7. 
Friedberge, C., W. Siede, et al. (1991). Cellular responses to DNA damage in yeast, in 
The Molecular and Cellular Biology of the Yeast Saccharomyces, edited by J. R 
BROACHJ., R PRINCLEan d E. W. JONES. Cold Spring Harbor, N.Y. 
Fuja, T. J., F. Lin, et al. (2004). "Somatic mutations and altered expression of the 
candidate tumor suppressors CSNKI epsilon, DLG1, and EDDIhHYD in 
mammary ductal careinoma." Cancer Res 64(3): 942-51. 
Fujimori, A., Y. Matsuda, et al. (1998). "Cloning and mapping ofNp95 gene which 
encodes a novel nuclear protein associated with cell proliferation." Mamm 
Genome 9(12): 1032-5. 
Funabiki, H., K. Kumada, et al. (1996). "Fission yeast CuH and Cut2 are essential for 
sister chromatid separation,concentrate along the metaphase spindle and form 
large complexes." Embo J 15(23): 6617-28. 
62 
Galan, J. M. and R. Haguenauer-Tsapis (1997). "Ubiquitin lys63 is involved in 
ubiquitination of a yeast plasma membrane protein." Embo J 16(19): 5847-54. 
Galan, J. M., V. Moreau, et al. (1996). "Ubiquitination mediated by the NpilpIRsp5p 
ubiquitin-protein ligase is required for endocytosis of the yeast uracil permease." 
J Biol Chem 271(18): 10946-52. 
Garcia-Ramirez, M., F. Dong, et al. (1992). "Role of the histone "tails" in the folding of 
oligonucleosomes depleted of histone HL" J Biol Chem 267(27): 19587-95. 
Gesbert, F., V. Malarde, et al. (2005). "Ubiquitination of the common cytokine receptor 
gammac and regulation of expression by an ubiquitinationldeubiquitination 
machinery." Biochem Biophys Res Commun 334(2): 474-80. 
Ghosh, A. K., A. L. Reddi, et al. (2004). "Biochemical basis for the requirement of 
kinase activity for Cbl-dependent ubiquitinylation and degradation of a target 
tyrosine kinase." J Biol Chem 279(34): 36132-41. 
Gilon, T., o. Chomsky, et al. (1998). "Degradation signals for ubiquitin system 
proteolysis in Saccharomyces cerevisiae." Embo J 17(10): 2759-66. 
Gimenez-Bonafe, P., E. Ribes, et al. (2002). "Chromatin condensation, cysteine-rich 
protamine, and establishment of disulphide interprotamine bonds during 
spermiogenesis of Eledone cirrhosa (Cephalopoda)." Eur J Cell Biol 81(6): 341-9. 
Glickman, M. H., D. M. Rubin, et al. (1998). "A subcomplex of the proteasome 
regulatory particle required for ubiquitin-conjugate degradation and related to the 
COP9-signalosome and eIF3." CeIl94(5): 615-23. 
Glickman, M. H., D. M. Rubin, et al. (1998). "The regulatory particle of the 
Saccharomyces cerevisiae proteasome." Mol Cell Biol 18(6): 3149-62. 
Glotzer, M., A. W. Murray, et al. (1991). "Cyclin is degraded by the ubiquitin pathway." 
Nature 349(6305): 132-8. 
Goebl, M. G., J. Yochem, et al. (1988). "The yeast cell cycle gene CDC34 encodes a 
ubiquitin-conjugating enzyme." Science 241(4871): 1331-5. 
Goldknopf,1. L., C. W. Taylor, et al. (1975). "Isolation and characterization ofprotein 
A24, a "histone-like" non-histone chromosomal protein." J Biol Chem 250(18): 
7182-7. 
Goldstein, G., M. Scheid, et al. (1975). "Isolation of a polypeptide that has lymphocyte-
differentiating properties and is probably represented universally in living ceIls." 
Proc Natl Acad Sci USA 72(1): 11-5. 
Goodrich, J. S., K. N. Clouse, et al. (2004). "Hrb27C, Sqd and Otu cooperatively regulate 
gurken RNA localization and mediate nurse cell chromosome dispersion in 
Drosophila oogenesis." Development 131(9): 1949-58. 
GroIl, M., L. Ditzel, et al. (1997). "Structure of20S proteasome from yeast at 2.4 A 
resolution." Nature 386(6624): 463-71. 
Gu, J., S. G. Irving, et al. (1997). "URE, an initiator (lnr)-like site, suppresses the 
promoter of the rat dynorphin gene." Biochem Biophys Res Commun 231(1): 
172-7. 
Gu, J., K. Ren, et al. (1994). "Cloning of a DNA binding protein that is a tyrosine kinase 
substrate and recognizes an upstream initiator-like sequence in the promoter of 
the preprodynorphin gene." Brain Res Mol Brain Res 24(1-4): 77-88. 
Haas, A. L., P. M. Bright, et al. (1988). "Functional diversity among putative E2 
isozymes in the mechanism of ubiquitin-histone ligation." J Biol Chem 263(26): 
13268-75. 
63 
Haas, A. L., P. B. Reback, et al. (1991). "Ubiquitin conjugation by the yeast RAD6 and 
CDC34 gene products. Comparison to their putative rabbit homologs, E2(20K) 
AND E2(32K)." J Biol Chem 266(8): 5104-12. 
Haas, A. L. and 1. A. Rose (1982). "The mechanism of ubiquitin activating enzyme. A 
kinetic and equilibrium analysis." J Biol Chem 257(17): 10329-37. 
Hammond, D. E., S. Carter, et al. (2004). "Met receptor dynamics and signalling." Curr 
Top Microbiol Immuno1286: 21-44. 
Hampton, R. Y. (2002). "ER-associated degradation in protein quality control and 
cellular regulation." Curr Opin Cell Biol 14(4): 476-82. 
Handley, P. M., M. Mueckler, et al. (1991). "Molecular cloning, sequence, and tissue 
distribution of the human ubiquitin-activating enzyme El." Proc Nad Acad Sci U 
SA 88(1): 258-62. 
Hansen, 1. C. and J. Ausio (1992). "Chromatin dynamics and the modulation of genetic 
activity." Trends Biochem Sci 17(5): 187-91. 
Harris, K. F., 1. Shoji, et al. (1999). "Ubiquitin-mediated degradation of active Src 
tyrosine kinase." Proc Nad Acad Sci USA 96(24): 13738-43. 
Hatakeyama, S., M. Yada, et al. (2001). "U box proteins as a new family ofubiquitin-
protein ligases." J Biol Chem 276(35): 33111-20. 
Hatfield, P. M., J. Callis, et al. (1990). "Cloning ofubiquitin activating enzyme from 
wheat and expression of a functional protein in Escherichia coli." J Biol Chem 
265(26): 15813-7. 
Hauser, H. P., M. Bardroff, et al. (1998). "A giant ubiquitin-conjugating enzyme related 
to IAP apoptosis inhibitors." J Cell Biol 141(6): 1415-22. 
He, X., T. E. Patterson, et al. (1997). "The Schizosaccharomyces pombe spindle 
checkpoint protein mad2p blocks anaphase and genetically interacts with the 
anaphase-promoting complex." Proc Nad Acad Sci USA 94(15): 7965-70. 
Hein, C., J. Y. Springael, et al. (1995). "NPll, an essential yeast gene involved in induced 
degradation of Gap 1 and Fur4 permeases, encodes the Rsp5 ubiquitin-protein 
ligase." Mol MicrobioI18(1): 77-87. 
Henderson, M. J., A. J. Russell, et al. (2002). "EDD, the human hyperplastic discs protein, 
has a role in progesterone receptor co activation and potential involvement in 
DNA damage response." J Biol Chem 277(29): 26468-78. 
Hendriksen, P. J., J. W. Hoogerbrugge, et al. (1995). "Postmeiotic transcription of X and 
y chromosomal genes during spermatogenesis in the mouse." Dev Biol 170(2): 
730-3. 
Henry, K. W., A. Wyce, et al. (2003). "Transcriptional activation via sequential histone 
H2B ubiquitylation and deubiquitylation, mediated by SAGA-associated Ubp8." 
Genes Dev 17(21): 2648-63. 
Hershko, A. (2005). "The ubiquitin system for protein degradation and sorne of its roles 
in the control of the cell-division cycle (Nobel lecture)." Angew Chem Int Ed 
EngI44(37): 5932-43. 
Hershko, A. and A. Ciechanover (1998). "The ubiquitin system." Annu Rev Biochem 67: 
425-79. 
Hershko, A., A. Ciechanover, et al. (1980). "Proposed role of ATP in protein breakdown: 
conjugation of protein with multiple chains of the polypeptide of ATP-dependent 
proteolysis." Proc Nad Acad Sci USA 77(4): 1783-6. 
64 
Hershko, A., A. Ciechanover, et al. (2000). "Basic Medical Research Award. The 
ubiquitin system." Nat Med 6(10): 1073-8l. 
Hershko, A., H. Heller, et al. (1983). "Components ofubiquitin-protein ligase system. 
Resolution, affinity purification, and role in protein breakdown." J Biol Chem 
258(13): 8206-14. 
Hicke, L. (1999). "Gettin' down with ubiquitin: turning off cell-surface receptors, 
transporters and channels." Trends Cell Biol 9(3): 107-12. 
Hicke, L. (2001). "Protein regulation by monoubiquitin." Nat Rev Mol Cell Biol 2(3): 
195-20l. 
Hicke, L. and R. Dunn (2003). "Regulation of membrane protein transport by ubiquitin 
and ubiquitin-binding proteins." Annu Rev Cell Dev Biol 19: 141-72. 
Hicke, L., B. Zanolari, et al. (1998). "Cytoplasmic tail phosphorylation of the alpha-
factor receptor is required for its ubiquitination and intemalization." J Cell Biol 
141(2): 349-58. 
Hilt, W. and D. H. Wolf(1996). "Proteasomes: destruction as a programme." Trends 
Biochem Sci 21(3): 96-102. 
Hochstrasser, M. (1996). "Ubiquitin-dependent protein degradation." Annu Rev Genet 30: 
405-39. 
Hofmann, R. M. and C. M. Pickart (1999). "Noncanonical MMS2-encoded ubiquitin-
conjugating enzyme functions in assembly of novel polyubiquitin chains for DNA 
repair." Ce1l96(5): 645-53. 
Hopfner, R., M. Mousli, et al. (2000). "ICBP90, a novel human CCAAT binding protein, 
involved in the regulation of topoisomerase IIalpha expression." Cancer Res 
60(1): 121-8. 
Hoppe, T., G. Cassata, et al. (2004). "Regulation of the myosin-directed chaperone UNC-
45 by a novel E31E4-multiubiquitylation complex in C. elegans." Cell118(3): 
337-49. 
Hoppe, T., K. Matuschewski, et al. (2000). "Activation of a membrane-bound 
transcription factor by regulated ubiquitinlproteasome-dependent processing. " 
Celll02(5): 577-86. 
Hou, D., C. Cenciarelli, et al. (1994). "Activation-dependent ubiquitination ofa T cell 
antigen receptor subunit on multiple intracellular lysines." J Biol Chem 269(19): 
14244-7. 
Hu, M., P. Li, et al. (2002). "Crystal structure of a UBP-family deubiquitinating enzyme 
in isolation and in complex with ubiquitin aldehyde." Cell111(7): 1041-54. 
Huang, D. T., D. W. Miller, et al. (2004). "A unique EI-E2 interaction required for 
optimal conjugation of the ubiquitin-like protein NEDD8." Nat Struct Mol Biol 
11(10): 927-35. 
Huang, D. T., H. Walden, et al. (2004). "Ubiquitin-like protein activation." Oncogene 
23(11): 1958-7l. 
Huang, F., D. Kirkpatrick, et al. (2006). "Differential Regulation ofEGF Receptor 
Intemalization and Degradation by Multiubiquitination within the Kinase 
Domain." Mol Ce1l21(6): 737-48. 
Huang, H., A. Kahana, et al. (1997). "The ubiquitin-conjugating enzyme Rad6 (Ubc2) is 
required for silencing in Saccharomyces cerevisiae." Mol Cell Biol 17(11): 6693-
9. 
65 
Huang, L., E. Kinnucan, et al. (1999). "Structure of an E6AP-UbcH7 complex: insights 
into ubiquitination by the E2-E3 enzyme cascade." Science 286(5443): 1321-6. 
Huckins, C. (1971). "The spennatogonial stem cell population in adult rats. 1. Their 
morphology, proliferation and maturation." Anat Rec 169(3): 533-57. 
Huckins, C. (1978). "Spennatogonial intercellular bridges in whole-mounted 
seminiferous tubules from nonnal and irradiated rodent testes." Am J Anat 153(1): 
97-121. 
Huibregtse, J. M., M. Scheffner, et al. (1995). "A family ofproteins structurally and 
functionally related to the E6-AP ubiquitin-protein ligase." Proc Natl Acad Sci U 
SA 92(11): 5249. 
Huibregtse, J. M., M. Scheffner, et al. (1993). "Cloning and expression of the cDNA for 
E6-AP, a prote in that mediates the interaction of the human papillomavirus E6 
oncoprotein with p53." Mol Cell Biol 13(2): 775-84. 
Huibregtse, J. M., J. C. Yang, et al. (1997). "The large subunit of RNA polymerase II is a 
substrate of the Rsp5 ubiquitin-protein ligase." Proc Nad Acad Sci USA 94(8): 
3656-61. 
Hwang, W. W., S. Venkatasubrahmanyam, et al. (2003). "A conserved RING finger 
protein required for histone H2B monoubiquitination and cell size control." Mol 
Cellll(1): 261-6. 
Irniger, S., S. Piatti, et al. (1995). "Genes involved in sister chromatid separation are 
needed for B-type cyclin proteolysis in budding yeast." Cell 81(2): 269-78. 
Ishido, S., C. Wang, et al. (2000). "Downregulation of major histocompatibility complex 
class 1 molecules by Kaposi's sarcoma-assoeiated herpesvirus K3 and K5 
proteins." J Virol 74(11): 5300-9. 
Jasinskiene, N., A. Jasinskas, et al. (1995). "Embryonic regulation of histone 
ubiquitination in the sea urchin." Dev Genet 16(3): 278-90. 
Jason, L. J., S. C. Moore, et al. (2002). "Histone ubiquitination: a tagging taïl unfolds?" 
Bioessays 24(2): 166-74. 
Jensen,1. P., P. W. Bates, et al. (1995). "Identification of a family of closely related 
human ubiquitin conjugating enzymes." J Biol Chem 270(51): 30408-14. 
Jentsch, S., J. P. McGrath, et al. (1987). "The yeast DNA repaïr gene RAD6 encodes a 
ubiquitin-conjugating enzyme." Nature 329(6135): 131-4. 
Jentsch, S., W. Seufert, et al. (1991). "Genetic analysis of the ubiquitin system." Biochim 
Biophys Acta 1089(2): 127-39. 
Jentsch, S., W. Seufert, et al. (1990). "Ubiquitin-conjugating enzymes: nove! regulators 
of eukaryotic cells." Trends Biochem Sei 15(5): 195-8. 
Jiang, F. and R Basavappa (1999). "Crystal structure of the cyclin-specific ubiquitin-
conjugating enzyme from clam, E2-C, at 2.0 A resolution." Biochemistrv 38(20): 
6471-8. 
Jiang, J., C. A. Ballinger, et al. (2001). "CHIP is a U-box-dependent E3 ubiquitin ligase: 
identification ofHsc70 as a target for ubiquitylation." J Biol Chem 276(46): 
42938-44. 
Joazeiro, C. A. and A. M. Weissman (2000). "RING fmger proteins: mediators of 
ubiquitin ligase activity." Celll02(5): 549-52. 
Johnson, P. R, R Swanson, et al. (1998). "Degradation signal masking by 
heterodimerization of MATalpha2 and MATaI blocks their mutual destruction by 
the ubiquitin-proteasome pathway." Ce1l94(2): 217-27. 
66 
Johnston, J. A., C. L. Ward, et aI. (1998). "Aggresomes: a cellular response to misfolded 
proteins." J Cell Biol 143(7): 1883-98. 
Kaiser, P., K. Flick, et al. (2000). "Regulation of transcription by ubiquitination without 
proteolysis: Cdc34/SCF(Met30)-mediated inactivation of the transcription factor 
Met4." Celll02(3): 303-14. 
Kao, C. F., C. Hillyer, et al. (2004). "Rad6 plays a role in transcriptionaI activation 
through ubiquitylation of histone H2B." Genes Dev 18(2): 184-95. 
Kassenbrock, C. K. and S. M. Anderson (2004). "Regulation ofubiquitin protein ligase 
activity in c-Cbl by phosphorylation-induced conformationaI change and 
constitutive activation by tyrosine to glutamate point mutations." J Biol Chem 
279(27): 28017-27. 
Kavakebi, P., B. Hausott, et al. (2005). "The N-end rule ubiquitin-conjugating enzyme, 
HR6B, is up-regulated by nerve growth factor and required for neurite 
outgrowth." Mol Cell Neurosci 29(4): 559-68. 
Kay, G. F., A. Ashworth, et al. (1991). "A candidate spermatogenesis gene on the mouse 
y chromosome is homologous to ubiquitin-activating enzyme El." Nature 
354(6353): 486-9. 
Kerr, J. B. and D. M. de Kretser (1974). "Proceedings: The role of the Sertoli cell in 
phagocytosis of the residuaI bodies ofspermatids." J Reprod Fertil36(2): 439-40. 
Kibel, A., O. Iliopoulos, et aI. (1995). "Binding of the von Hippel-Lindau tumor 
suppressor protein to Elongin Band C." Science 269(5229): 1444-6. 
Kilinc, F., S. Guvel, et aI. (2004). "p53 EXPRESSION AND APOPTOSIS IN 
VARICOCELE IN THE RAT TESTIS." J Uro1172(6 Pt 1): 2475-8. 
Kim, K. S., J. A. Foster, et al. (2001). "DifferentiaI release of guinea pig sperm 
acrosomaI components during exocytosis." Biol Reprod 64(1): 148-56. 
King, R. W., J. M. Peters, et al. (1995). "A 20S complex containing CDC27 and CDC16 
catalyzes the mitosis-specific conjugation ofubiquitin to cyclin B." CeIl81(2): 
279-88. 
Kishino, T., M. Lalande, et al. (1997). "UBE3A1E6-AP mutations cause Angelman 
syndrome." Nat Genet 15(1): 70-3. 
Koegl, M., T. Hoppe, et aI. (1999). "A novel ubiquitination factor, E4, is involved in 
multiubiquitin chain assembly." CeIl96(5): 635-44. 
Koepp, D. M., J. W. Harper, et al. (1999). "How the cyclin became a cyclin: regulated 
proteolysis in the cell cycle." CeIl97(4): 431-4. 
Kotani, S., H. Tanaka, et aI. (1999). "Regulation of APC activity by phosphorylation and 
regulatory factors." J Cell Biol 146(4): 791-800. 
Kowanetz, K., N. Crosetto, et al. (2004). "Suppressors ofT-cell receptor signaling Sts-l 
and Sts-2 bind to Cbl and inhibit endocytosis ofreceptor tyrosine kinases." J Biol 
Chem 279(31): 32786-95. 
Krajewski, S., S. Bodrug, et al. (1995). "lmmunohistochemicaI analysis of Mcl-l protein 
in human tissues. DifferentiaI regulation of Mcl-l and Bcl-2 protein production 
suggests a unique role for Mcl-l in control of programmed cell death in vivo." 
Am J PathoI146(6): 1309-19. 
Krogan, N. J., J. Dover, et al. (2002). "COMPASS, a histone H3 (Lysine 4) 
methyltransferase required for telomeric silencing of gene expression." J Biol 
Chem 277(13): 10753-5. 
67 
Kuhlbrodt, K., J. Mouysset, et al. (2005). "Orchestra for assembly and fate of 
polyubiquitin chains." Essays Biochem 41: 1-14. 
Kuhne, C. and L. Banks (1998). "E3-ubiquitin ligaselE6-AP links multicopy maintenance 
protein 7 to the ubiquitination pathway by a novel motif, the L2G box." J Biol 
Chem 273(51): 34302-9. 
Kumar, S., W. H. Kao, et al. (1997). "Physical interaction between specific E2 and Hect 
E3 enzymes determines functional cooperativity." J Biol Chem 272(21): 13548-
54. 
Kumar, S., A. L. Talis, et al. (1999). "Identification ofHHR23A as a substrate for E6-
associated protein-mediated ubiquitination." J Biol Chem 274(26): 18785-92. 
Kwon, J., T. Kikuchi, et al. (2003). "Characterization of the testis in congenitally 
ubiquitin carboxy-terminal hydrolase-l (Uch-Ll) defective (gad) mice." Exp 
Anim 52(1): 1-9. 
Kwon, J., K. Mochida, et al. (2005). "Ubiquitin C-terminal hydrolase L-l is essential for 
the early apoptotic wave of germinal cells and for sperm quality control during 
spermatogenesis." Biol Reprod 73(1): 29-35. 
Kwon, J., Y. L. Wang, et al. (2004). "Developmental regulation ofubiquitin C-terminal 
hydrolase isozyme expression during spermatogenesis in mice." Biol Reprod 
71(2): 515-21. 
Kwon, Y. T., Y. Reiss, et al. (1998). "The mouse and human genes encoding the 
recognition component of the N-end rule pathway." Proc Nad Acad Sci USA 
95(14): 7898-903. 
Kwon, Y. T., Z. Xia, et al. (2003). "Female lethality and apoptosis of spermatocytes in 
mice lacking the UBR2 ubiquitin ligase of the N-end rule pathway." Mol Cell 
Biol 23(22): 8255-71. 
Lachner, M. and T. Jenuwein (2002). "The many faces ofhistone lysine methylation." 
CUIT Opin Cell Biol 14(3): 286-98. 
Lahav-Baratz, S., V. Sudakin, et al. (1995). "Reversible phosphorylation controls the 
activity of cyclosome-associated cyclin-ubiquitin ligase." Proc Nad Acad Sei U S 
A 92(20): 9303-7. 
Laine, A. and Z. Ronai (2005). "Ubiquitin chains in the ladder of MAPK signaling." Sei 
STKE 2005(281): re5. 
Lake, M. W., M. M. Wuebbens, et al. (2001). "Mechanism ofubiquitin activation 
revealed by the structure of a bacterial MoeB-MoaD complex." Nature 414(6861): 
325-9. 
Lalli, M. and Y. Clermont (1981). "Structural changes of the head components of the rat 
spermatid during late spermiogenesis." Am J Anat 160(4): 419-34. 
Lalli, M. F. (1972). the formation of the head of the rat spermatozoon. Montreal, McGill 
University. Ph.D 
Laney, J. D. and M. Hochstrasser (1999). "Substrate targeting in the ubiquitin system." 
Ce1l97(4): 427-30. 
Lawson, T. G., D. L. Gronros, et al. (1999). "Identification and characterization ofa 
protein destruction signal in the encephalomyocarditis virus 3C protease." J Biol 
Chem 274(14): 9904-80. 
Leblond, C. P. and Y. Clermont (1952). "Definition of the stages of the cycle of the 
seminiferous epithelium in the rat." Ann N Y Acad Sei 55(4): 548-73. 
68 
Leblond, C. P. and Y. Clennont (1952). "Spenniogenesis ofrat, mouse, hamster and 
guinea pig as revealed by the periodic acid-fuchsin sulfurous acid technique." Am 
J Anat 90(2): 167-215. 
Lecker, S. H. (2003). "Ubiquitin-protein ligases in muscle wasting: multiple parallel 
pathways?" CUIT ODin Clin Nutr Metab Care 6(3): 271-5. 
Lee, K. H., G. J. Song, et al. (2003). "Ubiquitin-specific protease activity ofUSP9Y, a 
male infertility gene on the Y chromosome." Reorod Fertil Dev 15(1-2): 129-33. 
Levinger, L. and A. Varshavsky (1982). "Selective arrangement ofubiquitinated and Dl 
protein-containing nucleosomes within the Drosophila genome." Ce1l28(2): 375-
85. 
Li, W., S. Nagaraja, et al. (1993). "Effects ofhistone acetylation, ubiquitination and 
variants on nucleosome stability." Biochem J 296 (Pt 3): 737-44. 
Lin, H. and S. S. Wing (2000). "Identification ofrabbit reticulocyte E217K as a UBC7 
homologue and functional characterization of its core domain loop." J Biol Chem 
275(37): 29178. 
Lin, M., A. Harman, et al. (1997). "Spenniogenesis and spenniation in a marsupial, the 
tammar wallaby (Macropus eugenii)." J Anat 190 (Pt 3): 377-95. 
Littlepage, L. E. and J. V. Rudennan (2002). "Identification of a new APC/C recognition 
domain, the A box, which is required for the Cdh1-dependent destruction of the 
kinase Aurora-A during mitotic exit." Genes Dev 16(17): 2274-85. 
Liu, J., J. Stevens, et al. (2001). "Siah-1 mediates a novel beta-catenin degradation 
pathway linking p53 to the adenomatous polyposis coli protein." Mol Cell 7(5): 
927-36. 
Liu, Y. C. (2004). "Ubiquitin ligases and the immune response." Annu Rev Immuno122: 
81-127. 
Liu, Y. C., J. Penninger, et al. (2005). "Immunity by ubiquitylation: a reversible process 
of modification." Nat Rev ImmunoI5(12): 941-52. 
Liu, Z., A. L. Haas, et al. (1996). "Characterization of a novel keratinocyte ubiquitin 
carrier protein." J Biol Chem 271(5): 2817-22. 
Liu, Z., R. Oughtred, et al. (2005). "Characterization ofE3Histone, a novel testis 
ubiquitin protein ligase which ubiquitinates histones." Mol Cell Biol 25(7): 2819-
31. 
Lorenzetti, D., C. E. Bishop, et al. (2004). "Deletion of the Parkin coregulated gene 
causes male sterility in the quaking(viable) mouse mutant." Proc Nad Acad Sci U 
SA 101(22): 8402-7. 
Luger, K., A. W. Mader, et al. (1997). "Crystal structure of the nucleosome core particle 
at 2.8 A resolution." Nature 389(6648): 251-60. 
Lyakhovich, A. and M. P. Shekhar (2004). "RAD6B overexpression conf ers 
chemoresistance: RAD6 expression during cell cycle and its redistribution to 
chromatin during DNA damage-induced response." Oncogene 23(17): 3097-106. 
Ma, C. P., C. A. Slaughter, et al. (1992). "Identification, purification, and 
characterization of a protein activator (P A28) of the 20 S proteasome 
(macropain)." J Biol Chem 267(15): 10515-23. 
Magnifico, A., S. Ettenberg, et al. (2003). "WW domain HECT E3s target Cbl RING 
fmger E3s for proteasomal degradation." J Biol Chem 278(44): 43169-77. 
69 
/-_.-
Makarova, K. S., L. Aravind, et al. (2000). "A novel superfamily of predicted cysteine 
proteases from eukaryotes, viruses and Chlamydia pneumoniae." Trends Biochem 
Sci 25(2): 50-2. 
Mallery, D. L., C. J. Vandenberg, et al. (2002). "Activation of the E3 ligase function of 
the BRCA1/BARDl complex by polyubiquitin chains." Embo J 21(24): 6755-62. 
Manandhar, G., P. Sutovsky, et al. (1998). "Centrosome reduction during mouse 
spermiogenesis." Dev Biol 203(2): 424-34. 
Mancini, A, A Koch, et al. (2002). "c-Cbl associates direcdy with the C-terminal tail of 
the receptor for the macrophage colony-stimulating factor, c-Fms, and down-
modulates this receptor but not the viral oncogene v-Fms." J Biol Chem 277(17): 
14635-40. 
Mansfield, E., E. Hersperger, et al. (1994). "Genetic and molecular analysis of 
hyperplastic discs, a gene whose product is required for regulation of cell 
proliferation in Drosophila melanogaster imaginal discs and germ cells." Dev 
Biol 165(2): 507-26. 
Mao, Y., F. Senic-Matuglia, et al. (2005). "Deubiquitinating function ofataxin-3: insights 
from the solution structure of the Josephin domain." Proc Natl Acad Sci USA 
102(36): 12700-5. 
Marmor, M. D. and Y. Yarden (2004). "Role ofprotein ubiquitylation in regulating 
endocytosis ofreceptor tyrosine kinases." Oncogene 23(11): 2057-70. 
Mastrandrea, L. D., J. You, et al. (1999). "E21E3-mediated assembly oflysine 29-linked 
polyubiquitin chains." J Biol Chem 274(38): 27299-306. 
Matsui, S. I., B. K. Seon, et al. (1979). "Disappearance of a structural chromatin protein 
A24 in mitosis: implications for molecular basis of chromatin condensation." 
Proc Nad Acad Sci USA 76(12): 6386-90. 
Matsuura, T., J. S. Sutc1iffe, et al. (1997). "De novo truncating mutations in E6-AP 
ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome." Nat Genet 15(1): 
74-7. 
Maytal-Kivity, V., N. Reis, et al. (2002). "MPN+, a putative catalytic motiffound in a 
subset of MPN domain proteins from eukaryotes and prokaryotes, is critical for 
Rpnll function." BMC Biochem 3(1): 28. 
McCullough, J., M. J. Clague, et al. (2004). "AMSH is an endosome-associated ubiquitin 
isopeptidase." J Cell Biol 166(4): 487-92. 
McGrath, J. P., S. Jentsch, et al. (1991). "UBA 1: an essential yeast gene encoding 
ubiquitin-activating enzyme." Embo J 10(1): 227-36. 
Meistrich, M. L. (1989). Histones and other basic nuc1ear proteins. Boca Raton, Fla., , 
CRC Press. 
Michael, D. and M. Oren (2003). "The p53-Mdm2 module and the ubiquitin system." 
Sernin Cancer Biol 13(1): 49-58. 
Mills, N. C., N. T. Van, et al. (1977). "Histones of rat testis chromatin during early 
postnatal development and their interactions with DNA" Biol Reprod 17(5): 760-
8. 
Min, J. H., H. Yang, et al. (2002). "Structure of an HIF-lalpha -pVHL complex: 
hydroxyproline recognition in signaling." Science 296(5574): 1886-9. 
Minsky, N. and M. Oren (2004). "The RING domain ofMdm2 mediates histone 
ubiquitylation and transcriptional repression." Mol CellI6(4): 631-9. 
70 
Mita, M. and P. F. Hall (1982). "Metabolism of round spermatids from rats: lactate as the 
preferred substrate." Biol Reprod 26(3): 445-55. 
Mitchell, M. J., D. R. Woods, et al. (1991). "Homology of a candidate spermatogenic 
gene from the mouse Y chromosome to the ubiquitin-activating enzyme El." 
Nature 354(6353): 483-6. 
Miura, M., H. Watanabe, et al. (2001). "Dynamic changes in subnuclear NP95 location 
during the cell cycle and its spatial relationship with DNA replication foci." Exp 
Cell Res 263(2): 202-8. 
Miura, T., W. Klaus, et al. (1999). "Characterization of the binding interface between 
ubiquitin and class 1 human ubiquitin-conjugating enzyme 2b by 
multidimensional heteronuclear NMR spectroscopy in solution." J Mol Biol 
290(1): 213-28. 
Mizuno, E., T. lura, et al. (2005). "Regulation of epidermal growth factor receptor down-
regulation by VBPY -mediated deubiquitination at endosomes." Mol Biol Cell 
16(11): 5163-74. 
Mochida, K., L. L. Tres, et al. (2000). "Structural features of the 26S proteasome 
complex isolated from rat testis and sperm tail." Mol Reprod Dev 57(2): 176-84. 
Monesi, v. (1965). "Synthetic activities during spermatogenesis in the mouse RNA and 
protein." Exp Cell Res 39(1): 197-224. 
Moore, S. C. and J. Ausio (1997). "Major role of the histones H3-H4 in the folding of the 
chromatin fiber." Biochem Biophys Res Commun 230(1): 136-9. 
Moore, S. C., L. Jason, et al. (2002). "The elusive structural role ofubiquitinated 
histones." Biochem Cell Biol 80(3): 311-9. 
Mori, H. and A. K. Christensen (1980). "Morphometric analysis of Leydig cells in the 
normal rat testis." J Cell Biol 84(2): 340-54. 
Mori, Y., F. Sato, et al. (2002). "Instabilotyping reveals unique mutational spectra in 
microsatellite-unstable gastric cancers." Cancer Res 62(13): 3641-5. 
Moustakas, A., S. Souchelnytskyi, et al. (2001). "Smad regulation in TGF-beta signal 
transduction." J Cell Sci 114(Pt 24): 4359-69. 
Moynihan, T. P., H. C. Ardley, et al. (1999). "The ubiquitin-conjugating enzymes UbcH7 
and UbcH8 interact with RING fingerlIBR motif-containing domains ofHHARI 
and H7-APl." J Biol Chem 274(43): 30963-8. 
Mueller, D. L. (2004). "E3 ubiquitin ligases as T cell anergy factors." Nat ImmunoI5(9): 
883-90. 
Muller, D., M. Rehbein, et al. (1992). "Molecular characterization of a novel rat protein 
structurally related to poly(A) binding proteins and the 70K protein of the VI 
small nuclear ribonucleoprotein particle (snRNP)." Nucleic Acids Res 20(7): 
1471-5. 
Muthuswamy, S. K., M. Gilman, et al. (1999). "Controlled dimerization of ErbB 
receptors provides evidence for differential signaling by homo- and 
heterodimers." Mol Cell Biol 19(10): 6845-57. 
Muto, M., Y. Kanari, et al. (2002). "Targeted disruption ofNp95 gene renders murine 
embryonic stem cells hypersensitive to DNA damaging agents and DNA 
replication blocks." J Biol Chem 277(37): 34549-55. 
Ng, H. H., D. N. Ciccone, et al. (2003). "Lysine-79 ofhistone H3 is hypomethylated at 
silenced loci in yeast and mammalian cells: a potential mechanism for position-
effect variegation." Proc Nad Acad Sci V S A 100(4): 1820-5. 
71 
Ng, H. H., Q. Feng, et al. (2002). "Lysine methylation within the globular domain of 
histone H3 by Dotl is important for telomeric silencing and Sir protein 
association." Genes Dev 16(12): 1518-27. 
Ng, H. H., R M. Xu, et al. (2002). "Ubiquitination ofhistone H2B by Rad6 is required 
for efficient Dotl-mediated methylation of histone H3 lysine 79." J Biol Chem 
277(38): 34655-7. 
Nguyen, J. T., C. W. Turck, et al. (1998). "Exploiting the basis ofproline recognition by 
SH3 and WW domains: design ofN-substituted inhibitors." Science 282(5396): 
2088-92. 
Nicastro, G., R P. Menon, et al. (2005). "The solution structure of the Josephin domain 
of ataxin-3: structural determinants for molecular recognition." Proc Nad Acad 
Sci USA 102(30): 10493-8. 
Nickel, B. E., S. Y. Roth, et al. (1987). "Changes in the histone H2A variant H2AZ and 
polyubiquitinated histone species in developing trout testis." Biochemistry 26(14): 
4417-21. 
Nijman, S. M., M. P. Luna-Vargas, et al. (2005). "A genomic and functional inventory of 
deubiquitinating enzymes." Cell123(5): 773-86. 
Nishito, Y., M. Hasegawa, et al. (2006). "MEX is a testis-specific E3 ubiquitin ligase that 
promotes death receptor-induced apoptosis." Biochem J. 
Nislow, C., E. Ray, et al. (1997). "SET1, a yeast member of the trithorax family, 
functions in transcriptional silencing and diverse cellular processes." Mol Biol 
Ce1l8(12): 2421-36. 
Noma, K. and S. 1. Grewal (2002). "Histone H3 lysine 4 methylation is mediated by Set1 
and promotes maintenance of active chromatin states in fission yeast." Proc Natl 
Acad Sci USA 99 Suppl 4: 16438-45. 
Nuber, U., S. Schwarz, et al. (1996). "Cloning ofhuman ubiquitin-conjugating enzymes 
UbcH6 and UbcH7 (E2-F1) and characterization oftheir interaction with E6-AP 
and RSP5." J Biol Chem 271(5): 2795-800. 
Oda, H., S. Kumar, et al. (1999). "Regulation of the Src family tyrosine kinase Blk 
through E6AP-mediated ubiquitination." Proc Nad Acad Sci USA 96(17): 9557-
62. 
Ogunjimi, A A, D. J. Briant, et al. (2005). "Regulation ofSmurf2 ubiquitin ligase 
activity by anchoring the E2 to the HECT domain." Mol Cell19(3): 297-308. 
Orlicky, S., X. Tang, et al. (2003). "Structural basis for phosphodependent substrate 
selection and orientation by the SCFCdc4 ubiquitin ligase." Celll12(2): 243-56. 
Orlowski, M. (1990). "The multicatalytic proteinase complex, a major extralysosomal 
proteolytic system." Biochemistry 29(45): 10289-97. 
Orlowski, M. and S. Wilk (2000). "Catalytic activities of the 20 S proteasome, a 
multicatalytic proteinase complex." Arch Biochem Biophys 383(1): 1-16. 
Oughtred, R, N. Bedard, et al. (2002). "Characterization of ratl 00, a 300-kilodalton 
ubiquitin-protein ligase induced in germ cells of the rat testis and similar to the 
Drosophila hyperplastic discs gene." Endocrinology 143(10): 3740-7. 
Owens, T. J. and M. A. Hoyt (2005). "The D box asserts itself." Mol Cell18(6): 611-2. 
Ozkaynak, E., D. Finley, et al. (1984). "The yeast ubiquitin gene: head-to-tail repeats 
encoding a polyubiquitin precursor protein." Nature 312(5995): 663-6. 
Page, A. M. and P. Hieter (1999). "The anaphase-promoting complex: new subunits and 
regulators." Annu Rev Biochem 68: 583-609. 
72 
Pascual, J., M. Martinez-Yamout, et al. (2000). "Structure of the PHD zinc finger from 
human Williams-Beuren syndrome transcription factor." J Mol Biol 304(5): 723-9. 
Pastushok, L. and W. Xiao (2004). "DNA postreplication repair modulated by 
ubiquitination and sumoylation." Adv Protein Chem 69: 279-306. 
Patton, E. E., A. R. Willems, et al. (1998). "Combinatorial control in ubiquitin-dependent 
proteolysis: don't Skp the F-box hypothesis." Trends Genet 14(6): 236-43. 
Peng, J., D. Schwartz, et al. (2003). "A proteomics approach to understanding protein 
ubiquitination." Nat BiotechnoI21(8): 921-6. 
Peschard, P., T. M. Fournier, et al. (2001). "Mutation of the c-Cbl TKB domain binding 
site on the Met receptor tyrosine kinase converts it into a transforming protein." 
Mol Ce1l8(5): 995-1004. 
Peters, J. M., R. W. King, et al. (1996). "Identification ofBIME as a subunit of the 
anaphase-promoting complex." Science 274(5290): 1199-20l. 
Petroski, M. D. and R. J. Deshaies (2005). "Function and regulation of cul lin-RING 
ubiquitin ligases." Nat Rev Mol Cell Biol 6(1): 9-20. 
Pfleger, C. M. and M. W. Kirschner (2000). "The KEN box: an APC recognition signal 
distinct from the D box targeted by Cdhl." Genes Dev 14(6): 655-65. 
Pham, A. D. and F. Sauer (2000). "Ubiquitin-activating/conjugating activity ofTAFII250, 
a mediator of activation of gene expression in Drosophila." Science 289(5488): 
2357-60. 
Pickart, C. M. (2001). "Mechanisms underlying ubiquitination." Annu Rev Biochem 70: 
503-33. 
Pickart, C. M. and M. J. Eddins (2004). "Ubiquitin: structures, functions, mechanisms." 
Biochim Biophys Acta 1695(1-3): 55-72. 
Plant, P. J., F. Lafont, et al. (2000). "Apical membrane targeting ofNedd4 is mediated by 
an association ofits C2 domain with annexin XIIIb." J Cell Biol 149(7): 1473-84. 
Plemper, R. K. and D. H. Wolf(1999). "Retrograde protein translocation: ERADication 
of secretory proteins in health and disease." Trends Biochem Sci 24(7): 266-70. 
Poccia, D. L., M. V. Simpson, et al. (1987). "Transitions in histone variants during sea 
urchin spermatogenesis." Dev Biol 121(2): 445-53. 
Pruss, D., Hayes, J.J., and Wolffe, A. (1995). Histone and DNA contributions 
to nucleosome structure. The nucleus. Greenwich, Conn. ,Jai Press Inc. 
Pusch, W., D. Jahner, et al. (1998). "Molecular cloning and testicular expression ofthe 
gene transcripts encoding the murine multiubiquitin-chain-binding protein 
(Mcbl)." Gene 207(1): 19-24. 
Qiu, L., C. Joazeiro, et al. (2000). "Recognition and ubiquitination ofNotch by Itch, a 
hect-type E3 ubiquitin ligase." J Biol Chem 275(46): 35734-7. 
Rajapurohitam, V., C. R. Morales, et al. (1999). "Activation ofa UBC4-dependent 
pathway of ubiquitin conjugation during postnatal development of the rat testis." 
Dev Biol 212(1): 217-28. 
Ramakrishnan, V. (1997). "Histone structure and the organization of the nucleosome." 
Annu Rev Biophys Biomol Struct 26: 83-112. 
Rechsteiner, M., L. Hoffman, et al. (1993). "The multicatalytic and 26 S proteases." l 
Biol Chem 268(9): 6065-8. 
Rivett, A. J. (1989). "The multicatalytic proteinase. Multiple proteolytic activities." l 
Biol Chem 264(21): 12215-9. 
73 
Rivkin, E., E. B. Cullinan, et al. (1997). "A protein associated with the manchette during 
rat spermiogenesis is encoded by a gene of the TBP-l-like subfamily with highly 
conserved ATPase and protease domains." Mol Reprod Dev 48(1): 77-89. 
Robzyk, K., 1. Recht, et al. (2000). "Rad6-dependent ubiquitination ofhistone H2B in 
yeast." Science 287(5452): 501-4. 
Rock, K. L., C. Gramm, et al. (1994). "Inhibitors of the proteasome block the degradation 
ofmost cell proteins and the generation of peptides presented on MHC class 1 
molecules." Cell 78(5): 761-71. 
Roest, H. P., W. M. Baarends, et al. (2004). "The ubiquitin-conjugating DNA repair 
enzyme HR6A is a maternaI factor essential for early embryonic development in 
mice." Mol Cell Biol 24(12): 5485-95. 
Roest, H. P., J. van Klaveren, et al. (1996). "Inactivation of the HR6B ubiquitin-
conjugating DNA repair enzyme in mice causes male sterility associated with 
chromatin modification." CeIl86(5): 799-810. 
Rolfe, M., P. Beer-Romero, et al. (1995). "Reconstitution ofp53-ubiquitinylation 
reactions from purified components: the role ofhuman ubiquitin-conjugating 
enzyme UBC4 and E6-associated protein (E6AP)." Proc Nat! Acad Sci USA 
92(8): 3264-8. 
Rome, S., E. Meugnier, et al. (2004). "The ubiquitin-proteasome pathway is a new 
partner for the control of insulin signaling." CUIT Opin Clin Nutr Metab Care 7(3): 
249-54. 
Roosen-Runge, E. C. (1977). The Process ofSpermatogenesis in Animals. Cambtidge 
Cambtidge University Press. 
Roosen-Runge, E. C. and L. o. Giesel, Jr. (1950). "Quantitative studies on 
spermatogenesis in the albino rat." Am J Anat 87(1): 1-30. 
Rossmann, M. G., D. Moras, et al. (1974). "Chemical and biological evolution of 
nucleotide-binding protein." Nature 250(463): 194-9. 
Roth, S. Y., J. M. Denu, et al. (2001). "Histone acetyltransferases." Annu Rev Biochem 
70: 81-120. 
Rotin, D., O. Staub, et al. (2000). "Ubiquitination and endocytosis of plasma membrane 
proteins: role ofNedd4/Rsp5p family ofubiquitin-protein ligases." J Membr Biol 
176(1): 1-17. 
Roussel, M. F., S. A. Shurtleff, et al. (1990). "A point mutation at tyrosine-809 in the 
human colony-stimulating factor 1 receptor impairs mitogenesis without 
abrogating tyrosine kinase activity, association with phosphatidylinositoI3-kinase, 
or induction of c-fos and junB genes." Proc Nat! Acad Sci USA 87(17): 6738-42. 
Rubin, C., G. Gur, et al. (2005). "Negative regulation ofreceptor tyrosine kinases: 
unexpected links to c-Cbl and receptor ubiquitylation." Cell Res 15( 1): 66-71. 
Rudolph, M. J., M. M. Wuebbens, et al. (2001). "Crystal structure ofmolybdopterin 
synthase and its evolutionary relationship to ubiquitin activation." Nat Struct Biol 
8(1): 42-6. 
Russell, L. (1977). "Movement of spermatocytes from the basal to the adluminal 
compartment of the rat testis." Am J Anat 148(3): 313-28. 
Russell, L. (1980). "Sertoli-germ cell interrelations: a review." Gamete Research 3: 179-
202. 
74 
Russell, L. (1993). Morphological and functional evidence for Sertoli-germ cell 
relationships. In Russell LD and Griswold MD Ceds) The Sertoli Cell. Clearwater, 
FL, Cache River Press. 
Russell, L. and Y. Clermont (1976). "Anchoring device between Sertoli cells and late 
spermatids in rat seminiferous tubules." Anat Rec 185(3): 259-78. 
Russell, L. and B. Frank (1978). "Characterization of rat spermatocytes after plastic 
embedding." Arch Androll(1): 5-18. 
Russell, L. D. (1978). "The blood-testis barrier and its formation relative to spermatocyte 
maturation in the adult rat: a lanthanum tracer study." Anat Rec 190(1): 99-111. 
Russell, L. D., Ettlin, R. A., Sinha Hikim, A. P., Clegg, E. D. (1990). Histolodyand 
histopathological evaluation of the testis. Clearwater, FI, Cache River Press. 
Russell, L. D., J. C. Goh, et al. (1988). "The consequences of actin disruption at Sertoli 
ectoplasmic specialization sites facing spermatids after in vivo exposure of rat 
testis to cytochalasin D." Biol Reprod 39(1): 105-18. 
Russell, L. D., 1. P. Lee, et al. (1983). "Development of the acrosome and alignment, 
elongation and entrenchment of spermatids in procarbazine-treated rats." Tissue 
CellI5(4): 615-26. 
Russell, L. D., N. K. Saxena, et al. (1989). "Cytoskeletal involvement in spermiation and 
sperm transport." Tissue Ce1l21(3): 361-79. 
Saleh, A., M. Collart, et al. (1998). "TOMlp, a yeast hect-domain protein which 
mediates transcriptional regulation through the ADAISAGA coactivator 
complexes." J Mol Biol 282(5): 933-46. 
Santamaria, L., R. Martin, et al. (1993). "Protein gene product 9.5 and ubiquitin 
immunoreactivities in rat epididymis epithelium." Histochemistrv 100(2): 131-8. 
Santos-Rosa, H., R. Schneider, et al. (2002). "Active genes are tri-methylated at K4 of 
histone H3." Nature 419(6905): 407-11. 
Sasaki, T., A. Toh-e, et al. (2000). "Extragenic suppressors that rescue defects in the heat 
stress response of the budding yeast mutant toml." Mol Gen Genet 262(6): 940-8. 
Sassone-Corsi, P. (2002). "Unique chromatin remodeling and transcriptional regulation 
in spermatogenesis." Science 296(5576): 2176-8. 
Sawada, N., O. Ochi, et al. (1975). "Electron microscope studies on sperm differentiation 
in marine annelid worms." Development, Growth and Differentiation, 17(2): 77-
87. 
Saxena, D. K., 1. Tanii, et al. (2000). "Behaviour and role of an intra-acrosomal antigenic 
molecule, acrin 3, during mouse fertilisation in vitro." Zygote 8(4): 329-38. 
Saxena, D. K., 1. Tanii, et al. (1999). "Role ofintra-acrosomal antigenic molecules acrin 
1 (MN7) and acrin 2 (MC41) in penetration of the zona pellucida in fertilization 
in mice." J Reprod Fertil117(1): 17-25. 
Scheel, H., S. Tomiuk, et al. (2003). "Elucidation of ataxin-3 and ataxin-7 function by 
integrative bioinformatics." Hum Mol Genet 12(21): 2845-52. 
Scheffner, M., J. M. Huibregtse, et al. (1994). "Identification of a human ubiquitin-
conjugating enzyme that mediates the E6-AP-dependent ubiquitination ofp53." 
Proc Nat! Acad Sci USA 91(19): 8797-801. 
Scheffner, M., J. M. Huibregtse, et al. (1993). "The HPV-16 E6 and E6-AP complex 
functions as a ubiquitin-protein ligase in the ubiquitination ofp53." Cell 75(3): 
495-505. 
75 
Scheffner, M., U. Nuber, et al. (1995). "Protein ubiquitination involving an EI-E2-E3 
enzyme ubiquitin thioester cascade." Nature 373(6509): 81-3. 
Schild, L., Y. Lu, et al. (1996). "Identification of a PY motif in the epithelial Na channel 
subunits as a target sequence for mutations causing channel activation found in 
Liddle syndrome." Embo J 15(10): 2381-7. 
Schulze, C. (1974). "On the morphology of the human Sertoli cell." Cell Tissue Res 
153(3): 339-55. 
Schwab, M., A. S. Lutum, et al. (1997). "Yeast Hctl is a regulator of Clb2 cyclin 
proteolysis." Cell90(4): 683-93. 
Schwartz, D., N. Goldfinger, et al. (1993). "Expression ofp53 protein in spermatogenesis 
is confined to the tetraploid pachytene primary spermatocytes." Oncogene 8(6): 
1487-94. 
Schwarz, S. E., J. L. Rosa, et al. (1998). "Characterization ofhuman hect domain family 
members and their interaction with UbcH5 and UbcH7." J Biol Chem 273(20): 
12148-54. 
Schwob, E., T. Bohm, et al. (1994). "The B-type cyc1in kinase inhibitor p40SICI controls 
the G 1 to S transition in S. cerevisiae." Cell 79(2): 233-44. 
Seale, R. L. (1981). "Rapid turnover of the histone-ubiquitin conjugate, protein A24." 
Nuc1eic Acids Res 9(13): 3151-8. 
Seol, J. H., R. M. Feldman, et al. (1999). "Cdc53/cullin and the essential Hrtl RING-H2 
subunit of SCF define a ubiquitin ligase module that activates the E2 enzyme 
Cdc34." Genes Dev 13(12): 1614-26. 
Seufert, W., B. Futcher, et al. (1995). "Role ofa ubiquitin-conjugating enzyme in 
degradation ofS- and M-phase cyc1ins." Nature 373(6509): 78-81. 
Seufert, W. and S. Jentsch (1990). "Ubiquitin-conjugating enzymes UBC4 and UBC5 
mediate selective degradation ofshort-lived and abnormal proteins." Embo J 9(2): 
543-50. 
Shang, F., G. Deng, et al. (2001). "Ubiquitin-activating enzyme (El) isoforms in lens 
epithelial cells: origin of translation, E2 specificity and cellular localization 
determined with novel site-specific antibodies." Exp Eye Res 73(6): 827-36. 
Shcherbik, N. and D. S. Haines (2004). "Ub on the move." J Cell Biochem 93(1): 11-9. 
Shekhar, M. P., A. Lyakhovich, et al. (2002). "Rad6 overexpression induces 
multinuc1eation, centrosome amplification, abnormal mitosis, aneuploidy, and 
transformation." Cancer Res 62(7): 2115-24. 
Shirayama, M., W. Zachariae, et al. (1998). "The Polo-like kinase Cdc5p and the WD-
repeat protein Cdc20p/fizzy are regulators and substrates of the anaphase 
promoting complex in Saccharomyces cerevisiae." Embo J 17(5): 1336-49. 
Sigismund, S., S. Polo, et al. (2004). "Signaling through monoubiquitination." CUIT Top 
Microbiol Immuno1286: 149-85. 
Singer, M. S., A. Kahana, et al. (1998). "Identification ofhigh-copy disruptors of 
telomeric silencing in Saccharomyces cerevisiae." Genetics 150(2): 613-32. 
Skowyra, D., D. M. Koepp, et al. (1999). "Reconstitution ofGl cyc1in ubiquitination 
with complexes containing SCFGrrl and Rbx1." Science 284(5414): 662-5. 
Soboleva, T. A. and R. T. Baker (2004). "Deubiquitinating enzymes: their functions and 
substrate specificity." CUIT Protein Pept Sci 5(3): 191-200. 
Sommer, T. and S. Jentsch (1993). "A protein translocation defect linked to ubiquitin 
conjugation at theendoplasmic reticulum." Nature 365(6442): 176-9. 
76 
Spence, J., R R Gali, et al. (2000). "Cell cycle-regulated modification of the ribosome 
by a variant multiubiquitin chain." Celll02(1): 67-76. 
Spence, J., S. Sadis, et al. (1995). "A ubiquitin mutant with specific defects in DNA 
repair and multiubiquitination." Mol Cell Biol 15(3): 1265-73. 
Sprando, R L. and L. D. Russell (1987). "Comparative study of cytoplasmic elimination 
in spermatids ofselected mammalian species." Am J Anat 178(1): 72-80. 
Spruck, C., H. Strohmaier, et al. (2001). "A CDK-independent function ofmammalian 
Cks1: targeting of SCF(Skp2) to the CDK inhibitor p27Kipl." Mol Cell 7(3): 
639-50. 
Staub, O., S. Dho, et al. (1996). "WW domains ofNedd4 bind to the proline-rich PY 
motifs in the epithelial Na+ channel deleted in Liddle's syndrome." Embo J 
15(10): 2371-80. 
Staub, O., 1. Gautschi, et al. (1997). "Regulation of stability and function of the epithelial 
Na+ channel (ENaC) by ubiquitination." Embo J 16(21): 6325-36. 
Steinhauer, W. R, R C. Walsh, et al. (1989). "Sequence and structure of the Drosophila 
melanogaster ovarian tumor gene and generation of an antibody specific for the 
ovarian tumor protein." Mol Cell Biol 9(12): 5726-32. 
Stephen, A. G., J. S. Trausch-Azar, et al. (1996). "The ubiquitin-activating enzyme El is 
phosphorylated and localized to the nucleus in a cell cycle-dependent manner." J 
Biol Chem 271(26): 15608-14. 
Stephen, A. G., J. S. Trausch-Azar, et al. (1997). "Identification ofa region within the 
ubiquitin-activating enzyme required for nuclear targeting and phosphorylation." 
J Biol Chem 272(16): 10895-903. 
Strahl, B. D. and C. D. Allis (2000). "The language of covalent histone modifications." 
Nature 403(6765): 41-5. 
Strohmaier, H., C. H. Spruck, et al. (2001). "Human F -box protein hCdc4 targets cyclin E 
for proteolysis and is mutated in a breast cancer cellline." Nature 413(6853): 
316-22. 
Strous, G. J., C. A. dos Santos, et al. (2004). "Ubiquitin system-dependent regulation of 
growth hormone receptor signal transduction." CUIT Top Microbiol Immuno1286: 
81-118. 
Stumptner, C., H. Heid, et al. (1999). "Analysis ofintracytoplasmic hyaline bodies in a 
hepatocellular carcinoma. Demonstration of p62 as major constituent." Am J 
PathoI154(6): 1701-10. 
Sudakin, V., D. Ganoth, et al. (1995). "The cyclosome, a large complex containing 
cyclin-selective ubiquitin ligase activity, targets cyclins for destruction at the end 
of mitosis." Mol Biol Cell 6(2): 185-97. 
Sun, C., H. Skaletsky, et al. (1999). "An azoospermic man with a de novo point mutation 
in the Y-chromosomal gene USP9Y." Nat Genet 23(4): 429-32. 
Sun, Z. W. and C. D. Allis (2002). "Ubiquitination of histone H2B regulates H3 
methylation and gene silencing in yeast." Nature 418(6893): 104-8. 
Sung, P., S. Prakash, et al. (1991). "Stable ester conjugate between the Saccharomyces 
cerevisiae RAD6 protein and ubiquitin has no biological activity." J Mol Biol 
221(3): 745-9. 
Sutovsky, P. (2003). "Ubiquitin-dependent proteolysis in mammalian spermatogenesis, 
fertilization, and sperm quality control: killing three birds with one stone." 
Microsc Res Tech 61(1): 88-102. 
77 
Sutovsky P, M. G., Schatten G. (1999). "Biogenesis of the 
centrosome during mammalian gametogenesis and fertilization." Protoplasma 206: 249-
262. 
Sutovsky, P., R. D. Moreno, et al. (1999). "Ubiquitin tag for spenn mitochondria." 
Nature 402(6760): 371-2. 
Sutovsky, P., R. D. Moreno, et al. (2000). "Ubiquitinated spenn mitochondria, selective 
proteolysis, and the regulation of mitochondrial inheritance in mammalian 
embryos." Biol Reprod 63(2): 582-90. 
Sutovsky, P., y. Terada, et al. (2001). "Ubiquitin-based spenn assay for the diagnosis of 
male factor infertility." Hum Reprod 16(2): 250-8. 
Taillandier, D., L. Combaret, et al. (2004). "The role ofubiquitin-proteasome-dependent 
proteolysis in the remodelling ofskeletal muscle." Proc Nutr Soc 63(2): 357-61. 
Tanahashi, N., Y. Murakami, et al. (2000). "Hybrid proteasomes. Induction by 
interferon-gamma and contribution to ATP-dependent proteolysis." J Biol Chem 
275(19): 14336-45. 
Thien, C. B. and W. Y. Langdon (2001). "Cbl: many adaptations to regulate protein 
tyrosine kinases." Nat Rev Mol Cell Biol 2(4): 294-307. 
Thompson, W. E., J. Ramalho-Santos, et al. (2003). "Ubiquitination ofprohibitin in 
mammalian spenn mitochondria: possible roles in the regulation of mitochondrial 
inheritance and spenn qUality control." Biol Reprod 69(1): 254-60. 
Thome, A. W., P. Sautiere, et al. (1987). "The structure ofubiquitinated histone H2B." 
Embo J 6(4): 1005-10. 
Tipler, C. P., S. P. Hutchon, et al. (1997). "Purification and characterization of26S 
proteasomes from human and mouse spennatozoa." Mol Hum Reprod 3(12): 
1053-60. 
Trachtulec, Z., M. Mnukova-Fajdelova, et al. (1997). "Isolation of candidate hybrid 
sterility 1 genes by cDNA selection in a 1.1 megabase pair region on mouse 
chromosome 17." Mamm Genome 8(5): 312-6. 
Treier, M., L. M. Staszewski, et al. (1994). "Ubiquitin-dependent c-Jun degradation in 
vivo is mediated by the delta domain." Cell 78(5): 787-98. 
Turner, S. D., A. R. Ricci, et al. (2002). "The E2 ubiquitin conjugase Rad6 is required for 
the ArgRIMcml repression of ARGI transcription." Mol Cell Biol 22(12): 4011-
9. 
Tyers, M. and P. Jorgensen (2000). "Proteolysis and the cell cycle: with this RING 1 do 
thee destroy." CUIT Opin Genet Dev 10(1): 54-64. 
Uemura, T., E. Kubo, et al. (2000). "Temporal and spatiallocalization of novel nuclear 
protein NP95 in mitotic and meiotic cells." Cell Struct Funct 25(3): 149-59. 
Ulrich, H. D. and S. Jentsch (2000). "Two RING fmger proteins mediate cooperation 
between ubiquitin-conjugating enzymes in DNA repair." Embo J 19(13): 3388-97. 
Utsugi, T., A. Hirata, et al. (1999). "Yeast toml mutant exhibits pleiotropic defects in 
nuclear division, maintenance of nuclear structure and nucleocytoplasmic 
transport at high temperatures." Gene 234(2): 285-95. 
Utsugi, T., A. Toh-e, et al. (1995). "A high dose of the STMI gene suppresses the 
temperature sensitivity of the toml and htrl mutants in Saccharomyces 
cerevisiae." Biochim Biophys Acta 1263(3): 285-8. 
van der Knaap, J. A., B. R. Kumar, et al. (2005). "GMP synthetase stimulates histone 
H2B deubiquitylation by the epigenetic silencer USP7." Mol CellI7(5): 695-707. 
78 
Van Landuyt, L., W. Lissens, et al. (2001). "The role ofUSP9Y and DBY in infertile 
patients with severely impaired spermatogenesis." Mol Hum Reprod 7(7): 691-3. 
van Leeuwen, F., P. R. Gafken, et al. (2002). "Dotlp modulates silencing in yeast by 
methylation of the nucleosome core." CeIlI09(6): 745-56. 
Varshavsky, A. (1997). "The ubiquitin system." Trends Biochem Sci 22(10): 383-7. 
Varshavsky, A. (2005). "Regulated protein degradation." Trends Biochem Sci 30(6): 
283-6. 
Verdecia, M. A., C. A. Joazeiro, et al. (2003). "Conformational flexibility underlies 
ubiquitin ligation mediated by the WWPl HECT domain E3 ligase." Mol Cell 
11(1): 249-59. 
Verma, R., L. Aravind, et al. (2002). "Role ofRpnll metalloprotease in deubiquitination 
and degradation by the 26S proteasome." Science 298(5593): 611-5. 
Vilar, O., M. 1. Perez Del Cerro, et al. (1962). "The Sertoli cell as a "bridge cell" between 
the basal membrane and the germinal cells. Histochemical and electron 
microscope observations." Exp Cell Res 27: 158-61. 
Visintin, R., S. Prinz, et al. (1997). "CDC20 and CDHl: a family ofsubstrate-specific 
activators of APC-dependent proteolysis." Science 278(5337): 460-3. 
Vodermaier, H. C. (2004). "APC/C and SCF: controlling each other and the cell cycle." 
CUIT Biol 14(18): R787-96. 
Voges, D., P. Zwickl, et al. (1999). "The 26S proteasome: a molecular machine designed 
for controlled proteolysis." Annu Rev Biochem 68: 1015-68. 
Walden, H., M. S. Podgorski, et al. (2003). "The structure of the APPBPI-UBA3-
NEDD8-ATP complex reveals the basis for selective ubiquitin-like protein 
activation by an EL" Mol CeIlI2(6): 1427-37. 
Walden, H., M. S. Podgorski, et al. (2003). "Insights into the ubiquitin transfer cascade 
from the structure of the activating enzyme for NEDD8." Nature 422(6929): 330-
4. 
Wang, C., J. Xi, et al. (2001). "Solution structure of ThiS and implications for the 
evolutionary roots ofubiquitin." Nat Struct Biol 8(1): 47-51. 
Wang, H., L. Wang, et al. (2004). "Role ofhistone H2A ubiquitination in Polycomb 
silencing." Nature 431(7010): 873-8. 
Wang, x., C. He, et al. (2001). "Effects of histone acetylation on the solubility and 
folding of the chromatin fiber." J Biol Chem 276(16): 12764-8. 
Wefes, L, L. D. Mastrandrea, et al. (1995). "Induction ofubiquitin-conjugating enzymes 
during terminal erythroid differentiation." Proc Nat! Acad Sci USA 92(11): 
4982-6. 
Weissman, A. M. (2001). "Themes and variations on ubiquitylation." Nat Rev Mol Cell 
Biol 2(3): 169-78. 
West, M. H. and W. M. Bonner (1980). "Histone 2A, aheteromorphous family ofeight 
protein species." Biochemistry 19(14): 3238-45. 
West, M. H. and W. M. Bonner (1980). "Histone 2B can be modified by the attachment 
ofubiquitin." Nucleic Acids Res 8(20): 4671-80. 
Whitby, F. G., E. 1. Masters, et al. (2000). "Structural basis for the activation of20S 
proteasomes by Ils regulators." Nature 408(6808): 115-20. 
Wilkinson, C. R., M. Seeger, et al. (2001). "Proteins containing the UBA domain are able 
to bind to multi-ubiquitin chains." Nat Cell Biol 3(10): 939-43. 
79 
Wilkinson, K. D. (1997). "Regulation ofubiquitin-dependent processes by 
deubiquitinating enzymes." Faseb J 11(14): 1245-56. 
Wilkinson, K. D. (2000). "Ubiquitination and deubiquitination: targeting ofproteins for 
degradation by the proteasome." Sernin Cell Dev Biol 11(3): 141-8. 
Wing, S. S. (2003). "Deubiquitinating enzymes--the importance of driving in reverse 
along the ubiquitin-proteasome pathway." Int J Biochem Cell Biol 35(5): 590-605. 
Wing, S. S. (2005). "Control of ubiquitination in skeletal muscle wasting." Int J Biochem 
Cell Biol 37(10): 2075-87. 
Wing, S. S., N. Bedard, et al. (1996). "A novel rat homolog of the Saccharomyces 
cerevisiae ubiquitin-conjugating enzymes UBC4 and UBC5 with distinct 
biochemical features is induced during spermatogenesis." Mol Cell Biol 16(8): 
4064-72. 
Wing, S. S., F. Dumas, et al. (1992). "A rabbit reticulocyte ubiquitin carrier protein that 
supports ubiquitin-dependent proteolysis (E214k) is homologous to the yeast 
DNA repair gene RAD6." J Biol Chem 267(10): 6495-50l. 
Wing, S. S. and P. Jaïn (1995). "Molecular cloning, expression and characterization of a 
ubiquitin conjugation enzyme (E2(17)kB) highly expressed in rat testis." 
Biochem J 305 ( Pt 1): 125-32. 
Winston, J. T., P. Strack, et al. (1999). "The SCFbeta-TRCP-ubiquitin ligase complex 
associates specifically with phosphorylated destruction motifs in lkappaBalpha 
and beta-catenin and stimulates lkappaBalpha ubiquitination in vitro." Genes Dev 
13(3): 270-83. 
Wojeik, C., M. Benchaib, et al. (2000). "Proteasomes in human spermatozoa." Int J 
AndroI23(3): 169-77. 
Wojeikiewicz, R. J. (2004). "Regulated ubiquitination ofproteins in GPCR-initiated 
signaling pathways." Trends Pharmacol Sei 25(1): 35-4l. 
Wood, A., N. J. Krogan, et al. (2003). "Brel, an E3 ubiquitin ligase required for 
recruitment and substrate selection of Rad6 at a promoter." Mol CeIl11(1): 267-
74. 
Worthylake, D. K., S. Prakash, et al. (1998). "Crystal structure of the Saccharomyces 
cerevisiae ubiquitin-conjugating enzyme Rad6 at 2.6 A resolution." J Biol Chem 
273(11): 6271-6. 
Wu, R. S., K. W. Kohn, et al. (1981). "Metabolism ofubiquitinated histones." J Biol 
Chem 256(11): 5916-20. 
Wu, W. J., S. Tu, et al. (2003). "Activated Cdc42 sequesters c-Cbl and prevents EGF 
receptor degradation." CeIl114(6): 715-25. 
Wyce, A., K. W. Henry, et al. (2004). "H2B ubiquitylation and de-ubiquitylation in gene 
activation." Novartis Found Symp 259: 63-73; discussion 73-7, 163-9. 
Yamanaka, A., S. Hatakeyama, et al. (2000). "Cell cycle-dependent expression of 
mammalian E2-C regulated by the anaphase-promoting complexlcyclosome." 
Mol Biol CeIlH(8): 2821-3l. 
Yamashita, K., M. Shinohara, et al. (2004). "Rad6-Bre1-mediated histone H2B 
ubiquitylation modulates the formation of double-strand breaks during meiosis. " 
Proc Nad Acad Sei USA 101(31): 11380-5. 
Yang, Y., C. C. Li, et al. (2004). "Regulating the p53 system through ubiquitination." 
Oncogene 23(11): 2096-106. 
80 
Yao, T. and R. E. Cohen (2002). "A cryptic protease couples deubiquitination and 
degradation by the proteasome." Nature 419(6905): 403-7. 
y aron, A, A Hatzubai, et al. (1998). "Identification of the receptor component of the 
IkappaBalpha-ubiquitin ligase." Nature 396(6711): 590-4. 
y e, Y. (2005). "The role of the ubiquitin-proteasome system in ER quality control." 
Essays Biochem 41: 99-112. 
Yi, J. J. and M. D. Ehlers (2005). "Ubiquitin and protein turnover in synapse function." 
Neuron 47(5): 629-32. 
Yokouchi, M., T. Kondo, et al. (1999). "Ligand-induced ubiquitination of the epidermal 
growth factor receptor involves the interaction of the c-Cbl RING finger and 
UbcH7." J Biol Chem 274(44): 31707-12. 
Y oshida, M., K. Y oshida, et al. (2006). "Poly(A) binding protein (P ABP) homeostasis is 
mediated by the stability ofits inhibitor, Paip2." Embo J 25(9): 1934-44. 
Yu, Y. E., Y. Zhang, et al. (2000). "Abnormal spermatogenesis and reduced fertility in 
transition nuclear protein I-deficient mice." Proc Natl Acad Sci USA 97(9): 
4683-8. 
Yuan, x., M. Miller, et al. (1996). "Duplicated proteasome subunit genes in Drosophila 
melanogaster encoding testes-specific isoforms." Genetics 144(1): 147-57. 
Zacksenhaus, E. and R. Sheinin (1990). "Molecular cloning, primary structure and 
expression of the human X linked AlS9 gene cDNA which complements the ts 
AlS9 mouse L cell defect in DNA replication." Embo J 9(9): 2923-9. 
Zhang, H., R. Kobayashi, et al. (1995). "pl9Skpl and p45Skp2 are essential elements of 
the cyclin A-CDK2 S phase kinase." Ce1l82(6): 915-25. 
Zhang, J., T. Bardos, et al. (2002). "Cutting edge: regulation ofT cell activation 
threshold by CD28 costimulation through targeting Cbl-b for ubiquitination." J 
ImmunoI169(5): 2236-40. 
Zhang, Y. (2003). "Transcriptional regulation by histone ubiquitination and 
deubiquitination." Genes Dev 17(22): 2733-40. 
Zhang, Y. and D. Reinberg (2001). "Transcription regulation by histone methylation: 
interplay between different covalent modifications of the core histone ta ils. " 
Genes Dev 15(18): 2343-60. 
Zhao, M., C. R. Shirley, et al. (2004). "Nucleoprotein transitions during spermiogenesis 
in mice with transition nuclear protein tnp 1 and tnp2 mutations." Biol Reprod 
71(3): 1016-25. 
Zhao, M., C. R. Shirley, et al. (2001). "Targeted disruption of the transition protein 2 
gene affects sperm chromatin structure and reduces fertility in mice." Mol Cell 
Biol 21(21): 7243-55. 
Zheng, N., B. A Schulman, et al. (2002). "Structure of the Cull-Rbxl-Skpl-F boxSkp2 
SCF ubiquitin ligase complex." Nature 416(6882): 703-9. 
Zheng, N., P. Wang, et al. (2000). "Structure of a c-Cbl-UbcH7 complex: RING domain 
function in ubiquitin-protein ligases." Celll02(4): 533-9. 
Zhong, Q., W. Gao, et al. (2005). "Mule/ARF-BPl, a BH3-only E3 ubiquitin ligase, 
catalyzes the polyubiquitination of Mcl-l and regulates apoptosis." CellI21(7): 
1085-95. 
Ziemba, H., L. P. Bialy, et al. (2002). "Proteasome localization and ultrastructure of 
spermatozoa from patients with varicocele--immunoelectron microscopic study." 
Folia Histochem CytobioI40(2): 169-70. 
81 
Zwicld, P., W. Baumeister, et al. (2000). "Dis-assembly lines: the proteasome and related 
ATPase-assisted proteases." CUIT Opin Struct Biol 10(2): 242-50. 
82 
Chapter2 
Characterization ofE3Histone, a Novel Testis Ubiquitin Protein Ligase Which 
Ubiquitinates Histones 
Running title 
Characterization of a Ligase which Ubiquitinates Histones 
2.1. Abstract 
During spermatogenesis a large fraction of cellular proteins is degraded as the 
spermatids evolve to their elongated mature forms. In particular, histones must be 
degraded in early elongating spermatids to permit chromatin condensation. Our 
laboratory previously demonstrated activation of ubiquitin conjugation during 
spermatogenesis. This activation is dependent on the ubiquitin conjugating enzyme (E2) 
UBC4 and a testis particular isoform, UBC4-testis, is induced when histones are 
degraded. Therefore we tested whether there are UBC4 dependent ubiquitin protein 
ligases (E3s) that can ubiquitinate histones. Indeed a novel enzyme, E3Histone, was found 
that could conjugate ubiquitin to histones Hl, H2A, H2B, H3 and H4 in vitro. Only the 
UBC4/UBC5 family ofE2s supported E3Histone_dependent ubiquitination ofhistone H2A, 
and ofthis family, UBC4-1 and UBC4-testis are the preferred E2s. We purified this ligase 
activity 3600 fold to near homogeneity. Mass spectrometry of the final material revealed 
the presence of a 482 kDa HECT domain containing protein, which was previously 
named LASUI. Anti-LASUI antibodies immunodepleted E3Histone activity. Mass 
spectrometry and size analysis by gel filtration and glycerol gradient centrifugation 
suggested that E3Histone is a monomer of LASUI. Our assays also show that this enzyme is 
the major UBC4-1 dependent histone ubiquitinating E3. E3Histone is therefore a HECT-
domain E3 that likely plays an important role in the chromatin condensation that occurs 
during spermatid maturation. 
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2.2. Introduction 
Spennatogenesis is a complex developmental process during which stem cell 
spennatogonia are transfonned into highly differentiated spennatids (Clermont 1993). 
This transformation Can be divided into three phases. The first phase is the proliferative 
phase in which spermatogonia undergo successive mitotic divisions. Subsequently, in the 
meiotic phase, spermatogonia are transformed into spennatocytes in which the genetic 
material undergoes homologous recombination and two sequential cell divisions, 
resulting in haploid spermatids. In the final spermiogenic phase, the spennatids are 
transfonned into cells structurally equipped to reach and fertilize the eggs. During 
spermiogenesis, each immature spermatid develops an acrosome and taïl, reorganizes its 
mitochondria and loses most of its cytoplasm. 
Proteolysis plays an important role in these developmental phases. In the first two 
phases, proteolysis is essential in regulating cell cycle. Proteolysis also appears important 
for the third spermiogenic phase. During this cellular remodeling of haploid spermatids, 
many proteins are degraded. Histones are among the key proteins that undergo proteolysis 
(Meistrich 1989). Upon degradation in early and late elongated spermatids, histones are 
replaced by transition proteins which in turn are replaced by protamines (Meistrich 1989). 
The substitution of histones by protamines is essential to pennit the condensation of 
chromatin into the narrow head of the compact and elongated mature spermatid. The 
mechanisms underlying the degradation of histones remain unclear. Previous work 
suggests that many proteins are removed in a cytoplasmic droplet that is phagocytosed by 
the adjacent Sertoli cells (Russell and Clennont 1976; Morales 1985). However, the 
ubiquitin system appearS to be involved in this loss of cellular proteins. Indeed, 
ubiquitinated histones have been detected in the testis of different species (Agell, Chiva et 
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al. 1983; Nickel, Roth et al. 1987; Chen, Sun et al. 1998; Baarends, Hoogerbrugge et al. 
1999). During rooster (Agell, Chiva et al. 1983) and mouse (Baarends, Hoogerbrugge et 
al. 1999) spermatogenesis, ubiquitinated histone H2A are at the highest levels before the 
replacement of histones by protamines in late spermatids. During trout germ cell 
maturation, the levels of monoubiquitinated histone H2B decreased while those of doubly 
ubiquitinated histone H2B increased (Nickel, Roth et al. 1987). Ubiquitinated H3 was 
first identified in the study of rat spermatogenesis, with the highest level in elongated 
spermatids (Chen, Sun et al. 1998). The results from these studies suggest that 
ubiquitination plays an important role in histone replacement. 
Conjugation of ubiquitin to proteins requires the sequential cooperation of three 
enzymes (rev. in (Hershko and Ciechanover 1998; Pickart 2001». The ubiquitin 
activating enzyme (El) hydrolyses ATP to convert ubiquitin into an activated form, 
which is covalently linked at its carboxyl terminus to a cysteine residue of the El enzyme 
via a high energy thioester linkage. The activated ubiquitin molecule is then transferred to 
the second enzyme ofthis pathway, a ubiquitin conjugating enzyme (E2), and the 
activated form is maintained through the formation of a thioester linkage with a cysteine 
residue of the E2 enzyme. The third enzyme in the process, the ubiquitin protein ligase 
(E3), supports the transfer ofubiquitin to substrates. 
E3 is the key to specificity ofubiquitin conjugation as it recognizes substrates (rev. in 
(Hershko and Ciechanover 1998; Pickart 2001». There are two major classes ofE3 
enzymes. One class is the RING finger containing E3s. This type ofE3 functions as a 
scaffold protein that binds both the E2 and the substrate, permitting ubiquitin to be 
transferred from the E2 to the substrate. The RING finger domain chelates two Zn2+ ions, 
and is essential for interaction with the E2. The other class of E3 enzymes is the HECT 
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domain containing E3s. These E3s support ubiquitination in a process that requires two 
steps. First, ubiquitin is transferred from E2 to the E3 via a thioester linkage with a 
cysteine residue in the HECT domain, and then ubiquitin is transferred from the E3 to the 
substrate. This family of E3s therefore requires a free thiol group for its function. 
The E3 covalently links the ubiquitin moiety by its C-terminal residue to the g-amino 
group of an intemallysine residue of the target protein (Hershko and Ciechanover 1998; 
Pickart 2001) or in sorne cases to the o-amino group at the N-terminus of the protein 
(Ciechanover and Ben-Saadon 2004). Monoubiquitination has important functions as a 
signal (rev. in (Hicke 2001)). Monoubiquitination of membrane proteins signals their 
intemalization to endosomes that traffic to lysosomes for degradation (Rotin, Staub et al. 
2000; Hicke 2001). Histone monoubiquitination regulates gene transcription. 
Monoubiquitination of histone H2B in yeast results in telomeric gene silencing by 
stimulating the methylation of histone H3 on lysine 4 and lysine 79 (Sun and Allis 2002), 
while monoubiquitination of histone H3 in yeast results in activation of transcription 
(Briggs, Xiao et al. 2002). For most ubiquitination though, a polyubiquitin chain is 
usually formed after the linkage of ubiquitin to the substrate protein (Hershko and 
Ciechanover 1998). When linked via the lysine 48 residue of each ubiquitin, these chains 
usually target the attached protein to the 26S proteasome for degradation (Chau, Tobias et 
al. 1989). Chains consisting of non-lysine 48 linkages appear to have non-proteolytic 
functions. For example, lysine 63 linked ubiquitin chains can mediate DNA repair and 
signaling via the NF-KB pathway (Spence, Sadis et al. 1995; Hofmann and Pickart 1999; 
Deng, Wang et al. 2000; Spence, Gali et al. 2000). 
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Previous work in our laboratory supports a role for ubiquitination during 
spennatogenesis. The rate of ubiquitin conjugation increases during the first wave of 
spennatogenesis that occurs in early postnatallife (Rajapurohitam, Morales et al. 1999). 
This increase in conjugation appears dependent on the UBC4 family ofE2s. UBC4 is 
induced during spennatogenesis (Rajapurohitam, Morales et al. 1999). This activation is 
at least partly due to induction ofUBC4 isofonns. UBC4 is highly expressed in the testis 
and it is widely expressed in many different tissues. A particular testis specific UBC4 
isofonn, UBC4-testis, is induced in round spennatids and early elongated spennatids 
(Wing, Bedard et al. 1996). 
To further explore the role ofthis UBC4 dependent ubiquitination during male genn 
cell development, we have been identifying UBC4-dependent E3s expressed in the testis. 
Since histones are known to be ubiquitinated and degraded in early elongated spennatids 
when UBC4-testis is induced, we hypothesized that histones may be substrates of a UBC4 
dependent E3. Therefore we used 1251 -histone H2A as a substrate to biochemically screen 
for UBC4 dependent E3 activity in testis extracts. Interestingly, a HECT domain E3 was 
identified to be able to conjugate ubiquitin to different core histones. We now de scribe 
the characterization of this new E3. 
87 
2.3. Methods 
Iodination of proteins-The chloramine-T method was used to label bovine ubiquitin with 
Na1251 to a specific radioactivity of3000 cpmlpmol, and histones Hl, H2A, H3 and H4 
(Boehringer Mannheim) to 375,000 cpml~g. Unincorporated 1251 was removed by passing 
the reaction products over a Sephadex G25 column. 
Preparation and quantification of enzymes-El was isolated from rabbit liver by ubiquitin 
affinity chromatography as previously described (Haas and Bright 1988). Bacterially 
expressed recombinant UBC4-1, UBC4-testis, E214K, UBC7, UbcH6, UbcH7 and 
UbcHlO proteins were prepared as described previously (Wing, Dumas et al. 1992; Wing 
and Jain 1995; Nuber, Schwarz et al. 1996; Wing, Bedard et al. 1996; Townsley, 
Aristarkhov et al. 1997; Bastians, Topper et al. 1999; Lin and Wing 1999). UBC4-1, 
UBC4-testis and E214K enzymatic activity were quantified by measuring the initial release 
of radioactive pyrophosphate following incubation in the presence of (y_32p) ATP, 
ubiquitin and El (Haas and Rose 1982). The remaining E2s were quantified using a 
thioester assay (Oughtred, Bedard et al. 1998) (see below). Recombinant GST fused to 
the RING domain of the E3 ARNIP (GST-ARNIP) was expressed in E.co/i and purified 
by glutathione Sepharose beads (Beitel, Elhaji et al. 2002). 
Conjugation Assay-To measure the conjugation ofubiquitin to histone substrates, the 
reaction mixture contained in a final volume of20 ~l: 10 ~l of the fractions from each 
protein purification step, 50 mM Tris-HCI, pH 7.5, 1 mM DTT, 2 mM MgCh, 2 mM 
ATP, 0.5 units pyrophosphatase, 12.5 mM phosphocreatine, 2.5 units of creatine kinase, 
50 nM El, 30 ~M 1251-histone H2A and 250 nM ofUBC4-1 or UBC4-testis. AlI ubiquitin 
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conjugation reactions used to screen fractions for E3Histone activity were initiated with 25 
/lM of reductively methylated ubiquitin (RMUb), prepared and quantified as described 
(Hershko and HelIer 1985), and incubated for 1 hour at 37°C. Reaction products were 
separated by SDS PAGE, and the results were detected by autoradiography. 
For quantification ofE3Histone activity, the peak fractions from each purification step 
were tested in the conjugation assay at 30 OC for only 10 min. Under these conditions of 
shorter time and lower temperature, the assay was linear with respect to the amount of 
enzyme. E3Histone activity was quantified by adding up the intensity of each band 
multiplied by the number of ubiquitin moieties linked to histone H2A in that band. 
Conjugation assays which tested the ability of different E2s to support E3-mediated 
ubiquitination of histone H2A contained E2 enzymatic concentrations between 150-300 
nM. The conjugation assay comparing different E2s or l25I-histone types were carried out 
under quantification conditions (i.e. 30 OC for 10 min). 
In the assays of testing the substrate specificity (Fig. 1 C) and E2 specificity of 
E3Histone (Fig. ID) and testing the different results ofE3Histone mediated ubiquitination of 
histone H2A with wild type ubiquitin (Ub) and methylated ubiquitin (MeUb) (Fig. lB), 
the E3Histone used were purified with two anion exchange columns, Q-Sepharose and 
Mono Q columns, and a gel filtration column, Superdex 200 column (See E3Histone 
purification in methods for details). 
For the conjugation assay with ARNIP, a RING-finger E3, the components and their 
concentrations were the same as those with E3Histone except that the E3 ARNIP was used 
at a concentration of 1 /lM, 2 /lI of 50 /lM 125I-ubiquitin was used to start the reaction, and 
there was no histone H2A. Since there was no exogenous substrate, autoubiquitinating 
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activity was measured. The reaction was incubated at 37°C for one hour. Reaction 
products were resolved by SDS-PAGE, and detected by autoradiography. 
Thioester Assay-The components for a 10 J..lI reaction were as follows: 1 J..lI of 10x 
thioester buffer (0.5 M Tris-HCl pH 7.5, 0.1 M MgCh, 20 mM ATP, 5 mM DTT), 1 J..lI 
inorganic pyrophosphatase (0.5 units/J..lI) (Sigma) and 1 J..lI of El (1 J..lM). 1 J..lI of 50 J..lM 
125r-ubiquitin was used to start the reaction. The reaction was incubated at 37°C for 1 min. 
Laemmli sample buffer without 2-mercaptoethanol was used to stop the reaction and the 
products were separated by SDS PAGE at 4 oC. The gel was dried and results were 
detected by autoradiography. 
Preparation oftestis extracts-Testes from Sprague-Dawley rats (200 g, Charles River 
Laboratories) were sliced and homogenized at 4 oC with a Potter-Elvehjem tissue grinder 
(Fisher) in 5 volumes ofice-cold homogenization buffer (50 mM Tris, pH 7.5, 1 mM 
DTT). Bovine testes were homogenized in 3 volumes ofhomogenization buffer using a 
Waring blender. The homogenate was centrifuged at 10,000 g for 15 min., and the 
supernatant at 100,000 g for one hour. 
Bovine E3Histone purification-The 100,000 g supernatant was subjected to purification by 
the following steps. After each step, the fractions were assayed as described above to 
detect their ability to support UBC4-dependent conjugation of ubiquitin to histone H2A. 
The peak fractions were pooled for the next step. 
The 100,000 g supernatant was loaded onto a 50 mm x 35 cm DEAE-cellulose 
(Whatman DE-52) column, equilibrated with the homogenization buffer. Bound proteins 
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were stepwise eluted with 0.1 M, 0.2 M and 0.3 M NaCI in 50 mM Tris, pH 7.5, 4 oC, 1 
mM DTT. Most of the E3Histone eluted with buffer containing 0.2 M salt. 
The E3Histone activity collected was precipitated by 0-50% ammonium sulfate 
precipitation. The pellet was redissolved in and dialyzed against homogenization buffer. 
The dialyzed sample was then loaded onto a 26 mm x 20 cm quatemary amine anion 
exchange column (Pharmacia Amersham Biotech, Q Sepharose) equilibrated with the 
homogenization buffer. Bound proteins were eluted with a 0-0.5 M NaCI gradient (in 50 
mM Tris, pH 7.5,1 mM DTT). 
Peak fractions containing E3Histone activities eluted at ~ 0.4 M NaCl. They were 
pooled and dialyzed against homogenization buffer containing 0.7 M (N~)2S04, and 
loaded onto an 8 mm x 7.5 cm Phenyl 5PW column. Bound proteins were eluted with a 
0.7 M - 0 M (N~)2S04 gradient in 50 mM Tris, pH 7.5,1 mM DTT. 
The peak fractions eluting at ~ 0.24 M (N~)2S04 were pooled, dialyzed overnight 
against homogenization buffer and then loaded onto a 5 mm x 5 cm quatemary amine 
anion exchange column (Pharmacia Amersham Biotech, Mono Q) equilibrated with the 
homogenization buffer. Retained proteins were eluted with the same gradient as for the Q 
Sepharose chromatography noted above. 
The peak fractions eluting at ~ 0.4 M NaCI were then concentrated using Centriplus 
10 concentrators (Amicon). The concentrated eluate was further purified on a 10 mm x 30 
cm gel filtration column (Superdex 200, Pharmacia Amercham Biotech). 
The peak fractions were pooled and centrifuged on a 10%-40% glycerol gradient in 
10 mM Tris-Cl, pH 7.5. The centrifugation was performed at 28,000 rpm in a SW 40Ti 
rotor (Beclanan) for 16 hours at 4 oC. 
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Free thiol group requirement test-To test ifE3Histone might be a HECT domain E3, we 
assessed whether a free thiol group was required for activity. Partially purified enzyme 
following the Superdex 200 chromatography step for the conjugation assay was treated 
with 5 mM N-ethylmaleimide (NEM) on ice for 5 min, and then 2.5 mM DTT was added 
to quench the remaining NEM. To confirm the effectiveness of the NEM treatment, 1 
pmol of El was similarly treated and then subjected to a thioester assay for activity. To 
confirm that there was sufficient quenching ofNEM by DTT, buffer was treated with the 
same amount ofNEM and DTT prior to use in an assay of El for thiolester activity. 
Zn2+ ion requirement test-To test if the E3Histone might be a RING domain E3, we assessed 
whether divalent cations were required for the activity. Glycerol gradient fraction #4 or 
20 pmol of recombinant GST-ARNIP were treated with 10 mM EDTA at 4°C overnight. 
MgCh lO mM was added to bind the residual EDTA prior to use in a conjugation assay. 
The treated E3s were then tested in conjugation assays. To confirm the function of Zn2+, 
the E3Histone containing fraction, HIC fraction #55 or 20 pmol of recombinant GST-
ARNIP were treated with a relatively zinc specific chelator TPEN, 3.2 mM. The assay 
was performed as above. 
Mass spectrometry analysis-Following glycerol gradient centrifugation, the fractions 
were analyzed for E3Histone activity and protein composition by both native gel and SDS-
PAGE. Prominent bands comigrating with E3Histone activity were excised and analyzed at 
the Harvard Microchemistry Facility. The proteins in the bands were digested with 
trypsin, after which the peptides were resolved and analyzed by microcapillary reverse-
phase HPLC, directly coupled to the nano-electrospray ionization source of an ion trap 
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mass spectrometer. These MSIMS spectra were then correlated with known sequences 
using the algorithm Sequest developed at the University of Washington (Eng 1994), and 
programs developed at Harvard University (Chittum, Lane et al. 1998). MSIMS peptide 
sequences were then reviewed for consensus with known proteins and the results 
manually confirmed for fidelity. 
Antibody design, production and purification -A fragment encoding 185 amino acid 
residues on the N-terminal part ofLASUl was amplified by RT-PCR using testis mRNA 
as a template. The amplified nucleotide fragment was cloned into pET15b vector 
(Novagen) and expressed in E. coli BL21. The expressed protein contained aN-terminal 
His tag fusion and was purified on a Ni2+ column. Rabbits were injected with the protein 
in Freund's adjuvant, and after two boosts the serum was collected and the antibody 
purified on a column containing GST fused to the protein fragment. 
Immunoblotting and immunoprecipitation-Rabbit sera against LASU1 diluted 1000 times 
or purified LASU1 antibody diluted to 2.7 ,...g/ml were used for immunoblotting on PVDF 
membranes (Millipore). Immunoblots were visualized by chemiluminescence using the 
ECL detection system (Amersham). Antibody against the 20S proteasome (Affiniti) was 
used to detect the 20S proteasome subunits. 
To immunoprecipitate LASU1 from E3Histone containing fractions, an equal volume of 
LASUI antiserum or pre-immune serum and protein A beads were incubated at 4°C for 2 
hours as described elsewhere (King, Peters et al. 1995). Beads were washed three times in 
immunoprecipitation (lP) buffer, 20 mM Tris-HCl pH 7.5 at 4°C, 1 % NP40, 50 mM 
NaCI, protease inhibitor cocktail (Roche), then incubated with an equal volume of 
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E3Histone containing fraction at 4°C for 2 hours. Beads were washed as before. The pellet 
and the supematant were assayed for E3Histone activity as described above. 
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2.4. Results 
Identification and characterization of E3Histone Since a specific E2, UBC4, is induced 
in elongating spennatids when histones are removed from spennatids (Rajapurohitam, 
Morales et al. 1999), we used 125I-histone H2A as a substrate and UBC4 as the E2 to 
screen biochemically for a ubiquitin prote in ligase that can ubiquitinate histones 
(Methods). When this assay was applied to a rat testis extract (Fig. lA), multiple high 
molecular weight fonns ofhistone H2A were generated (lane 2), compared to the 
negative control (lane 1) which was an assay done in the absence of the testis extract. 
These results indicated the presence of an E3 in the testis that can ubiquitinate the histone. 
We carried out the assay with reductively methylated (RM) ubiquitin, as it resulted in 
easily visible and quantifiable monoubiquitinated fonns of H2A. In contrast, use of wild 
type ubiquitin resulted in a high molecular weight smear at the top of the gel (Fig. lB, 
lane 1 compared with lane 3). The presence of multiple bands when RMUb was used 
must represent monoubiquitination of histone H2A on multiple lysine residues. This 
suggests that at least in vitro this ubiquitination is not site specific on histone H2A. Since 
the substrate of the reaction, 125I-histone H2A, showed a strong signal whose shadow 
rendered difficult observation of the 8kDa higher monoubiquitination band on film, we 
typically ran the substrate off the gel. Our more recent assays used a phosphorimager 
which does not generate a large shadow because of a shorter path (no intensifying screen) 
to the detection plate. One picture was shown with the substrate kept on the gel by 
detecting with phosphorimager (Fig. lB). To characterize further this E3, the testis extract 
was fractionated on a Mono Q anion exchange column. The E3 activity eluted at ~O.4 M 
salt (Fig. lA, lanes 5, 6). This E3 activity was designated as E3Histone. 
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Since aIl of the different types of histones are degraded during spennatogenesis, we 
tested if this E3 can ubiquitinate other histones besides histone H2A (Fig. 1 C). Histones 
Hl, H2B, H3 and H4 were radiolabeled and incubated in the presence of El, UBC4, RM-
Ub with or without E3Histone. High molecular weight fonns of the histones were observed 
for aIl the histone types tested, but only in the presence ofE3Histone, indicating that 
E3Histone could ubiquitinate all core histones tested here in vitro. 
Since E3s generally interact with specific E2s, we tested the ability of different E2s to 
support ubiquitination ofhistone H2A (Fig. ID). Of the E2s tested, only UBC4-1, UBC4-
testis and UBC H7 supported E3Histone dependent ubiquitination. These three E2s belong 
to the UBC4/UBC5 family of E2s. 
E3Histone is a HECT domain E3. There are two major families ofE3s, RING finger E3s 
and HECT domain E3s. To assess whether E3Histone might be a HECT domain E3, we 
tested whether E3Histone activity requires the presence of a free thiol group (Fig. 2A left). 
E3Histone Was treated with N-ethylmaleimide (NEM) to inactivate thiol groups. Following 
addition of dithiothreitol (DTT) to quench the excess NEM, the treated E3Histone was 
reassayed for E3 activity (Fig. 2A left, lane 3). After the treatment, E3Histone lost its 
activity as did El when similarly treated and tested in a thioester assay as a positive 
control (Fig. 2A left lane 3 & right lane 3). The loss of activity was not due to inactivation 
of El or E2 in the assay from incomplete quenching ofNEM by DTT as identical 
treatment of a mock sample with NEM and DTT did not affect the activity of 
subsequently supplemented El in a thioester assay (Fig. 2A right, lane 4). Thus, this E3 
could require a free thiol group for its function and may therefore be a HECT domain E3. 
However, at this point we can not rule out the possibility that under the conditions 
employed the NEM may have reacted with other nucleophiles besides thiol groups. Since 
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RING finger motifs chelate Zn2+ ions, we tested E3Histone for the requirement of divalent 
cations by incubating it with the chelater EDTA or a relatively zinc specific chelator 
TPEN (Fig. 2B). Following incubation, the remaining EDTA or TPEN was bound by 
adding excess Mg2+ to avoid intereference by the chelators of the El mediated activation 
ofubiquitin, which requires Mg2+. The treated enzyme was reassayed in the conjugation 
assay. E3Histone activity was unaffected by EDTA treatment (Fig. 2B, lane 4) or TPEN 
treatment (Fig. 2B, lane 12). The enzymatic activity ofthe E3Histone was lower in the 
TPEN study due to the use of a different fraction. To confirm that this treatment was 
effective at chelation, we applied the identical protocol to a sample of ARNIP (Fig. 2B), a 
known RING finger E3 (Beitel, Elhaji et al. 2002). Indeed ARNIP autoubiquitination 
activity was lost upon treatment (Fig. 2B, lanes 8, 16), indicating that the negative result 
with E3Histone was valid. These data together suggest that E3Histone is probably a REeT 
domainE3. 
LASUI is a component ofE3Histone. To identify this new E3, we purified it to near 
homogeneity by the sequential application of different protein purification methods 
(details are in the Methods). To obtain an adequate amount ofpurified enzyme, we started 
with an extract prepared from bovine testes. After the multi-step purification (Fig. 3A), 
the specific enzyme activity was 3600 fold that of the crude extract (Fig. 3B). The 
precipitation of the activity by relatively low concentrations of ammonium sulfate 
suggested that the enzyme was probably large in size. This was indeed confirmed by the 
gel filtration chromatography step which suggested a molecular mass of ~600 kDa for 
this enzyme (Data not shown and Fig. 7 A). Therefore, we subjected it to a final step of 
purification by centrifugation on a glycerol gradient. The fractions from this last 
purification step were assayed for E3Histone activity (Fig. 4A) and the protein components 
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analyzed by denaturing and native gel electrophoresis (Fig. 4B, 4C). Native gel 
e1ectrophoresis revealed a single major band (Fig. 4B). This band was cut and analyzed 
by tandem mass spectrometry (MS). SDS-PAGE revealed a number of bands ranging 
from ~30 kDa to >180 kDa (Fig. 4C). Several bands on this denaturing gel appeared to 
comigrate closely with E3Histone activity (Fig. 4A) and so were also cut and analyzed by 
tandem MS. Interestingly, analysis of the band from native gel electrophoresis (Table 1) 
identified 68 peptides corresponding to a human 370 kDa HECT domain containing 
protein previously named LASUI (Gu, Dubner et al. 1995; Gu, Irving et al. 1997). This 
appeared to be the dominant prote in in the band and indicated that LASUI was likely to 
be E3Histone or a part ofE3Histone. 
Interestingly, the second largest number of peptides in the native band corresponded 
to an unnamed protein (giI26340188) whose C-terminal356 amino acids are the same as 
amino acid residues 41-397 in the N-terminal part ofLASUI (Fig. SA). Searching the 
EST data base identified other independent sequences ofLASUI in this region and 
revealed that the first 40 amino acids of LASUI were miscoded because of a frame shift 
caused by an extra G at base 266 of the previous DNA sequence ofLASUl. Therefore the 
C-terminal396 amino acids of the unnamed protein are exactly the same as the N-
terminal 396 amino acids of LASUI. Furthermore, using the LASUI and unnamed 
protein sequences to probe the mouse genome database indicated that the DNA encoding 
these two putative proteins are adjacent to and overlapping each other on the X 
chromosome. Northem blot analysis oftestis mRNA with a probe against the overlapping 
region detected only a single band> 12 Kb in size (unpublished data). Finally, the cDNA 
clone #4017134 (Invitrogen) contains the overlapping region ofthese two proteins, and 
non-overlapping sequences of the unnamed protein and LASUI on the N terminus and C 
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tenninus, respectively. All ofthese independent pieces of evidence suggested very 
strongly that the unnamed protein and LASUI are parts of the same protein. The 
complete human LASUI has 4374 amino acids, and predicts a molecular weight of 481.9 
kDa, and a pl of 4.87. Mouse LASUI has 4377 amino acids, and predicts a molecular 
weight of 482.7 kDa, and a pl of 4.86. 
Mass spectrometrie analysis of the bands from the SDS-PAGE gel (Fig. 4C) revealed 
that all three bands contained LASUI and that the two larger ones also contained the 
unnamed protein. Those bands likely contain degradation fragments of LA SU 1. 
Domain analysis of this protein showed that it has a classical HECT domain at the C-
tenninal end (Fig. SA). In addition a UBA and a UlM domain, both known to function in 
ubiquitin binding are found in the overlapping region between the unnamed protein and 
LASUI. A WWE domain was also identified and this domain has been associated with 
proteins involved in regulation ofubiquitin dependent proteolysis (Aravind 2001). 
Finally, two domains with unknown function, DUF908 and DUF913, were identified in 
the N-tenninal region located in the unnamed protein (Fig. SA). Interestingly, most of the 
other proteins that contain these two domains appear to be related to the 374 kDa S. 
cerevisiae HECT domain ligase TOMI (Duncan, Umen et al. 2000) (Fig. SB, SC). TOMI 
and the complete LASUI share high degrees of similarity in these domains and in the 
HECT domain, but are relatively poorly conserved elsewhere showing only 17.3% and 
34.7% overall amino acid identity and similarity respectively. 
To continn that E3Histone indeed contains LASU1, an antibody was raised against a 
His tagged fragment ofLASUI containing residues 353-538 of the LASUI sequence 
(residues 1367-1552 of the complete protein). The antibody was affinity purified on a 
column bearing the fragment fused to GST. This antibody was tested for its ability to 
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immunoprecipitate E3Histone (Fig. 6A). The antibody, but not the pre-immune serum, 
bound E3Histone activity confinning that LASU1 is a part ofE3Histone. Since UBC4 appears 
to be the cognate E2 for E3Histone, we tested for the presence ofUBC4 in the 
immunoprecipitated LASU1 (Fig. 6B). UBC4 was not detectable in the pellet, suggesting 
that the interaction is transient which is consistent with UBC4-Ub thioester acting as a 
substrate in the reaction. 
E3Histone appears to be a monomeric proteine To detennine ifE3Histone is a monomeric 
protein or multisubunit complex, we estimated the molecular mass of this E3. Since 
purifying the protein resulted in significant degradation, we chromatographed a crude 
testis extract on a Superdex 200 gel filtration column (Fig 7A). The peak ofE3Histone 
eluted at fraction # 19. When compared to the elution positions of protein standards, this 
corresponded to a molecular mass of ~600 kDa. Immunoblotting revealed that LASU1 
protein comigrated as expected with E3Histone activity. 
Since gel filtration chromatography is not a precise method of sizing such large 
proteins, density gradient centrifugation was also used to estimate the molecular mass of 
E3Histone. Glycerol gradient centrifugation was perfonned on E3Histone and also on 
thyroglobulin (667 kDa) and the 20S proteasome (700 kDa) which were used as standards 
(Fig. 7B). The peak ofthyroglobulin was in fraction #13, the peak of the 20S proteasome 
was in Fraction #13 and 14, while that ofE3Histone was detected in fraction #11. Thus 
E3Histone is smaller than the 20S proteasome (700 kDa) and thyroglobulin (667 kDa), 
supporting a size of ~600 kDa. 
To detennine ifE3Histone contains other subunits besides LASU1, the anti-LASU1 
antibody was covalently linked to protein A beads by DMP, and the covalently linked 
antibody was used to immunoprecipitate E3Histone from a crude rat testis extract. The 
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proteins immunoprecipitated by the antibody were resolved by SDS PAGE. Several 
protein bands that were in the pellet immunoprecipitated by the antibody but not by the 
rabbit IgG control were cut and analyzed by mass spectrometry (data not shown). There 
was only one protein, heat shock protein 70 (HSP70), that was present in the proteins 
identified in the E3Histone band on native gel electrophoresis (Fig. 4B). However, in both 
cases, the numbers of peptides ascribed to HSP70 were small and to date we have not 
been able to confirm this finding by western blot analysis using anti-HSP70 antibody of 
the E3Histone immunoprecipitated using anti-LASUI A (data not shown). On the other 
hand, all of LASUI comigrated with E3Histone (Fig. 7 A and 7B). Taken together, these 
data suggest that E3Histone probably consists simply of the 482 kDa protein LASUI. 
E3Histone is the major UBC4-1 dependent E3 that ubiquitinates histone mA in the 
testis. So far two different Ring domain E3s, Np95 (Citterio, Papait et al. 2004) and 
BRCAI/BARDI (Mallery, Vandenberg et al. 2002), have been found to ubiquitinate 
histone H2A in vitro by cooperation with UBCH5B, the human homolog of UBC4-1. 
Therefore we tested whether other UBC4-dependent E3s besides E3Histone are present in 
the testis. We fractionated a testis extract on the Superdex 200 gel filtration column (Fig. 
7 A) and glycerol gradient (Fig. 7B), and screened fractions for their ability to ubiquitinate 
histone H2A in the presence of UBC4-1. In both cases, we did not find any significant 
activity in fractions other than the ones containing E3Histone. Therefore, E3Histone appears to 
be the major UBC4-1 dependent E3 in the testis that ubiquitinates histone H2A. 
101 
2.5. Discussion 
During spermatid maturation, several chromatin rearrangements occur. lnitially, the 
histones are replaced by transition proteins which in turn are finally replaced by 
protamines (Oliva and Dixon 1991). Histones are still degraded when genes encoding 
transition proteins are inactivated in the mouse indicating that the loss of histones is not 
due to simply displacement by the transition proteins (Yu, Zhang et al. 2000). 
Ubiquitination of several histones is increased just prior to their degradation (Meistrich 
1989) suggesting that ubiquitin dependent proteolysis plays an important role in histone 
replacement. In this paper, we have identified and characterized a new testis ubiquitin 
protein ligase, E3Histone, which is an excellent candidate ligase for mediating 
ubiquitination of histones. It ubiquitinates aIl core histones in vitro (Fig. lA, lB). With 
wild type ubiquitin, E3Histone produced much higher molecular weight forms ofhistone 
than when MeUb was used (Fig. lB), indicating that E3Histone can form polyubiquitin 
chains on histones, thus conferrlng the potential for recognition and degradation by the 
proteasome. Its preferred interaction with UBC4 would also be consistent with such a role 
as UBC4 isoforms are induced in early elongating spermatids (Rajapurohitam, Morales et 
al. 1999) when histones begin to be replaced. Indeed, the induction of UBC4 may be a 
mechanism by which histone ubiquitination and degradation is initiated and regulated. 
Mass spectrometric analysis identified E3Histone as a HECT domain containing ligase, 
previously named LASU1. This was consistent with our observations that E3Histone 
activity was abolished by the sulfhydryl reactive compound N-ethylmaleimide, but not by 
the divalent cation chelator EDTA (Fig. 2). In addition, our EST sequence analysis 
corrected a frame shift inducing sequencing error present in the previous sequence of 
LASU1, thus resulting in a much longer N-terminus that includes what was hitherto a 
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protein ofunknown function. Remarkably, mass spectrometric coupled to bioinformatics 
analyses of this bovine enzyme was able to identify 88 peptides matching the human 
LASUI or mouse unnamed protein sequence. This suggests a significant degree of 
conservation of sequence amongst these species which was conflrmed by observation of 
97.7% and 98.5% identity and similarity respectively between mouse and human 
sequences present in the EST databases. AlI other proteins identified in the analyses had 
fewer than seven matching peptides suggesting that LASUI was the dominant protein in 
this enzyme. None of the other identified proteins appeared to be a potentialligase. The 
predicted molecular weight of 482 kDa was reasonably close to the estimated molecular 
mass of ~600 kDa ofE3Histone considering the limited prediction ofmass estimation by 
chromatography for such a large protein. And the enzyme bound to anion exchange 
columns as would be expected for a protein with an acidic pl. AlI of these observations 
together argue strongly that LASUI is E3Histone. The latter findings also suggest that 
E3Histone functions as a monomeric protein, but the mass determinations are not precise 
enough to rule out the presence of an additional small subunit(s), particularly 
nonstoichiometrically in subsets of the enzyme molecules. 
Interestingly, LASUI was found expressed in many different tissues at both mRNA 
and protein levels, and more highly expressed in testis, brain, lung and kidney 
(unpublished data). E3Histone could therefore have other important roles in different tissues 
besides its function on chromatin condensation in elongated spermatids. It is possible that 
it may play a role in ubiquitination of histones in other cells. However, in most celIs, 
ubiquitination of histones appears to modify function rather than target for degradation. In 
eukaryotic celIs, 10-15% of total histone H2A is ubiquitinated (West and Bonner 1980), 
while 10% ofhistone H2B is ubiquitinated in yeast (Robzyk, Recht et al. 2000) and 1.5% 
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of cellular histone H2B is monoubiquitinated in higher eukaryotes (West and Bonner 
1980). The function of this ubiquitination remains largely unknown except for a few 
examples. Monoubiquitination of histone H2B in S. cerevisiae leads to methylation of 
histone H3 on its lysine 4 and lysine 79 residues which in turn causes telomeric gene 
silencing (Briggs, Xiao et al. 2002; Sun and Allis 2002). This ubiquitination is mediated 
by the RING domain containing E3, Brel, which relies on Rad6p, as its cognate E2 
(Robzyk, Recht et al. 2000; Hwang, Venkatasubrahmanyam et al. 2003; Wood, Krogan et 
al. 2003). Inactivation of a mouse homolog of Rad6p leads to defective spermatogenesis 
but does not appear to prevent histone degradation. Furthermore, monoubiquitination of 
histone Hl in Drosophila by TAFn250, another RING finger containing protein, result in 
transcriptional activation (Pham and Sauer 2000). These results taken together support a 
Hnk between histone ubiquitination and gene transcription. In addition, two other 
ubiquitin protein ligases also belonging to the RING domain E3 family, BRCA1/BARD1 
(Mallery, Vandenberg et al. 2002) and Np95 (Citterio, Papait et al. 2004), have been 
recently shown to promote ubiquitination of histone in vitro. 
In this paper, we have identified for the first time, a HECT domain containing E3 that 
ubiquitinates histones. Besides a role in mediating histone degradation, this ubiquitination 
could also be involved in transcriptional regulation. Indeed, previous studies with the rat 
homolog ofLASUl suggested that it may function as a DNA-binding transcriptional 
regulator (Gu, Dubner et al. 1995; Gu, Irving et al. 1997). The most similar other known 
E3s are S. cerevisiae Tom1 and E3s closely related to Tom1. Tom1 mutants are 
pleiotropic and include defects in transcription that appear to be mediated through ADA 
coactivator proteins (Saleh, Collart et al. 1998) as well as defects in export of mRNA 
(Utsugi, Hirata et al. 1999; Duncan, Umen et al. 2000; Sasaki, Toh-e et al. 2000). 
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Suppressors of tom 1 mutants include STOl/G4p2/STMl a basic protein partially 
homologous to histone Hl that can bind to G4 nucleic acids (Frantz and Gilbert 1995; 
Utsugi, Toh-e et al. 1995; Nelson, Musso et al. 2000). Thus, Tom1 appears to interact 
with basic nucleic acid binding proteins and in that way is similar to our demonstrated 
ability ofLASUl to interact with and ubiquitinate histones. 
LASU1 is here demonstrated to be one of the largest E3s to be characterized to date. 
Like other large E3s such as the 374 kDa Tom1 (Utsugi, Toh-e et al. 1995) and 300 kDa 
EDD (Oughtred, Bedard et al. 2002), the large size likely permits it to interact with a 
variety of substrates and to exert a large number of functions which remain to be defined. 
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Table 1 
Reference No. Protein name Species Peptide Present in 
Number SOS Bands 
gil22090626 HECT domain protein LASU1 Homo sapiens 68 A,B,C 
gi126340188 unnamed protein product Mus musculus 20 B,C 
gil10436857 unnamed protein product Homo sapiens 7 A 
gil25140230 similar to tripeptidyl peptidase Il Homo sapiens 7 B 
gil1061310 valyl-tRNA synthetase 7 B 
gi12493459 Protein kinase C substrate, 60.1 kOa protein, heavy chain (PKCSH) 3 A 
(80K-H protein) 
giI28478776 similarto Elongation factor 1-gamma (EF-1-gamma) (eEF-1B Mus musculus 7 
gamma) 
gil28189194 similar to pancreatic tumor-related protein Bos taurus 3 
gi1417844 VAL YL-TRNA SYNTHETASE (VALlNE--TRNA LlGASE) (VALRS), 2 
gil27807311 vesicle docking protein p115 Bos taurus 5 
gil232037 Elongation factor 1-gamma (EF-1-gamma) (eEF-1B gamma) 3 
gil12804891 Similar to tubulin, beta 5 Homo sapiens 4 
gil6015101 Endoplasmin (94 kOa glucose-regulated protein) (GRP94) 5 
gil25021127 similar to transitional endoplasmic reticulum ATPase (EC 3.6.1.-) Mus musculus 2 
[validated]- rat 
gil4204880 heat shock protein Homo sapiens 3 
gil11265337 hypothetical protein OKFZp434K0126.1 - human (fragment) 3 
gi11174593 TUBULIN ALPHA-2/ALPHA-4 CHAIN 2 
gil12847562 unnamed protein product [Mus musculus] 2 
Table 2. MSIMS analysis of the band isolated from the native acrylamide gel (Fig. 4B). 
Proteins also detected in the tandem mass spectrometry analysis's reports ofbands A, B 
or C from the denaturing gel (Fig. 4C) are indicated. 
106 
Figure Legends 
Fig. 1: Identification and initial characterization of E3Histone. A, A soluble testis 
extract was chromatographed on a Mono Q anion exchange column. The 100,000 g 
supematant of the rat testis extract (load), water as a negative control (Ctl-) and eluted 
fractions were tested for the ability to support conjugation ofubiquitin to 1251-labelled 
histone H2A in the presence of El and UBC4. Lane 3-8 are the fractions eluting at 
approximately 0.4 M NaCI that contained the activity. B, E3Histone (lane 1 & 3) or water 
(Ctl-) was used for the ubiquitin conjugation assay of 1251-labelled histone H2A with wild 
type ubiquitin or methylated ubiquitin. C, Different 1251-labelled histones were tested in 
the conjugation assay in the presence (+) or absence (-) ofE3Histone. D, E3Histone mediated 
ubiquitination was tested in the presence or absence (ctl-) of the indicated E2s. A -D, 
Reaction products were resolved by SDS-PAGE and detected by autoradiography. *, 
background bands. Arrows show single monoubiquitination form ofhistone H2A. Note 
that in panels A, C, D, the free histone substrates were ran out of the gels because they 
created large shadows when the gels were exposed to film with the use of intensifying 
screens. B-D, the source ofE3Histone is described in Conjugation Assay in Methods. 
Fig. 2: E3Histone is probably a HECT do main containing E3. A, E3Histone requires a free 
thiol group for its E3 activity. Left, In the conjugation assay, E3Histone was first treated 
with or without N-ethylmaleimide (NEM). Excess NEM was then quenched by DTT, and 
the other components of the conjugation assay were added. Products of the assay were 
resolved by SDS PAGE and detected by autoradiograghy. Right, To confirm that both the 
NEM treatment and quenching by DTT were adequate, El was treated sequentially with 
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NEMlDTT (lane 3) or added subsequently to buffer that had been similarly treated with 
NEMlDTT (lane 4), and then assayed for its ability to form a thioester bond with 1251_ 
ubiquitin. Reaction products were resolved by SDS PAGE at 4°C under non-reducing 
conditions and detected by autoradiography. B, E3Histone does not require divalent cations 
for its function. E3Histone was treated with EDTA (lane 3 & 4) or TPEN (lane Il & 12). 
Remaining chelators were then quenched with excess Mg2+ (lane 4 and lane 12) or not 
(lane 3 and lane Il) prior to assaying for ubiquitination of histone H2A. To confirm the 
efficacy of the treatment, the RING finger E3 ARNIP was similarly treated, and then 
assayed for its autoubiquitination ability by incubation with El, UBC4-1 and 1251_ 
ubiquitin (lane 5-8 & lane 13-14). Products were resolved by SDS PAGE and detected by 
autoradiography. 
Fig. 3: Purification of E3Histone from bovine testis extract. A, E3Histone purification 
scheme. The salts used to elute proteins in each step are shown on the right of the 
purification tree. Arrows indicate the salt concentration at which the enzyme eluted. 
Buffers used were as described in Methods. B, Protein Purification Table. Aliquots of the 
pooled fractions from each protein purification step were assayed under quantification 
conditions (see Methods) to measure E3Histone activity. The results were detected by 
phosphorimager and quantified as described in the methods. 
Fig. 4: Analysis of the fractions from the last purification step. A, Fractions from the 
glycerol gradient centrifugation were assayed for E3Histone activity. As described in 
Methods, MeUb was used to start the reaction. The results were detected by 
autoradiography. B, Protein fractions were resolved on a 5 % native acrylamide gel and 
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detected by colloidal blue staining. C, Protein fractions were resolved by 7%-15% 
gradient SDS PAGE and detected by colloidal blue staining. Arrows in panels B and C 
show the bands cut for tandem mass spectrometric analysis. 
Fig. 5: Structure of LASUI. A. Domain analysis of LASUI and the unnamed protein. 
The region used to generate an anti-LASUI antibody is shown. B. Alignment of DUF908. 
C. Alignment of DUF913. In Band C, shown are the conserved residues in the domain. 
gi:16944653, related to TOMI protein; gi:22832284, CG8184-PB; gi:26327257, 
unnamed protein product; gi:22532851, Hypothetical protein Y67D8C.5; gi:3176689, 
Contains similarity to ubiquitin carboxyl-terminal hydrolase 14; gi:2440180, 
SPACI9D5.04; gi:927738, Tomlp; gi:23499033, ubiquitin-protein ligase 1; gi:8778329, 
FI4J16.l0. 
Fig. 6: E3Histone contains HE CT domain protein LASUI. A. E3Histone was 
immunoprecipitated with pre-immune serum (PIS) or anti-LASUI antiserum (Ab). Left, 
Western blot of the indicated sample with anti-LASUI antibody. Right, Samples were 
assayed for E3Histone activity. B. UBC4 was not co-immunoprecipitated with E3histone. 
Crude testis extract was immunoprecipitated with the LASUI antibody, and then the 
supernatants and pellets were subjected to immunoblotting with anti-LASUI antibodyor 
anti-UBC4 antibody. Multiple bands in the LASUI blot likely represent degradation 
products ofLASUI during the procedure. CTL, the same amount ofsample before 
immunoprecipitation (IP). S, supernatant. P, pellet. 
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Fig. 7: E3Histone appears to be a monomeric protein. A, Separation of a crude testis 
extract using a Superdex 200 gel filtration column. Top, Fractions were assayed for 
E3Histone activity as described in Fig. 1. Elution positions and molecular weights of the 
protein standards are shown. Bottom, Western blot of the fractions with the anti-LASU1 
antibody. Arrow shows the LASU1 band. B, Separation of a crude testis extract by 
glycerol gradient centrifugation. The sample or purified 20S proteasome or thyroglobulin 
were applied to a 4%-40% glycerol gradient and subjected to the centrifugation at 30,000 
rpm in a SW 40Ti rotor for 20 hours at 4 oc. Top, Fractions from 4%-40% glycerol 
gradient centrifugation were assayed for E3Histone activity. Bottom, Detection ofprotein 
standards and LASU1. 20S proteasome and LASU1 were detected by western blotting, 
respectively. Thyroglobulin was detected by Commas sie blue staining. 
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Bridge of Chapter 2 & 3 
In Chapter 2, we identified E3Histone, a monomer ofHECT domain containing protein 
LASUl, as the major Ubc4-dependent E3 ligase in the testis for histone ubiquitination in 
vitro. E3Histone is therefore likely involved in histone degradation during spermatogenesis 
which is required for the normal maturation of spermatids. Since histones are degraded 
specifically in late round and early elongating spermatids, to further evaluate the possible 
function ofLASUl on histone degradation, we determined which cell types in the testis 
express E3Histone ILASUI in this chapter. Since E3Histone ILASUI is a novel E31igase with 
other substrates such as Mc1-1 and p53, we also determined its distribution among 
different tissues. 
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Chapter3 
Expression of the ubiquitin protein ligase, E3Histone /LASUlI Mule/ARF-BPl, in 
Rodent Tissues and Its Regulation during Spermatogenesis 
Running title 
Expression ofE3Histone ILASUl/Mule/ARF-BP1 
3.1. Abstract 
We recently purified the ubiquitin protein ligase, E3Histone ILASUI (Mule/ARP-BPI) 
from the testis and found that it stimulated ubiquitination of aIl the core histones in vitro 
(Liu, Oughtred et al. 2005). Since histones are ubiquitinated at various stages of 
spermatogenesis, we studied the expression ofE3Histone ILASUI during this process. 
During the first wave of spermatogenesis in the neonatal rat, E3Histone ILASUI rnRNA was 
highly expressed at day 10 and gradually decreased with age. Levels of the protein cise 
and feIl, peaking at day 20. Consistent with these findings, LM (Light microscopy) and 
EM (Electro microscopy) immunohistochemistry determined that E3Histone ILASUI was 
highly expressed in nuclei from spermatogonia to mid-pachytene cells. The strongest 
expression was in nuclei from leptotene to mid-pachytene cells, suggesting that E3Histone 
/LASUI may be involved in histone ubiquitination in spermatocytes. There was no 
obvious staining ofE3Histone /LASUI in spermatids when histones are ubiquitinated and 
degraded. E3Histone /LASUI was also widely expressed in different rodent tissues at both 
rnRNA and protein levels. It was mainly expressed in the cytoplasm, except in neuronal 
cells of the brain and in early germ cells of the testis, where it was expressed in the 
nucleus. In most tissues, E3Histone ILASUI was expressed in epithelia. These results 
suggest that E3Histone ILASUI may play a role in chromatin modification in spermatocytes, 
but also has functions in other tissues. 
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3.2. Introduction 
Spermatogenesis is the process ofproducing haploid spermatids, one of the most 
highly specialized cell types, in the seminiferous tubules of the testis. It is a complex 
developmental process involving mitotic proliferation, meiotic divisions and extensive 
haploid spermatid cell remodeling. It starts with successive mitotic divisions of the stem 
cell spermatogonia to pro duce diploid spermatocytes. After two meiotic divisions of 
spermatocytes, haploid round spermatids are formed. These round spermatids are 
transformed through significant remodeling into highly differentiated spermatozoa. 
The prophase of the first meiotic division, including leptotene, zygotene, pachytene 
and diplotene, are very long compared to the subsequent phases of meiotic divisions. It 
can occupy up to 90% of the entire duration of meiosis. It starts from leptotene ceIls, in 
which the chromatin begins to condense. In zygotene ceIls, chromatin has been 
condensed into chromosomes, which begin to be paired in an apparatus called the 
synaptonemal complex. In pachytene ceIls, the chromosomes are fully paired. Genetic 
recombination or crossing over occurs at this stage, resulting in the exchange of distal 
portions of the paired chromosomes. Histones appear to be highly ubiquitinated in 
pachytene cells (Chen, Sun et al. 1998; Baarends, Hoogerbrugge et al. 1999). In diplotene 
ceIls, the paired chromosomes are separated. Diplotene phase and the following meiotic 
divisions are short lasting. Haploid spermatids are formed after two meiotic divisions, 
and then undergo a remodeling process. 
Protein degradation is involved in haploid spermatid remodeling. The mature 
spermatid loses almost aIl of its cytoplasm, and the nuclear volume shrinks to less than 
5% ofthat ofsomatic cells (Sawada, Ochi et al. 1975). The chromatin is extremely 
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compact in the nuclei of mature spennatids. Histones are replaced by transition proteins 
in late round and early elongating spennatids (Meistrich 1989). The substitution of 
histones by transition proteins and subsequently by protamines pennits chromatin 
condensation. When genes encoding transition proteins are inactivated in the mouse, 
histones are still degraded, indicating that the loss of histones is not simply due to 
displacement by the transition proteins (Yu, Zhang et al. 2000). It remains unclear how 
histones are degraded. Many proteins are removed in a cytoplasmic drop let that is 
phagocytosed by the adjacent Sertoli cells during the remodeling of spennatids (Russell 
and Clennont 1976). But the ubiquitin proteasome pathway may also play an important 
role in this process (Rajapurohitam, Morales et al. 1999). Ubiquitinated histones have 
been detected in the testis ofvarious species (Agell, Chiva et al. 1983; Nickel, Roth et al. 
1987; Chen, Sun et al. 1998; Baarends, Hoogerbrugge et al. 1999). Ubiquitination is 
activated during development of the testis and the rate of conjugation of ubiquitin to 
proteins appears to peak at the stage when histones are replaced by transition proteins 
(Rajapurohitam, Morales et al. 1999). Thus, histones may be degraded by the ubiquitin 
proteasome degradation pathway. 
Ubiquitination requires sequential cooperation of three enzymes, ubiquitin activating 
enzyme (El), ubiquitin conjugating enzyme (E2) and ubiquitin protein ligase (E3). Of 
these, E3 plays the important role of recognizing substrates and catalyzing the final step 
of ubiquitination-transferring ubiquitin from E2 to the substrate. Increased ubiquitination 
occurs during spennatogenesis and appears due to activation of a UBC4 dependent 
pathway of conjugation (Rajapurohitam, Morales et al. 1999). Expression of UBC4 
appears maximal in late round and early elongating spennatids when the degradation of 
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histones occurs. Thus, we searched for a ligase that would polyubiquitinate histones. We 
recently purified a novel E3, which may be the E3 ligase for histone ubiquitination in 
spermatogenesis (Liu, Oughtred et al. 2005). This E3, E3HistonelLASU1, is ~500 kDa 
HECT domain containing protein. It polyubiquitinates all the core histones in vitro. 
Furthermore, it is the major UBC4-dependent histone-ubiquitinating E3 in testis (Liu, 
Oughtred et al. 2005). Finally, UBC4-1 and UBC4-testis, E2s required for the activation 
ofubiquitination during spermatogenesis, are the preferred E2s for E3Histone ILASUI 
dependent ubiquitination of histone. This ligase is therefore a good candidate E3 ligase 
required for histone ubiquitination during spermatid maturation. 
To further verify the possible function ofE3Histone ILASUI in the testis, in this paper 
we studied the regulation of expression ofthis E3 during spermatogenesis. Three recent 
studies have identified two additional substrates for E3HistonelLASU. The same ligase was 
identified as Mule (Mcl-l ubiquitin protein ligase E.3) (Zhong, Gao et al. 2005) or 
LASUI (Warr, Acoca et al. 2005) for ubiquitination of the antiapoptotic protein Mcl-l. 
One other study identified it as ARF-BPI (ARFtumor suppressor Qinding12roteinD and 
demonstrated that it can ubiquitinate the tumor suppressor protein p53 (Chen, Kon et al. 
2005). Since E3Histone ILASUI has these other substrates, we therefore also surveyed the 
expression ofE3Histone ILASUI/ Muie/ARF-BPI in different tissues and determined its 
subcellular localization. 
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3.3. Material and methods 
Preparation of tissue extracts- Male Sprague-Dawley rats or male CD-l mice (Charles 
River Laboratories) were decapitated under anesthesia. The indicated tissues were 
isolated quicklyand homogenized using a Potter-Elvehjem homogenizer (except for heart 
and skeletal muscles in which a polytron tissue disruptor was used) in 50 mM Tris, pH 
7.5, 1 mM dithiothreitol (DTT), 0.25 M sucrose, 1 mM EDTA, 1 mM 
phenylmethylsulfonyl fluoride, 10 f.lglml pepstatin A, and 10 f.lglmlleupeptin at 4 oC 
(5 ml/g tissue). The homogenates were centrifuged at 10,000 g for 10 min, and then the 
supematant was centrifuged at 100,000 g for 60 min. The final supematants were stored 
at -80 oC until use. 
RNA analysis-RNA was prepared from rat tissues by the guanidium thiocyanate CsCI 
method (AusubeI1993). Expression ofE3Histone ILASUI was determined by RNA 
blotting (Northem analysis). Samples of RNA (20f.lg) were resolved on 1 % 
formaldehyde-containing agarose gels followed by transfer to nylon membranes and 
cross-linking with UV light. The membranes were hybridized with 32p labeled probes, 
washed, and then subjected to autoradiography. Single stranded cDNA probes were 
prepared by PCR based amplification using E3Histone ILASUI containing plasmid DNA as 
template and a reverse primer (primer for N-terminal probe: 5' gccacttgattcaaccacc 3' 
(complementary to nt 4638-3656 of the fuliiength E3Histone ILASU1, Gene bank 
accession No. AY929611), primer for C -terminal probe: 5' gaatgggtcaagggaggatg 3' 
(complementary to nt 11792-11811 ofE3Histone /LASU1). 
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Preparation of tissue sections-Male Sprague-Dawley rats or CD-l mice were 
exsanguinated under isoflurance anaesthesia. Indicated tissues were isolated and fixed in 
periodate-Iysine-paraformaldehyde solution (PLP solution: 10 mM sodium periodate 
(Sigma), 75 mM L-Iysine (Sigma), 2% paraformaldehyde (WN) (Sigma)) at 4 oC for 24 
hours. After fixation the samples were washed twice with PBS and then stored in PBS 
solution prior to paraffin embedding. Embedded samples were sectioned at 4 /lm (bone 
was decalcified prior to paraffin section). 
E3Histone /LASUI antibodies-LASUI-A antibody was prepared as described (Liu, 
Oughtred et al. 2005) against amino acid residues 1367 to 1552 of the human E3Histone 
ILASUI sequence (identical sequence in mouse E3Histone ILASUI). Commercial LASUI 
antibodies BL671 and BL672 from Bethyl Laboratories were also used. The epitopes 
recognized by BL671 and BL672 map to residues 1939 to 1989, and 3764 to 3814, 
respectively, ofhuman E3Histone ILASUI. The mouse ortholog is highly conserved at both 
sites with only two amino acids differences from the human sequence. 
Light microscopie immunohistochemistry-Tissue sections were re-hydrated and heated in 
1 % sodium citrate at 70 oC for 30 minutes to expose the epitopes. Specimens were 
incubated with E3Histone ILASUI primary antibody (10 /lg/ml), at room temperature 
overnight. For negative controls, antigen neutralized antibody was used. After washing 
with high salt and low salt washing buffers (50 mM Tris-HCl, pH 7.6, 500 mM NaCI 
(high salt), 150 mM NaCI (low salt), 0.01% Tween-20), the sections were incubated with 
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biotinylated goat anti-rabbit IgG (Sigma) at room temperature for 45 minutes. After three 
washes, the Vectastain ABC-AP (Vector Laboratories, UK) alkaline phosphatase 
detection reagent was applied according to the manufacturer' s instructions. Samples were 
treated with Vector methyl green nuclear counterstain and mounted with Kaiser's 
glycerol jelly. 
Electron micros co pic immunocytochemistry-Rat testes were fixed by a 1 O-min perfusion 
through the abdominal aorta with 0.5% glutaraldehyde and 4% paraformaldehyde in 
0.1 M phosphate buffer. Tissue was then embedded in Lowicryl K4M as previously 
described (Oko, Hermo et al. 1993). Ultrathin sections were mounted on 300-mesh 
Formvar-coated nickel grids. Each grid containingnumerous sections was floated on a 
drop of20 mM Tris-bufferedsaline (TBS) (pH 7.4) containing 10% goat serum and then 
incubated for 1 h with BL671 antibody in TBS. The grids were washed three times for 
5 min each in TBS containing 0.5% Tween 20 and then incubated for 1 h with colloidal 
gold (diameter, 10 nm)-conjugated goat anti-rabbit antibody (diluted 1:20 in TBS). The 
sections were washed three times for 5 min each in TBS containing 0.05% Tween 20 and 
then once in distilled water. They were counterstained with uranyl acetate in 30% ethanol 
for 2 min followed by lead citrate for 30 s. As a negative control, the LASU1 antibodies 
were preincubated with the peptide antigen for 1 h at 37°C before being used on the 
sections. Electron micrographs were obtained on a Philips 400 electron microscope. 
Immunojluorescence-FR3T3 fibroblasts were grown on coverslips, and then fixed with 
paraformaldehyde solution (4% paraformaldehyde, pH 7.4) at room temperature for 10 
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minutes. After three washes with PBS, fixed cells were permeabilized with 0.2% Triton 
X100 (in PBS) at room temperature for 10 minutes. NaBHt (0.5 mg/ml in PBS) was then 
applied to decrease the background. Following blocking of non-specifie binding sites by 
incubation with 3% inactivated normal goat serum with 1 % Triton X100 at room 
temperature for one hour, the cells were exposed to anti-LASU1-A antibody (6.3 J.lg/ml), 
for one hour. Following washing, cells were incubated with second antibody conjugated 
to FITC (Sigma F-1262), at room temperature for one hour. After washing, DAPI (2 
J.lg/ml) was applied to stain the nuclei. Coverslips were mounted with Moviol and the 
signaIs detected using a fluorescence microscope. 
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3.4. Results 
Developmental regulation of expression of E3Histone ILASUI Since histones are 
ubiquitinated and degraded in early elongating spermatids, but also found to be 
ubiquitinated in primary spermatocytes (Agell, Chiva et al. 1983; Nickel, Roth et al. 1987; 
Chen, Sun et al. 1998; Baarends, Hoogerbrugge et al. 1999), we explored the regulation 
of expression ofE3Histone /LASUI during spermatogenesis. We first examined the 
regulation of expression ofE3Histone ILASUI at the levels ofboth rnRNA and protein 
during the first wave of spermatogenesis between birth and sexual maturation. U sing 
probes complementary to either the N terminal part or C terminal part ofE3Histone ILASU1 
rnRNA, we observed a single transcript above 1 ° kb, consistent with the size of E3Histone 
ILASU1 cDNA coding sequence of 13.1 kb. Therefore there is no apparent alternative 
splicing ofE3Histone ILASU1 rnRNA. E3Histone ILASU1 rnRNA was highly expressed in 
testis of young rats (Fig. lA). Quantification of the Northern blots showed that levels of 
E3Histone ILASU1 rnRNA gradually decreased from day 10 to day 30 oflife, after which it 
remained constant at low levels. E3Histone ILASU1 protein levels increased from day 10, 
appeared to peak at day 20, and then gradually decreased to day 35 (Fig. lB). These 
results suggest that E3Histone ILASU1 protein levels may be highly expressed in late 
pachytene or diplotene spermatocytes, which are the most advanced germ cells present at 
day 20 of life. 
To verify this, immunohistochemistry studies were used to detect E3Histone ILASU1 
expression in rat testis sections (Fig. 2). E3Histone ILASU1 was mainly expressed in the 
nuclei of spermatogonia and early spermatocytes (Fig. 2A, right panel). No staining was 
detected with pre-absorbed antibody (Fig. 2A, left panel). Detection under high 
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magnification showed E3Histone ILASUI is expressed in nuclei from spermatogonia to 
mid-pachytene cens. More mature germ cens did not express E3Histone ILASUI in the 
nucleus (Fig. 2B-C). The expression ofE3Histone ILASU1 in nuclei ofprimary 
spermatocytes was also detected by EM immunocytochemistry (Fig. 2D). Shown is the 
staining of the nucleus of a pachytene cen (Fig. 2D). The summary of the staining of 
E3Histone ILASUI and germ cens expressing E3Histone ILASUI are shown in (Fig. 2E-F). 
The expression ofE3Histone ILASUI was stronger in the nuclei ofprimary spermatocytes 
than in nuclei of spermatogonia. Amongst spermatocytes, E3Histone ILASU1 expression 
was highest in the nucleus of leptotene cens and early- to mid-pachytene cens (Fig. 2C). 
There appears a discrepancy between this result and that of Fig. 1. The developmental 
western blot oftestis extract showed the highest expression ofE3Histone ILASU1 at day 20 
after birth (Fig. 1). Although the most advanced germ cens at this stage are late 
pachytene cens and diplotene cens, the more abundant cens are primary spermatocytes 
earlier than mid pachytene. Since by LM immunohistochemistry, these cens have the 
highest expression ofE3Histone ILASUl, this may explain E3Histone ILASUI protein 
maximany expressed in the nucleus of leptotene and early- to mid-pachytene cens (Fig. 
2B-C), while western blot determined highest expression ofE3Histone ILASUI protein at 
day 20 after birth (Fig. lB). There is no obvious staining detected in spermatids or in 
Sertoli cens. (Fig. 2, B-C). 
E3Histone ILASUI is widely expressed in different tissues. Since the same protein has 
been shown to ubiquitinate Mcl-1 (Warr, Acoca et al. 2005; Zhong, Gao et al. 2005) and 
p53 (Chen, Kon et al. 2005), we tested whether E3Histone ILASUI is expressed in other 
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.- tissues and determined the subceIlular localization in those ceIls. E3Histone ILASUI rnRNA 
is widely expressed in different rat tissues (Fig. 3A), but more highly expressed in heart, 
brain and young rat testis. 
E3Histone ILASUI protein is aIso widely expressed in different rat tissues (Fig. 3B). 
Because E3Histone /LASUI is a very large protein, it is easily degraded during preparation 
of the homogenates. As a result, sorne of the tissues did not show the whole E3Histone 
ILASUI band, but only the degradation band (Fig. 3B). To determine the ceIl type and 
subcellular localization ofE3Histone ILASUl, different tissue sections were subjected to 
immunohistochemistry (Fig. 4). Antibodies against both the C- and N-termini ofE3Histone 
ILASUI respectively were used to confmn the results. In aIl tissues except in testis (as in 
discussion), the two antibodies gave the same results (Fig. 4). First we detected the 
expression ofE3Histone ILASUI in different tissues of the immune system. In the spleen, 
E3Histone ILASUI is expressed in B lymphocyte dependent regions (Fig. 4A, upper panels). 
However, in these regions, E3Histone ILASUI is not expressed in the lymphocytes, but 
mainly in the cytoplasm of non-lymphocytes in splenic nodules. In thymus, E3Histone 
ILASUI is expressed in meduIlary regions- again not in lymphocytes, but in epitheliaI 
ceIls and (Fig. 4A, middle panels). It is mainly expressed in the cytoplasm. In bone 
marrow, E3Histone ILASUI is expressed in the cytoplasm of a limited number of ceIls (Fig. 
4A, lower panels). 
ln abdominal tissues, E3Histone ILASUI is highly expressed in the renal tubules of the 
kidney, both proximal and distal tubules (Fig. 4B, upper panels). It is also expressed in 
hepatocytes in liver (Fig. 4B, lower panels). In both cases, E3Histone /LASUI was 
expressed in the cytoplasm. In muscle tissues, E3Histone ILASUI is expressed in cytoplasm 
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ofboth skeletal muscle and cardiac muscle cells (Fig. 4C). In brain, E3Histone /LASUI is 
expressed in Purkinje cells in the cerebellum (Fig. 4D, upper panels). It is mainly 
expressed in cytoplasm and may also be partially expressed in the nucleus. Surprisingly, 
in neurons ofvarious parts of the cerebrum, E3Histone /LASUI is mainly expressed in the 
nucleus (Fig. 4D, lower panels). 
From these tissue studies, E3Histone ILASUI was found to be mainly expressed in the 
cytoplasm of most mouse tissues, except in brain and testis. In neuronal cells in the 
cerebrum and early germ cells in the testis, E3Histone ILASUI is expressed mainly in the 
nucleus. Aiso E3Histone ILASUI was found mainly expressed in epithelia (kidney, spleen, 
thymus (Fig. 4); intestine, lung, breast (data not shown)). 
Subcellular localization of E3Histone /LASUI To further explore the subcellular 
expression ofE3Histone ILASU1, we evaluated E3Histone ILASUI expression in cultured 
cells by using immunofluorescence (Fig. SA). In FR3T3 fibroblasts (Fig. SA) and HEK 
293 cells (data not shown), E3Histone ILASUI is mainly expressed in the cytoplasm with a 
small amount of signal being localized in the nucleus. Western blot of cell fractionated 
samples of cytoplasm and nucleus also revealed the presence of most E3Histone ILASUI in 
cytoplasmic fractions (Fig. SB). 
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3.5. Discussion 
The E3Histone ILASUIligase has recently been implicated to be involved in the 
ubiquitination of several important proteins including the anti-apoptotic protein Mcl-l 
(Warr, Acoca et al. 2005; Zhong, Gao et al. 2005), the tumor suppressor p53 (Chen, Kon 
et al. 2005), and histones (Liu, Oughtred et al. 2005). However, the regulation ofthis 
ligase remains po orly defined. In this report we have, for the first time, characterized 
extensively and in detail the expression of this important ligase during spermatogenesis 
and in various tissues. 
In the testis, we observed that E3Histone ILASUI expression was highly regulated with 
expression detected mainly in spermatogonia and spermatocytes. This suggests that the 
enzyme may be involved in the ubiquitination of histones that occurs in spermatocytes. 
During spermatogenesis, histones appear to be highly ubiquitinated in pachytene cens 
(Chen, Sun et al. 1998; Baarends, Hoogerbrugge et al. 1999) and also in early elongating 
spermatids before histones are replaced by transition proteins (Agen, Chiva et al. 1983; 
Agell and Mezquita 1988; Chen, Sun et al. 1998; Baarends, Hoogerbrugge et al. 1999). In 
early-pachytene cens, ubiquitinated H2A is found mainly limited to the condensed and 
transcription inactive XY chromatin of the sex body, an inactive nuclear structure that 
contains the heterochromatic X and Y chromosomes, distributes to the entire nucleus in 
mid-pachytene cens and concentrates again to the sex body in late-pachytene cens 
(Baarends, Hoogerbrugge et al. 1999). Since it has been reported that histone 
modification alters nucleosome stability and thereby may facilitate processes that require 
access to DNA (Li, Nagaraja et al. 1993), ubiquitination of histone H2A during 
pachytene may facilitate replacement of somatic histones by the testis specific isotypes 
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that are synthesized in pachytene cells (Poccia, Simpson et al. 1987; Meistrich 1989; 
Drabent, Bode et al. 1996). Thus, E3Histone ILASU1 expressed in the nucleus ofpachytene 
cells may be involved in the replacement of somatic histones by ubiquitination, and it 
may thereby be involved in extensive chromatin reorganization occurring in this stage 
through mediating histone ubiquitination. 
In addition, it is now well established that histone ubiquitination can regulate 
transcription of specifie genes (Zhang 2003). In these cases, the histones are 
monoubiquitinated. In vitro, E3Histone ILASU1 clearly manifests polyubiquitination of 
histones, but it is possible that in an in vivo context, the localization of enzyme and 
substrate in the presence of other regulatory proteins and/or deubiquitinating enzymes 
may limit the activity ofE3Histone ILASU1 to monoubiquitination. 
Although our original hypothesized function for E3Histone ILASU1 was a role in the 
polyubiquitination and degradation of histones in early elongating spermatids, no 
expression ofE3Histone ILASU1 was detected in spermatids by immunohistochemistry 
using the LASU1-A antibody generated in our laboratory. However, because of the 
relative insensitivity of immunohistochemistry, we cannot exclude the possibility that 
E3Histone ILASU1 is expressed at low levels in spermatids. Indeed to date, we have found 
it expressed in all cultured celllines that we have tested. Furthermore, Mcl-1 and p53, 
substrates of E3Histone/LASU1 , are essential cellular proteins expressed in most of cells 
(Chen, Kon et al. 2005; Warr, Acoca et al. 2005; Zhong, Gao et al. 2005). Therefore it is 
very likely that E3HistoneILASU1 itselfis also a widely expressed enzyme. Using 
commercial antibodies derived against two distinct peptides from the enzyme, we did 
detect staining of the acrosomes oflate round and early elongating spermatids (steps 2-8) 
131 
in addition to the staining of spermatogonia and spermatocytes observed with our own 
antibody. Preabsorption of the commercial antibodies with antigen eliminated the 
acrosomal staining supporting that this staining was specific. However, when used in 
EM immunohistochemistry, these antibodies did not label the acrosomes of spermatids 
(data not shown), but did label the nuclei of spermatocytes. This in conjunction with the 
known propensity of the acrosome to be a site of non-specific binding of antibody has led 
us to take the conservative interpretation that E3HistoneILASUI is not present in 
spermatids. Ultimately, to evaluate more precisely the role ofE3HistoneILASUI in 
spermatids or in spermatocytes will require generation of conditional knockout mice 
using promoters that will activate expression of cre recombinase in haploid (protamine 
driven cre) (Steger 1999) and diploid germ cells (Sycp-l driven cre) (Vidal, Sage et al. 
1998; Sage, Martin et al. 1999), respectively. 
Our data showed that E3HistoneILASUI was mainly expressed in the cytoplasm of 
most tissues, except in early germ cells in the testis and neuronal cells in cerebrum where 
it was mainly expressed in the nucleus (Fig. 4). E3Histone ILASUI was mainly expressed in 
epithelia (Fig.4 and data not shown). These results indicate that E3Histone /LASUI must 
have other functions besides its role in spermatogenesis. As described earlier, E3Histone 
/LASUI acts on Mcl-l and p53. Thus, the functions ofE3Histone ILASUI in cytoplasm is 
likely to be linked to downregulation ofMcl-1 and p53 through ubiquitination, while in 
nucleus E3Histone /LASUI may be involved in the regulation of histones and p53 as weIl. 
The subcellular localiztion ofE3Histone ILASUI in different tissues may be regulated 
by the modulated exposure of the nucleus localization signal ofE3Histone ILASU1, which 
is located at the middle of the protein distal to the WWE domain (Chen, Kon et al. 2005). 
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Since this E3 is involved in apoptosis (Chen, Kon et al. 2005; Warr, Acoca et al. 2005; 
Zhong, Gao et al. 2005), it would be interesting to test ifE3Histone ILASUI is shuttled 
between nucleus and cytoplasm under apoptotic stimuli. 
E3Histone ILASUI is one of the large st RECT domain E3 ligases known. Therefore it 
likely has many more substrates besides histones, Mcl-l and p53. Indeed, inactivation of 
E3Histone ILASUl/Mule/ARF-BP1 suppresses the growth ofp53 null cells in a manner 
reminiscent of ARP induction (Chen, Kon et al. 2005), suggesting that there are 
additional substrate(s) that mediate the function ofthis E3 on cell growth. Identification 
ofthese other substrate(s) ofE3Histone ILASUI will enlarge our understanding of the 
functions of this E3. 
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Figure legends 
Fig. 1 Expression ofE3Histone ILASU1 during postnatal development of rat testis. A. 
mRNA from the testes of rats at different ages (days) were used in Northern Blot with 
probes against 5'- or 3'-ends ofE3Histone ILASUl. E3Histone ILASU1 mRNA was quantified 
and normalized to the level of 18S RNA in the same lane. Means ± standard error are 
shown (n=3 for each time point). B. Rat testes homogenate at different ages (days) were 
used in Western Blot with LASU1-A antibody. E3Histone ILASU1protein was quantified 
and normalized to the level of ~-Actin in the same lane. Means ± standard error are 
shown. (n=3 for each time point, shown is a representative blot) * indicates the major 
degradation product ofE3Histone ILASU1 found in the extracts. 
Fig. 2 Immunohistochemistry of rat testis. A. Shown are cross sections of tubules from an 
adult rat (3-4 month old). Right, staining with antibody against C-terminal region of 
E3Histone ILASU1. Left, Negative control in which the antibody was pre-absorbed with the 
antigen. (Magnification 10X) B. Magnification of the stained sections. Left panel, 
magnification (20X) image; Right panel, magnification (40X) image: red arrow shows 
nuclear staining of spermatogonia; blue arrow shows nuclear staining of spermatocyte 
(pachytene ceIl). C. Magnified image of the right panel in B. The stages of the 
seminiferous tubules are indicated. Arrows indicate same germ cells as in B. D. Detection 
of nuclear expression of E3Histone ILASU1 in pachytene cell by EM immunocytochemistry. 
The black spots are the go Id particles indicating the positive staining ofE3Histone ILASU1. 
The nucleus shows blurry background. E. Summary of the expression ofE3Histone ILASU1 
during rat spermatogenesis. E3Histone ILASU1 was expressed in nucleus of germ cells 
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from early spermatogonia to mid-pachytene cells (red continuous lines). The stages with 
highest expression ofE3Histone ILASUI were shown by heavier lines. F. Summary of the 
expression of LASUI in different germ cells. 
Fig. 3 Expression ofE3Histone ILASUI in different rat tissues. A. Detection ofE3Histone 
/LASUI mRNA by Northern Blot. B. Detection ofE3Histone ILASUI protein expression 
by Western Blot with E3Histone ILASUI antibody. * indicates the major degradation 
product ofE3Histone /LASUI. 
Fig. 4 Immunohistochemistry staining of different mouse tissues using two different 
E3Histone ILASUI antibodies. Expression ofE3Histone ILASUI is identified as the red 
product of the alkaline phosphatase reaction. The nuc1ei are identified as blue products of 
the Vector methyl green reaction. A-D. Left, negative controls with preabsorbed antibody; 
Middle, detection with LASUI-A antibody; right, detection with BL672 antibody. A. 
Expression ofE3Histone ILASUI in different tissues of immune system. Upper, E3Histone 
/LASUI is expressed in cytoplasm of non-lymphocytes in spleen; Middle, E3Histone 
/LASUI is expressed in cytoplasm of epithelial cells in the medullary region of the 
thymus; Lower, E3Histone ILASUI is expressed in cytoplasm of some cells in bone. B. 
Expression ofE3Histone ILASUI in cytoplasm ofrenal tubules and hepatocytes in kidney 
and liver, respectively. C. Expression ofE3Histone ILASUI in cytoplasm ofmusc1e cells. D. 
Expression ofE3Histone ILASUI in brain. Upper, E3Histone ILASUI is expressed in 
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cytoplasm ofPurkinje cells; Middle, E3Histone ILASUI is expressed in nucleus of neuronal 
cells in cortex. 
Fig. 5 Subcellular localization ofE3Histone ILASUI in culture cells. A. FR3T3 fibroblasts 
were analyzed by immunofluorescence using LASUI-A antibody. DAPI staining shows 
nucleus. B. Western blot offractionated cell cytoplasm and nucleus using LASUI-A 
antibody and H2A antibody as a nuclear marker. 
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Bridge of Chapter 3 & 4 
In Chapter 3, we showed that E3Histone ILASUI is widely expressed in various rodent 
tissues. Previous studies suggest that E3Histone ILASUI may regulate gene transcription. It 
is known that monoubiquitination of histones can regulate gene transcription. Therefore, 
in this chapter we tested ifE3Histone ILASUI mediates histone ubiquitination in somatic 
cells. Our collaborator determined that E3Histone ILASUI contains a BH3 domain, a 
conserved domain originally described in Bel-2, and that E3Histone ILASUI specifically 
interacts with the proapoptotic protein Mel-l which is degraded by the ubiquitin 
proteasome pathway. To demonstrate if Mel-l is a substrate ofE3Histone ILASUl, we also 
tested the ability of purified E3Histone ILASUI to ubiquitinate Mel-l in vitro. 
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Chapter4 
Evaluation of the roles of E3HistoneILASUl on the ubiquitination of histones in 
somatic cells and of Mcl-l in vitro 
4.1. Abstract 
E3Histone ILASU1 ubiquitinates histones in vitro and may regulate the ubiquitination 
and degradation of histones during spermatogenesis (Liu, Oughtred et al. 2005). Since 
E3Histone ILASU1 was found widely expressed in different tissues (Chapter 3), there must 
be other functions ofthis E3 other than its role in spermatogenesis. E3Histone ILASU1 was 
previously suggested to affect gene transcription. Since histone monoubiquitination can 
regulate gene transcription, we tested using siRNA approaches ifE3Histone /LASU1 
ubiquitinates histones in somatic cells. Depletion ofE3Histone ILASU1 by siRNA did not 
result in any changes of the levels of free or ubiquitinated histones H2A, H2B, H3 and 
H4. 
Bioinformatics analysis revealed the presence of a BH3 region in E3Histone ILASU1 
protein sequence. The BH3 region is a conserved region of Bc1-2 that is essential for 
heterodimerization among Bc1-2 family members. E3Histone ILASU1 was shown to 
specifically interact with Mc1-1, a BH3 containing antiapoptotic protein that is degraded 
by the ubiquitin proteasome degradation pathway. We therefore tested whether Mc1-1 is a 
substrate ofE3Histone /LASUl. Indeed, purified E3Histone ILASU1 was able to stimulate 
polyubiquitination of Mc1-1 in vitro. E3Histone ILASU1 may therefore regulate cell 
apoptosis by mediating the degradation ofMc1-1. 
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4.2. Introduction 
Although histone H2A was the first protein ever identified to be ubiquitinated 
(Goldknopf, Taylor et al. 1975), the precise mechanism and functional significance of 
histone ubiquitination still remain unclear. Only very recently has the function of 
monoubiquitination of histone H2B become defined (Emre and Berger 2004). As 
described in detail in Chapter 1 (1.3. Histone Ubiquitination), monoubiquitination of 
histone Hl, H2A and H2B has been shown to be capable ofregulation of gene 
transcription (Bignell, Warren et al. 2000; Jason, Moore et al. 2002; Emre and Berger 
2004; Caron, Boyault et al. 2005; Chen, Kon et al. 2005), and may also be involved in 
cell cycle (Citterio, Papait et al. 2004) and in gene silencing, meiosis, and specific gene 
induction during spermatogenesis (Baarends, Hoogerbrugge et al. 1999; Sassone-Corsi 
2002; Lewis, Abbott et al. 2003; Sutovsky 2003). Polyubiquitination of histones has also 
been demonstrated in the testis. The function of histone polyubiquitination remains 
unknown, but is likely to be important in mediating the loss of histones during 
. . 
spermlOgeneSlS. 
Our studies described in Chapter 2 identified a novel ubiquitin protein ligase, 
E3HistonelLASU1, which may mediate histone ubiquitination and degradation during 
spermatogenesis (Liu, Oughtred et al. 2005). E3Histone/LASU1, purified from testis, 
showed ubiquitin protein ligase activity for different core histones in vitro (Liu, Oughtred 
et al. 2005). Although E3HistoneILASU1 was purified from testis, we also observed that 
this E3 was expressed widely in different tissues (Chapter 3), suggesting that there must 
be other functions ofE3HistoneILASU1 besides its possible role in spermatogenesis. Early 
studies worked on a fragment ofE3Histone ILASU1, UreB1, which only contains the 
HECT domain (Gu, Ren et al. 1994; Gu, Dubner et al. 1995; Gu, Irving et al. 1997). 
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UreBl has a DNA binding domain and specifically binds to the upstream regulatory 
element (URE) that contains the consensus initiator sequence in the promo ter of the rat 
prodynorphin gene (Gu, Ren et al. 1994). A gene reporter assay determined that UreB1 
suppresses gene expression by binding to URE (Gu, Irving et al. 1997). This result 
suggests that E3Histone /LASU1 might be a transcriptional regulator. In support ofthis, 
Tom1, which appears to be an ortholog ofE3Histone ILASUI in yeast, also has a role in 
transcriptional regulation as shown by null mutation studies (Saleh, Collart et al. 1998). 
In the absence ofTOM1p, the normal associations of the transcriptional regulator ADA 
with the TATA-binding protein (TBP) are reduced. TBPs are DNA binding proteins that 
are required for gene initiation. The action ofTOM1p is likely mediated through 
ubiquitination since mutation of critical Cys in the RECT domain results in similar 
changes in transcription as the null mutation. Similarly, E3Histone /LASUI may have a role 
in gene transcription in mammals. Since monoubiquitination of histones is known to 
regulate gene transcription (Bignell, Warren et al. 2000; Jason, Moore et al. 2002; Emre 
and Berger 2004; Caron, Boyault et al. 2005; Chen, Kon et al. 2005), and E3Histone 
/LASUI stimulated ubiquitination of core histones in vitro (Liu, Oughtred et al. 2005), 
we reasoned that E3Histone might regulate gene transcription via monoubiquitinating 
histones in somatic cells. Therefore we inhibited the expression ofE3Histone ILASUI 
protein by using siRNA to test if the levels offree histones and/or the ubiquitination of 
histones are affected. 
Interestingly, a screen of a protein database using a bioinformatics pro gram identified 
E3Histone ILASU1 as a BR3 region containing protein (Warr, Acoca et al. 2005). BR3 
region is a conserved region of Bcl-2 that is required for the interaction of sorne Bcl-2 
family members (Shibue and Taniguchi 2006). Furthermore, Shore and his colleagues 
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determined that E3Histone ILASU1 specifically interacts with Mel-l, but not with Bel-2 or 
with Bel-xl. Mel-1 is an BH3 containing antiapoptotic protein (Edwards, Derouet et al. 
2004; Le Gouill, Podar et al. 2004; Michels, Johnson et al. 2005), which sequesters Bak, 
a proapoptotic proteÏn, under normal conditions (Willis, Chen et al. 2005). Upon 
apoptotic stimulus, prosurvival Mel-1 is targeted for rapid degradation by the ubiquitin 
proteasome pathway, and this degradation is required to initiate apoptosis (Cuconati, 
Mukherjee et al. 2003; Nijhawan, Fang et al. 2003). Mel-1 is therefore a good candidate 
substrate ofE3Histone /LASUl. 
Thus, in this chapter, we studied if histones are substrates ofE3HistoneILASU1 in 
somatic cells and if Mel-1 is also a substrate ofthis E3 in vitro. 
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4.3. Methods 
siRNA mediated depletion ofE3Histone /LASU1-Cells used for siRNA transfection were 30-
40% confluent. The transfection protocol was according to the manufacturer's 
instructions (Invitrogen Plus Reagent). The final siRNA concentration was 20 nM. Cells 
were split the day after the transfection and harvested after another two days. siRNA 
oligonucleotide C was designed from human E3Histone ILASU1 nt 12556-12674 (mouse 
E3Histone ILASU1 nt 12665-12683). siRNA oligonucleotide F was designed to be 
complementary to human E3Histone ILASU1 nt 9003-9021 (mouse E3Histone ILASU1 nt 
11909-11928 with one mismatch at 11916). Control siRNA is a non-targeting siRNA 
which is not complementary to any of the known human and mouse genes (Dharmacon). 
Preparation ofhistone enriched protein samples-Cells were trypsinized from the cell 
culture plate, collected by centrifugation at 500 g, 4°C for 5 min, washed in 10 ml cold 
PBS buffer and then frozen in liquid nitrogen and stored at -80°C until processed. Cells 
were lysed by thawing on ice and resuspended in 1 ml co Id PBS with protease inhibitor 
cocktail (Roche). After incubation for 10 min on ice, the nuclei were collected by 
centrifugation as before. The supematant was the cytosolic fraction. The pellet was 
washed once with the same buffer. The pellet containing the nuclei was then resuspended 
in 1 ml 0.2 M H2S04 and incubated on ice for 30 min to extract the histones. The 
insoluble debris were removed by centrifugation at 13,OOOg in a microcentrifuge for 5 
min. The supematant containing the histones was transferred to a new eppendorf tube. 
Trichloroacetic acid (TCA) was added to 25% of the final solution and incubated on ice 
for 30 min to precipitate proteins. The pellet containing the precipitated histones was 
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centrifuged at 13,OOOg in a microcentrifuge for 20 min. The pellet was washed with 1 ml 
acetone and incubated on ice for 10 min to eliminate TCA. After centrifugation again 
13,OOOg in a micro centrifuge for 20 min, the pellet containing purified histones was air-
dried and resuspended in 20 III 0.1 M Tris-Cl buffer (pH 7.6). The histone enriched 
samples were then subjected to western blot and probed with antibodies against different 
histones (Upstate) and anti-ubiquitin antibody (Sigma), respectively. 
In vitro ubiquitination of Mcl-l-The reaction mixture contained the following in a final 
volume of20 Ill: 50 mM Tris-HCl (pH 7.5), 1 mM dithiothreitol (DTT), 2 mM MgCh, 
2 mM ATP, 0.5 U ofpyrophosphatase, 12.5 mM phosphocreatine, 2.5 U of creatine 
kinase, 50 nM El, 250 nM UBC4-1, 10 III ofpurified E3Histone /LASU1 (Liu, Oughtred et 
al. 2005), 50 IlM MG132, 2 IlM ofubiquitin aldehyde and 360 nM ofpurified 
recombinant Flag-Mcl-1-His6, with the small C-terminal transmembrane domain deleted. 
Ubiquitin conjugation reactions were initiated with 23 IlM GST-Ub (Boston Biochem), 
incubated for 1 h at 37°C, and then stopped by 2 mM N-ethylmaleimide (NEM). Mcl-1 
was isolated by affinity chromatography by Ni2+ beads (lnvitrogen), eluted with 350 mM 
imidazole and resolved by SDS-PAGE, followed by transfer to PVDF membranes. The 
membranes were then subjected to western blot and probed with anti-Flag antibody 
(Sigma) to detect Mcl-1 and with anti-GST antibody (Upstate) to detect ubiquitin, 
respectively. 
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4.4. Results 
Depletion of E3Histone ILASUI resulted in impaired cell growth. To detect the function 
ofE3Histone ILASUI in somatic cells, we depleted E3Histone ILASUI in HEK 293 cells by 
siRNA (Fig. 1). Compared with transfection without siRNA oligo (Mock) and control 
siRNA treatment (CTL-), E3Histone ILASUI protein was dramatically decreased with 
E3Histone ILASUI siRNA treatment (LASUl) (Fig. lA upper panel). Levels of actin were 
detected as a loading control. To demonstrate ifE3Histone ILASU has a role in cell growth, 
we determined the changes in cell number upon E3Histone ILASUI depletion. When 25 nM 
E3Histone ILASUI siRNA oligo C was used, the cell number decreased after three days to 
nearly half of the controls, while treatment with 50 nM of siRNA C resulted in decrease 
of the cell number to one third of the controls. Similarly, when cells were treated with 50 
nM siRNA F, the cell number decreased to half of the controls (Fig. lB). These dramatic 
decreases in cell number upon E3Histone ILASUI depletion suggests that E3Histone ILASUI 
may be required for cell proliferation or may inhibit cell death. 
Depletion of E3Histone ILASUI did not result in any changes in the levels of free or 
ubiquitinated histones. Ubiquitination of histones Can regulate gene transcription and 
cell proliferation. To test ifthat may be a reason for the decrease in cell number upon 
depletion ofE3Histone ILASUl, we measured levels ofubiquitinated histones under the 
same conditions (Fig. lC, ID). Since western blot ofthe whole celllysate using anti-
histone antibodies yielded only faint signals, we used acid extraction of nuclei to obtain 
histone enriched fractions which were then subjected to western blot to detect various 
histones (Fig. lC) and ubiquitin (Fig. ID), respectively. In the western blot detecting 
H2A under three different conditions (Fig. 1 C, upper left panel), there were no changes 
in the levels of free H2A (the strong band of approximately 17 kDa). The bands, just 
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below 24 kDa, likely represent monoubiquitinated H2A and were not changed either. The 
upper blurry bands could represent multiubiquitinated H2A or be cross reactive with 
other proteins. The monoubiquitinated H2A detected by a specific ubiquitinated H2A 
(uH2A) antibody showed no changes either (Fig. lA lower panel). Thus, the levels of 
free and ubiquitinated H2A were not changed upon depletion ofE3Histone ILASU1. In the 
western blot detecting H2B (Fig. 1 C, upper right panel), there were no changes in the 
level of the free H2B, the strongest band below 17 kDa. The band a bit higher then the 24 
kDa marker would be monoubiquitinated H2B and showed no dramatic changes either. 
The bands between 17 kDa and 24 kDa and the bands below H2B are likely background 
bands and did not change either. In the western blot detecting H3 and H4, respectively 
(Fig. 1 C, lower panels), there were no obvious ubiquitinated H3 or ubiquitinated H4 
bands detected. The arrows showed free H3 and H4 whose levels were not changed upon 
depletion ofE3Histone ILASUl. The faint blurry bands in those two panels are likely 
background bands. In summary, there were no obvious changes in H2A, H2B, H3 or H4 
ubiquitination, neither were there any changes in the levels of free histones, suggesting 
that E3Histone ILASU1 does not mediate histone degradation in HEK 293 cells. To confirm 
these results, we also probed the same set of samples with anti-ubiquitin antibody (Fig. 
ID). The bandjust below the 24 kDa marker is likely to be monoubiquitinated histone(s), 
while the band just below 33 kDa marker is likely diubiquitinated histones (Fig. ID). 
There are no obvious changes of ubiquitinated histones under three different conditions. 
The bands between the markers of 17 kDa and Il kDa are most likely generated from 
cross reaction with the abundant free histones (Fig. ID). Taken together, inhibition of 
E3Histone ILASU1 protein expression did not affect the levels offree or ubiquitinated core 
histones. 
148 
E3Histone ILASUI can ubiquitinate Mcl-l. To detennine ifE3Histone ILASUI is an E3 
ubiquitin ligase for Mel-l, we perfonned an in vitro ubiquitination assay using purified 
bovine E3Histone ILASUI (Liu, Oughtred et al. 2005) and recombinant Flag-Mel-l-His6 
lacking the C-tenninal transmembrane domain which is a very small fragment. The assay 
mixture contained El, E2 (rat Ubc4-l/human UBC H5B), E3Histone ILASU1, Mel-l, GST-
ubiquitin, and an ATP regeneration system. Reaction products were isolated by Ni2+ 
chromatography, resolved on SDS-P AGE and subsequently subjected to western blot 
with anti-Flag antibody to detect Mel-l(Fig. 2A) and with anti-GST antibody to detect 
ubiquitin (Fig. 2B). Addition ofE3Histone ILASUI resulted in Mel-l polyubiquitination 
(lane 4 of Fig. 2A, 2B), indicating that Mel-l is a substrate ofE3Histone ILASUI in vitro. 
The detection of sorne faint higher molecular weight bands in the absence of E3 Histone 
/LASUI (lane 2 of Fig. 2A, 2B) may reflect the ability of Ubc4-1 to ubiquitinate Mel-l; 
however, the presence ofE3Histone ILASUI dramatically stimulated the polyubiquitination 
ofMel-l (lane 4 of Fig. 2A, 2B). These findings support the role ofE3Histone ILASUI as a 
ligase for Mel-l. 
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4.5. Discussion 
In this study we demonstrated that E3Histone ILASUI is required for normal cell 
growth. However, these effects were not associated with any changes in levels of free or 
ubiquitinated histone H2A, H2B, H3 or H4. Thus, E3Histone ILASUI does not appear to be 
required for ubiquitination of histones in somatic cells. However, because it is known 
that ubiquitination of histones is cell cycle dependent (Wu, Kohn et al. 1981), it is 
possible that E3Histone ILASUI functions on histone ubiquitination at a specific stage of 
cell cycle, such as MlGl boundary. Further studies need to be done in synchronized cells 
to more conclusively determine ifE3Histone ILASUI is involved. Plasmids expressing 
tagged histones may also be employed to amplify the possible effects. 
Since proteasome inhibitor inhibits the degradation of Mcl-l (Cuconati, Mukherjee et 
al. 2003; Nijhawan, Fang et al. 2003), Mcl-l is triggered for degradation by the ubiquitin 
proteasome pathway. Purified E3Histone/LASUl showed ubiquitin protein ligase activity 
on Mcl-l in vitro (Fig 2). Moreover, Shore and his colleagues determined that the level 
ofMcl-l is upregulated upon depletion ofE3Histone ILASUI protein in Hela ceIls, further 
confirming that E3Histone ILASUI is responsible for degradation ofMcl-l. These results 
are consistent with those in the recent publication from Wang's group (Zhong, Gao et al. 
2005). Interestingly, another group reported that E3HistoneILASUl/Mule/ARF_BPl is also 
an important regulator ofthe ARF tumor suppressor (Chen, Kon et al. 2005). In p53 
positive ceIls, E3HistoneILASUl/Mule/ARF_BPl appears to be an E3 ligase for p53 
ubiquitination. As is weIl known, Mcl-l is an antiapoptotic protein (Edwards, Derouet et 
al. 2004; Le GouiIl, Podar et al. 2004; Michels, Johnson et al. 2005), while p53 has 
proapoptotic functions (Levine 1997; Brooks and Gu 2006; Pietsch, Humbey et al. 2006). 
The intriguing question remaining is how this E3 ligase, E3HistoneILASUl/Mule/ARF_ 
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BP 1, functions by having both proteins with opposite functions as substrates. One 
possible explanation is that the subcellular localization of the E3 could control its 
substrate accessibility and E3 activity (Shmue1i and Oren 2005). But the results of those 
two studies are contradictory with respect to the effect of depletion ofE3Histone ILASU1 
on cell response to apoptotic stimuli (Chen, Kon et al. 2005; Zhong, Gao et al. 2005). 
The biological impact of this E3 is possibly regulated in subtle ways, leading to very 
different outcomes even under superficially similar conditions (Shmueli and Oren 2005). 
These two studies used different methods to delete E3HistoneILASU1/Mule/ARF-BP1 
expression in cells, siRNA (Chen, Kon et al. 2005) versus hnRNA (Zhong, Gao et al. 
2005). These two methods may have depleted E3Histone ILASU1 to different levels and 
thereby yielded distinct results. In our study, we actually observed cell number 
decreasing upon depletion ofE3Histone ILASU1, consistent with the results from Gu's 
group (Chen, Kon et al. 2005). Further studies are needed to determine the precise 
function and mechanism ofthis E3 on cell apoptosis and proliferation. 
Since E3Histone/LASU1 has different substrates with different functions, sorne of 
which are even opposite to each other, and with the functions ofthis E3likely to be cell 
type specifie, it would be interesting to study the regulation of this E3 more precisely 
under these conditions. 
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Figure legend: 
Fig. 1. Depletion ofE3Histone ILASUlleads to decreased cell growth, but no change in 
histone ubiquitination. A. HEK 293 cells were transfected with control siRNA (CTL-), 
E3Histone ILASUI siRNA (LASU1) or no siRNA (Mock). Cytosolic fraction (Methods) 
was subjected to western blot with LASUI-A antibody. Actin was used as a loading 
control. Histone enriched samples were prepared (as in Methods) and were blotted with 
anti-uH2A antibody (Upstate). Asterisk shows the major degradation product ofE3Histone 
/LASUI. B. Cell number decreased upon E3Histone /LASUI depletion. Shown are results 
with different concentration of siRNA C or F. Means ± standard deviation are shown 
(n=3 for each point). C. Histone enriched samples were blotted with anti-H2A, H2B, H3 
and H4 antibodies (Upstate), respectively. Arrows indicate different free histones and 
ubiquitinated histones. D. Histone enriched samples were blotted with anti-ubiquitin 
antibody (Sigma). 
Fig. 2. E3Histone/LASUl ubiquitinates Mcl-l in vitro. El, E2, and an ATP regenerating 
system were incubated in the presence or absence ofpurified bovine E3Histone ILASU1, 
recombinant Flag -Mcl-l-His6, and GST-ubiquitin at 37°C for 1 h. Reaction products 
were recovered with Ne+ beads. Proteins eluted with 350 mM imidazole were resolved 
by SDS-PAGE and the products visualized by immunoblotting with (A) anti-Flag 
antibody, or (B) anti-GST antibody. 
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General discussion and original contribution 
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5.1. General discussion 
ln this thesis, 1 have identified and characterized a nove! ubiquitin protein ligase, 
E3HistoneILASUl. Structurally (Chapter 2), this enzyme is 482 kDa in size and therefore 
one of the largest HECT domain containing E3 enzymes known. Previous work had 
identified the enzyme only as incomplete carboxy-terminal fragments (Gu, Ren et al. 
1994; Gu, Irving et al. 1997). This work identified the complete sequence showing that it 
is a composite ofwhat was previously thought to be two genes, LASUI (giI22090626) 
and unnamed protein product (giI26340188). Like other members ofthis family, the 
HECT domain is located at the carboxy tenninal end of the molecule. The remaining N-
tenninal sequences contain a number of sequence motifs, UBA, UlM, WWE, BH3 and at 
the N-tenninal DUF 908 and DUF 913 domains (two domains with unknown function) 
(Liu, Oughtred et al. 2005; Warr, Acoca et al. 2005; Zhong, Gao et al. 2005). UBA 
(Hofmann and Bucher 1996) and UlM (Young, Deveraux et al. 1998; Hofmann and 
Falquet 2001) domains are ubiquitin interacting domains. UlM and UBA domains have 
been found in many proteins and are able to bind to both monoubiquitin and polyubiquitin 
chains (Hicke, Schubert et al. 2005). UIMs and UBA domains may play a role in adding 
multiple ubiquitin moieties onto the substrates of E3HistoneILASUI , and may also mediate 
E3HistoneILASUI autoubiquitination. WWE domain is named after its most conserved 
residues and is predicted to mediate specific protein-protein interactions in the ubiquitin 
and ADP-ribose conjugation systems (Aravind 2001). WWE domain may be essential for 
recruitment of the substrates or regulators. BH3 region is Bcl-2 homology region 3, which 
has been characterized in many proteins (Huang, Kahana et al. 1997; Lutz 2000). The 
BH3 region is essential for heterodimerization among Bcl-2 family proteins (Zha, Aime-
Sempe et al. 1996; Diaz, Oltersdorf et al. 1997) and appears to promote cell death (Lutz 
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2000). E3Histone/LASUI recruits Mcl-l for polyubiquitination via its BH3 region (Warr, 
Acoca et al. 2005; Zhong, Gao et al. 2005). DUF 908 and DUF 913 are domains with 
unknown functions. Interestingly, searches of the protein database reveal that all the 
proteins containing DUF 908 and DUF 913 domains are very large proteins and most of 
them are HECT domain containing proteins. Therefore it would be interesting to 
determine the functions of two domains. Currently yeast two hybrid studies with those 
two domains as baits are ongoing in our laboratory to identify the interacting proteins, 
which are possible substrates of this E3 or adaptor proteins required for the functions of 
E3HistonelLASU1. 
E3Histone appears to be a monomer ofLASU1 based on mass spectrometry analysis of 
the enzyme and size analysis by gel filtration and glycerol gradient centrifugation 
(Chapter 2). However, we cannot completely rule out the presence of additional small 
subunit(s), particularly nonstoichiometric ones in subsets of the enzyme molecules. We 
are currently cloning E3HistoneILASU1 into expression vectors. Ifwe are able to express 
the recombinant protein ofLASU1 using baculovirus for example, we will be able to 
anSwer this question by testing if LASU1 alone has the E3 ligase activity for histones in 
vitro. 
With respect to regulation, this thesis made a number of new observations. Although 
widely expressed in manY tissues, E3HistoneILASU1 is preferentially expressed in specific 
cell types and in epithelia in various tissues (kidney, spleen, thymus (Chapter 3); 
intestine, lung, breast (data not shown)). We also described for the first time 
developmental regulation of the enzyme in the testis showing that it is mainly expressed 
in the nuclei of spermatogonia and early spermatocytes. 
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Witbin the cell, its location can also be regulated. In most tissues, E3Histone ILASUI 
was mainly expressed in the cytoplasm, except in neuronal cells of the brain and in early 
germ cells of the testis, where it was expressed in the nucleus. Since E3HistoneILASUI has 
a nuclear localization signal, there may be a binding protein that regulates the presence of 
E3HistoneILASUl in nucleus or cytoplasm by exposing or hiding the nuclear localization 
signal ofE3Histone/LASUl. The localization in the nucleus or the cytoplasm likely 
determines the function ofE3HistoneILASUl by modulating accessibility to the substrates 
and/or by binding different positive or negative regulators in each compartment. For 
example, such regulation may determine the ability ofE3HistoneILASUl to ubiquitinate 
cytoplasmic Mcl-l or nuclear p53. 
Functionally, we have identified tbis enzyme as the major UBC4-dependent histone 
ubiquitinating ligase in the testis. As discussed above, the high expression of 
E3HistoneILASUl in nuclei of spermatogonia and primary spermatocytes suggested that 
this enzyme may be involved in the chromatin modifications that occur during mitosis in 
spermatogonia and meiosis in spermatocytes. Although LASUI-A antibody did not detect 
the expression ofE3HistoneILASUl in the germ cells in which histones are degraded, 
E3HistoneILASUl may still be expressed at a low level and may therefore still play a role in 
the loss of histones during spermiogenesis. These propositions will be further tested using 
transgenic models. Two different kinds ofE3Histone/LASUl knockout mice will be 
generated with tbis E3 deleted either specifically in germ cells later than pachytene cells 
or in all germ cells. Protamine genes are transcribed in step 1 to step 4 spermatids (Steger 
1999). Therefore the promoter of protamine genes could be used to express Cre, when the 
Cre-LoxP system is used to generate testis specific knockout ofE3Histone /LASUI to study 
its function on histone degradation. In addition, a dominant negative E3HistoneILASUl 
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transgenic mouse model bearing a mutation of the active site cysteine to alanine can be 
generated to confirm that the E3 ligase activity ofE3HistoneILASUl is required. The same 
set of studies can be done with E3Histone/LASUl deleted or mutated in all germ cells. 
The widespread expression raised the possibility that this enzyme might be involved 
in general histone ubiquitination and thereby have a role in the histone code. Such a role 
could have been an explanation for the defect in cell growth seen upon silencing 
expression of E3 HistonelLASU 1 (Chapter 4). However, inhibition ofE3HistoneILASUl 
protein expression in HEK 293 cells showed no changes in the level of histone 
ubiquitination (Chapter 4). It has been shown that histone ubiquitination is regulated 
through cell cycle (Wu, Kohn et al. 1981). Since ubiquitinated H2B and ubiquitinated 
H2A variants are absent from isolated metaphase chromosomes, but they are present in 
G 1 phase, E3Histone/LASUl may specifically function at M/G 1 boundary. It would be 
interesting to test how depletion of E3Histone ILASU 1 in synchronized cells at M/G 1 
boundary affects ubiquitination of histone H2A and/or H2B. Also, further studies could 
use plasmids expressing tagged histones to maximize the effects. 
Work by other groups has clearly identified important non-histone related functions of 
E3Histone ILASUI in the cell. Mcl-l and p53 have been identified as physiological 
substrates of the enzyme (Chen, Kon et al. 2005; Warr, Acoca et al. 2005; Zhong, Gao et 
al. 2005). Those three independent studies have revealed that E3Histone/LASUl regulates 
the cell response to stimulation of apoptosis (Chen, Kon et al. 2005; Warr, Acoca et al. 
2005; Zhong, Gao et al. 2005). Therefore unregulated E3HistoneILASUl may result in 
carcinogenesis. Future studies are needed to determine ifthere are mutation(s) of the 
E3Histone/LASUl gene in cancers, or ifE3Histone/LASUl activity is altered in cancers, 
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especially in carcinoma, since this enzyme has heen shown to he expressed primarily in 
epithelia (Chapter 3). 
The large size ofE3Histone/LASU1 indicates that the complete inventory offunctions 
and regulation of this enzyme remain to he determined. Our work has provided molecular 
tools that will enable the necessary cellular and transgenic studies to arrive at this goal. 
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5.2. Original contribution 
This thesis work has identified and characterized a novel ubiquitin protein ligase, 
E3HistoneILASU1/Mule/ARF_BP1. 
• E3HistoneILASUl can ubiquitinate an the core histones in vitro; 
• UBC4/5 family E2s appeared to be the preferred E2s supporting E3Histone/LASU1_ 
dependent histone ubiquitination; 
• E3HistoneILASUl appears to be a monomer of the RECT domain protein LASU1, 
nearly 500 kDa; 
• E3HistoneILASUl is the major UBC4 dependent E3 for histone ubiquitination in the 
testis; 
• The mRNA ofE3Histone/LASUl is highly expressed at the start of the first wave of 
spermatogenesis; 
• During the first wave ofrat spermatogenesis after birth, E3HistoneILASUl protein 
peaks at day 20 when the most advanced germ cens are late pachytene cens and 
diplotene cens; 
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• E3HistoneILASUI protein is highly expressed in nucleus of early primary 
spermatocytes; 
• E3HistoneILASUI is widely expressed in various tissues at both rnRNA and protein 
levels; 
• E3HistoneILASUI is mainly expressed in cytoplasm in most tissues, except in early 
germ cens and neuronal cens where it is mainly expressed in nucleus; 
• E3HistoneILASUI is widely expressed in different epithelia; 
• E3HistoneILASUI stimulates polyubiquitination of Mcl-l in vitro; 
• Deletion ofE3Histone/LASUI protein expression did not change the levels offree 
histones and ubiquitination of histones in HEK 293 cens. 
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